<SEC-DOCUMENT>0001193805-23-001637.txt : 20231221
<SEC-HEADER>0001193805-23-001637.hdr.sgml : 20231221
<ACCEPTANCE-DATETIME>20231221083050
ACCESSION NUMBER:		0001193805-23-001637
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20231218
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231221
DATE AS OF CHANGE:		20231221

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMMUNIC, INC.
		CENTRAL INDEX KEY:			0001280776
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				562358443
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36201
		FILM NUMBER:		231502884

	BUSINESS ADDRESS:	
		STREET 1:		1200 AVENUE OF THE AMERICAS
		STREET 2:		SUITE 200
		CITY:			NEW YORK
		STATE:			X1
		ZIP:			10036
		BUSINESS PHONE:		(332) 255-9818

	MAIL ADDRESS:	
		STREET 1:		1200 AVENUE OF THE AMERICAS
		STREET 2:		SUITE 200
		CITY:			NEW YORK
		STATE:			X1
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	VITAL THERAPIES INC
		DATE OF NAME CHANGE:	20040219
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>e619130_8k-immunic.htm
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:IMUX="http://imux.com/20231218">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_IMUX_imux.com_20231218 -->
<!-- Field: Set; Name: xdx; ID: xdx_048_20231218_20231218 -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0001280776 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:EntityCentralIndexKey">0001280776</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="imux-20231218.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2023-12-18">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001280776</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-12-18</xbrli:startDate>
        <xbrli:endDate>2023-12-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM <span id="xdx_909_edei--DocumentType_c20231218__20231218_zwqik4Pt6Q0e"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT<br />
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report (Date of earliest event reported):
<span id="xdx_90E_edei--DocumentPeriodEndDate_c20231218__20231218_zSYEd5TXmBDb"><ix:nonNumeric contextRef="AsOf2023-12-18" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 18, 2023</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90B_edei--EntityRegistrantName_c20231218__20231218_zzqJ6czTvc1e"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:EntityRegistrantName">IMMUNIC, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Exact name of registrant as specified in its
charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="text-align: center; width: 30%"><b><span id="xdx_90A_edei--EntityIncorporationStateCountryCode_c20231218__20231218_zhMUoZzv0WK"><ix:nonNumeric contextRef="AsOf2023-12-18" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 30%"><b><span id="xdx_902_edei--EntityFileNumber_c20231218__20231218_zjjEnyDAgM3c"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:EntityFileNumber">001-36201</ix:nonNumeric></span></b></td>
    <td style="text-align: center; width: 30%"><b><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20231218__20231218_zi4xdUTFdzk4"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:EntityTaxIdentificationNumber">56-2358443</ix:nonNumeric></span></b></td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: center"><b>(State or other jurisdiction<br />
of incorporation)</b></td>
    <td style="text-align: center"><b>(Commission File Number)</b></td>
    <td style="text-align: center"><b>(IRS Employer Identification No.)</b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20231218__20231218_zBSvubfCq68c"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:EntityAddressAddressLine1">1200 Avenue of the Americas</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressAddressLine2_c20231218__20231218_z4y7uFgJ1fJ4"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:EntityAddressAddressLine2">Suite 200</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90A_edei--EntityAddressCityOrTown_c20231218__20231218_zzN7xzFhhY2f"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:EntityAddressCityOrTown">New York</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressStateOrProvince_c20231218__20231218_zOKovsBKIj5h"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:EntityAddressStateOrProvince">NY</ix:nonNumeric></span> <span id="xdx_90E_edei--EntityAddressPostalZipCode_c20231218__20231218_z641XmK0AgM8"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:EntityAddressPostalZipCode">10036</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityAddressCountry_c20231218__20231218_zHf3Cj8ELg9i"><ix:nonNumeric contextRef="AsOf2023-12-18" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">USA</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Address of principal executive offices)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Registrant&#8217;s telephone number, including
area code: <span id="xdx_909_edei--CityAreaCode_c20231218__20231218_zlV2oRWwlLDb"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:CityAreaCode">(332)</ix:nonNumeric></span> <span id="xdx_90F_edei--LocalPhoneNumber_c20231218__20231218_zCUNzJnq9JW4"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:LocalPhoneNumber">255-9818</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90C_edei--WrittenCommunications_c20231218__20231218_z2mCN2HCA3ye"><ix:nonNumeric contextRef="AsOf2023-12-18" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_904_edei--SolicitingMaterial_c20231218__20231218_zLlUDJv7bwV1"><ix:nonNumeric contextRef="AsOf2023-12-18" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--PreCommencementTenderOffer_c20231218__20231218_zvojCcB7EU5k"><ix:nonNumeric contextRef="AsOf2023-12-18" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_90F_edei--PreCommencementIssuerTenderOffer_c20231218__20231218_zzeCzOPI5p6b"><ix:nonNumeric contextRef="AsOf2023-12-18" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="border: black 1pt solid; text-align: center; width: 35%">Title of each class</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center; width: 25%">Trading Symbol(s)</td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center">Name of exchange on which registered</td></tr>
  <tr style="vertical-align: top">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid"><b><span id="xdx_909_edei--Security12bTitle_c20231218__20231218_zZtbQZUhglE2"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:Security12bTitle">Common Stock, par value $0.0001</ix:nonNumeric></span></b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><b><span id="xdx_90B_edei--TradingSymbol_c20231218__20231218_ztO1GGgq91A9"><ix:nonNumeric contextRef="AsOf2023-12-18" name="dei:TradingSymbol">IMUX</ix:nonNumeric></span></b></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; text-align: center"><b><span id="xdx_90A_edei--SecurityExchangeName_c20231218__20231218_zKYfZW7kfPfk"><ix:nonNumeric contextRef="AsOf2023-12-18" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&#167; 240.12b2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Emerging growth company <span style="font-family: Times New Roman, Times, Serif"><span id="xdx_908_edei--EntityEmergingGrowthCompany_c20231218__20231218_zNRn6pnCMrt5"><ix:nonNumeric contextRef="AsOf2023-12-18" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act. Yes <span style="font-family: Times New Roman, Times, Serif">&#9744;</span> No <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; text-align: right; font-size: 8pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 5.02. Departure of Directors or Certain O&#64259;cers; Election
of Directors; Appointment of Certain O&#64259;cers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December 18, 2023, amendments were entered into to the service agreements
of various members of the management team (Vorstand) of Immunic AG, a wholly-owned subsidiary of Immunic, Inc. (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;).
Under German law, a company&#8217;s management team consists of employee members and is responsible for overseeing its daily business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dr. Daniel Vitt Agreement </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Immunic AG entered into a fifth addendum to the Service Agreement (as
amended, the &#8220;<span style="text-decoration: underline">Amended Vitt Agreement</span>&#8221;), dated September 29, 2016, as amended September 4, 2019, March 26, 2021, January
5, 2022 and January 16, 2023, between Immunic AG and Dr. Daniel Vitt, the Company&#8217;s Chief Executive Officer and President. Pursuant
to the Amended Vitt Agreement, Dr. Vitt will continue to serve on the management team of Immunic AG until December 31, 2026. Dr. Vitt
will receive an annual salary, effective January 1, 2024, of EUR 565,653, to be paid in 12 monthly installments, and a targeted yearly
bonus of up to EUR 311,573 upon achievement of certain targets. In connection with the Amended Vitt Agreement, Dr. Vitt was granted accelerated
vesting of stock options upon termination of employment under specified circumstances and a one-year exercise period following termination,
subject to specified conditions including providing post-employment assistance with the transition of his duties to other employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preceding summary does not purport to be complete and is qualified
in its entirety by reference to the Amended Vitt Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dr. Andreas Muehler Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Immunic AG entered into a fifth addendum to the Service Agreement (as
amended, the &#8220;<span style="text-decoration: underline">Amended Muehler Service Agreement</span>&#8221;), dated August 22, 2016, as amended September 4, 2019, June 2, 2021,
January 5, 2022 and January 16, 2023, between Immunic AG and Dr. Andreas Muehler, the Company&#8217;s Chief Medical Officer. Pursuant
to the Amended Muehler Service Agreement, Dr. Muehler will continue to serve on the management team of Immunic AG until December 31, 2026.
Dr. Muehler will receive an annual salary of EUR 231,825, to be paid in 12 monthly installments, and a targeted yearly bonus of up to
EUR 92,730 upon achievement of certain targets. In connection with the Amended Muehler Agreement, Dr. Muehler was granted accelerated
vesting of stock options upon termination of employment under specified circumstances and a one-year exercise period following termination,
subject to specified conditions including providing post-employment assistance with the transition of his duties to other employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr. Muehler also entered into a separate employment agreement (the
&#8220;<span style="text-decoration: underline">Muehler Employment Agreement</span>&#8221;) with the Company. The Muehler Employment Agreement provides that Dr. Muehler will continue
to serve as Chief Medical Officer until December 31, 2026, and will dedicate approximately 50% of his time to the affairs of the Company
and approximately 50% of his time to the affairs of Immunic AG. The Muehler Employment Agreement provides for an annual salary of $250,000
USD and an annual bonus of at least 40% of annual base salary upon achievement of certain targets. Dr. Muehler is also eligible for reimbursement
for certain expenses, and customary insurance and benefits programs of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preceding summaries do not purport to be complete and are qualified
in their entirety by reference to the Amended Muehler Service Agreement and Muehler Employment Agreement, which are filed as Exhibits
10.2 and 10.3 to this Current Report on Form 8-K and are incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Dr. Hella Kohlhof Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Immunic AG entered into a fifth addendum to the Service Agreement (as
amended, the &#8220;<span style="text-decoration: underline">Amended Kohlhof Agreement</span>&#8221;), dated September 29, 2016, as amended September 4, 2019, March 25, 2021,
January 5, 2022 and January 16, 2023, between Immunic AG and Dr. Hella Kohlhof, the Company&#8217;s Chief Scientific Officer. Pursuant
to the Amended Kohlhof Agreement, Dr. Kohlhof will continue to serve on the management team of Immunic AG until December 31, 2026. Dr.
Kohlhof will receive an annual salary of EUR 403,375, to be paid in 12 monthly installments, and a targeted yearly bonus of up to EUR
161,350 upon achievement of certain targets. In connection with the Amended Kohlhof Agreement, Dr. Kohlhof was granted accelerated vesting
of stock options upon termination of employment under specified circumstances and a one-year exercise period following termination, subject
to specified conditions including providing post-employment assistance with the transition of her duties to other employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preceding summary does not purport to be complete and is qualified
in its entirety by reference to the Amended Kohlhof Agreement, which is filed as Exhibit 10.4 to this Current Report on Form 8-K and is
incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; text-align: right; font-size: 8pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="width: 8%">
    <p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Exhibit
No.</b></p></td>
    <td style="width: 1%">&#160;</td>
    <td>
    <p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Exhibit Description</b></p></td></tr>
  <tr>
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top">10.1</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="e619130_ex10-1.htm">Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Daniel Vitt</a></td></tr>
  <tr>
    <td style="vertical-align: top">10.2</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="e619130_ex10-2.htm">Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Andreas Muehler</a></td></tr>
  <tr>
    <td style="vertical-align: top">10.3</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="e619130_ex10-3.htm">Employment Agreement, dated December 18, 2023, between Immunic, Inc. and Dr. Andreas Muehler</a></td></tr>
  <tr>
    <td style="vertical-align: top">10.4</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="e619130_ex10-4.htm">Fifth Addendum, dated December 18, 2023, to Service Agreement between Immunic AG and Dr. Hella Kohlhof</a></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt; text-align: right; font-size: 8pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td>Dated: December 21, 2023</td>
    <td colspan="2"><b>Immunic, Inc.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 50%">&#160;</td>
    <td style="width: 4%">&#160;</td>
    <td style="width: 35%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>By:</td>
    <td style="border-bottom: black 1pt solid">/s/ Daniel Vitt</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Daniel Vitt</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Chief Executive Officer</td></tr>
  </table>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

<p style="margin: 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwkAMhU/QO4RZS3+muLBLi4pYpZQibgebymA7KZnx70je0rFFDIEQ3vveE2ImNrTWHTKcllUBNfZDpxxChS0ymjN6R77dZeBvhRdtHSvjxvcH5uQZ9Mw8lLHywmi9a4tNBomMkkUkU4iTLE2h3Ivgq+dkWt2gcVp1oEwDJdPAGp3i15RQqycZ6l9j1RHZajI+Lown+Q0yTiQc6K4exFcLRZGLYDZOIDZMt+Fbc7OOelh12PsuO6H/DT4WdUlH -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>e619130_ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DIENSTVERTRAG</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SERVICE AGREEMENT</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">zwischen</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">between</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Immunic AG, <BR>
vertreten durch den Vorsitzenden des Aufsichtsrates</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Immunic AG, <BR>
represented by the Chairman of the Supervisory Board</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- nachfolgend &bdquo;Gesellschaft&quot; genannt -</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- hereinafter referred to as the &quot;Company&quot; -</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">und</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Herrn Daniel Vitt, </B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Mr. Daniel Vitt,</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- nachfolgend &bdquo;Vorstand&quot; genannt -</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- hereinafter referred to as the &quot;Board Member&quot; -</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Pr&auml;ambel</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-align: center; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Preamble</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Der Vorstand ist erstmalig mit Wirkung ab dem 01.01.2017 zum Mitglied des Vorstandes der Gesellschaft bestellt worden. Die letztmalige Bestellung zum Mitglied des Vorstandes endet mit Ablauf des 31.12.2023. Die dienstvertraglichen Beziehungen zwischen den Parteien werden durch den Dienstvertrag vom 29.&nbsp;September 2016 sowie diverser &Auml;nderungsvereinbarungen geregelt (&bdquo;Dienstvertrag&ldquo;). Der Vorstand ist mit <B>beigef&uuml;gten Aufsichtsratsbeschluss</B> erneut zum Mitglied des Vorstand der Gesellschaft bestellt worden, diesmal f&uuml;r den Zeitraum vom 01.01.2024 bis zum 31.12.2026 (&bdquo;Laufzeit&ldquo;). Dies vorausgeschickt, vereinbaren die Parteien den Dienstvertrag (einschlie&szlig;lich aller &Auml;nderungsvereinbarungen) mit Wirkung zum Ablauf des 31.12.2023 aufzuheben und durch den nachfolgenden neuen Dienstvertrag insgesamt f&uuml;r die Dauer der Laufzeit zu ersetzen. Diese Pr&auml;ambel ist integraler Bestandteil dieser Vereinbarung.</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board Member was appointed to the company's
    Board for the first time with effect from January 1, 2017. The last appointment as a member of the Board ends at the end of December 31,
    2023. The service contract between the parties is governed by the service contract dated September 29,&nbsp;2016 and various amendment
    agreements (&quot;Service Contract&quot;). The Board Member was reappointed to the company's Executive Board by the <B>attached Supervisory
    Board resolution</B>, this time for the period from January 1,&nbsp;2024 to December 31, 2026 (&quot;Term&quot;). With this in mind, the
    parties agree to terminate the Service Contract (including all amendment agreements) with effect from the end of December 31, 2023 and
    to replace it with the following new service contract in its entirety for the duration of the Term. This preamble is an integral part
    of this agreement.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 1<BR>
Aufgabenbereich und Pflichten</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 1<BR>
Responsibilities and Obligations</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Herr
Daniel Vitt wird f&uuml;r die Laufzeit als gesch&auml;ftsf&uuml;hrendes Vorstandsmitglied (Chief Executive Officer, CEO) der Gesellschaft
bestellt und vertritt die Gesellschaft gemeinsam mit einem Vorstand oder einem Prokuristen. Der Aufsichtsrat kann dem Vorstand Einzelvertretungsbefugnis
erteilen sowie von den Beschr&auml;nkungen des &sect;&nbsp;181 Alt. 2 BGB befreien.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Mr. Daniel Vitt is appointed as the executive Board Member (Chief Executive Officer, CEO) of the Company for the Term and represents the Company together with a member of the Management Board or an authorized signatory. The Supervisory Board may grant the Board Member sole power of representation as well as exemption from the restrictions of &sect; 181 Alt. 2 of the German Civil Code (BGB).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand f&uuml;hrt die Gesch&auml;fte der Gesellschaft nach Ma&szlig;gabe der Gesetze, der Satzung, der Gesch&auml;ftsordnung f&uuml;r den Vorstand und dieses Dienstvertrages. Der Vorstand hat insbesondere f&uuml;r die laut einer Gesch&auml;ftsordnung des Vorstands unter Zustimmungsvorbehalt stehenden Gesch&auml;fte und Ma&szlig;nahmen die Zustimmung des Aufsichtsrats einzuholen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall conduct the business of the Company in accordance with the law, the Articles of Association, the rules of procedure for the Management Board and this Service Agreement. In particular, the Board Member shall obtain the approval of the Supervisory Board for transactions and measures subject to approval in accordance with the rules of procedure of the Management Board.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dem Vorstand obliegen insbesondere die Aufgaben, die im Sinne des jeweiligen Gesch&auml;ftsverteilungsplans zum Gesch&auml;ftsbereich des gesch&auml;ftsf&uuml;hrenden Vorstandsmitglieds (CEO) geh&ouml;ren.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In particular, the Board Member is responsible for the tasks that belong to the business area of the executive Board Member (CEO) within the meaning of the respective schedule of responsibilities.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand &uuml;bernimmt auf Wunsch der Gesellschaft ohne weitere Verg&uuml;tung auch Positionen oder &Auml;mter bei mit der Gesellschaft verbundenen Unternehmen (&sect;&nbsp;15 AktG). Ebenso &uuml;bernimmt der Vorstand Positionen oder &Auml;mter bei Verb&auml;nden, Berufsvereinigungen oder sonstigen Organisationen, in denen die Gesellschaft oder ein verbundenes Unternehmen Mitglied ist. Ihm von dritter Seite diesbez&uuml;glich gew&auml;hrte Verg&uuml;tungen oder Aufwandsentsch&auml;digungen f&uuml;hrt der Vorstand an die Gesellschaft ab. Auf Wunsch der Gesellschaft legt der Vorstand im Interesse der Gesellschaft oder verbundener Unternehmen &uuml;bernommene Positionen oder &Auml;mter nieder und setzt sich nach besten Kr&auml;ften daf&uuml;r ein, dass von der Gesellschaft benannte Nachfolger in die Positionen oder &Auml;mter nachr&uuml;cken</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall, upon the Company's request, without any additional remuneration, also accept positions or offices in companies affiliated with the Company (Section&nbsp;15 Stock Corporation Act - <I>AktG</I>). In the same way, the Board Member shall also accept positions or offices in associations and professional or other organizations of which the Company or an affiliated Company is a member. The Board Member shall transfer to the Company any remuneration or allowances he receives from third parties in this respect. Upon the Company's request, the Board Member shall resign from any position or office accepted in the interests of the Company or an affiliated Company and he shall do his utmost to ensure that the person nominated by the Company shall succeed him in the position or office</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dienstort ist Gr&auml;felfing. Sofern die Pflichten nach diesem Vertrag es zulassen, ist der Vorstand frei in der Wahl des Ortes der Aus&uuml;bung seiner T&auml;tigkeit.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The place of work is Gr&auml;felfing. If the obligations according to this agreement allow it, the Board Member is free in the choice of the place of the exercise of its activity.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 2<BR>
Umfang der Dienste, Nebent&auml;tigkeiten</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 2<BR>
Scope of Service and Side Activity</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand stellt seine ganze Arbeitskraft und all sein Wissen und K&ouml;nnen in den Dienst der Gesellschaft. In der Bestimmung seiner T&auml;tigkeitszeiten ist der Vorstand im Rahmen der betrieblichen Erfordernisse frei.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall devote all his working capacity, knowledge and skills into the services of the Company. He shall be able to schedule his working hours, subject to business requirements.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die &Uuml;bernahme einer entgeltlichen Nebent&auml;tigkeit sowie von Aufsichts-rats-, Beirats- oder &auml;hnlichen Mandanten bedarf der vorherigen Zustimmung durch den Aufsichtsratsvorsitzenden.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The assumption of an ancillary commercial activity as well as mandates in a supervisory board or advisory board or similar mandates require the prior consent of the Chairman of the Supervisory Board.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dem Aufsichtsratsgremium ist bekannt, dass der Vorstand zum Zeitpunkt der Unterzeichnung dieses Vertrages die in <B>Anlage 2 </B>aufgelisteten Mandate innehat und erteilt zu deren Fortf&uuml;hrung seine Zustimmung.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Supervisory Board is aware that the Board Member holds the mandates listed in <B>Annex 2 </B>at the time of signing of this agreement and grants its approval to their continuation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>F&uuml;r den Vorstand gilt das Wettbewerbsverbot des &sect;&nbsp;88 AktG. W&auml;hrend der Dauer dieses Vertrages wird sich der Vorstand auch nicht an Unternehmen beteiligen, die mit der Gesellschaft in Wettbewerb stehen oder mit denen die Gesellschaft Gesch&auml;ftsverbindungen unterh&auml;lt, es sei denn, der Aufsichtsrat hat vorher seine schriftliche Zustimmung erteilt.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member is subject to the non-competition clause of Section 88 of the German Stock Corporations Act (AktG). During the term of this agreement, the Board Member will also not invest in companies that compete with the Company or with which the Company has business relationships, unless the Supervisory Board has given its prior written consent.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Das Wettbewerbsverbot gilt nicht f&uuml;r Beteiligungen an Unternehmen in Gestalt von Wertpapieren, die an B&ouml;rsen gehandelt und zum Zwecke der Kapitalanlage erworben werden. Dar&uuml;ber hinaus sind etwaig bestehende, vorrangige Regelungen aus einem Investment Agreement und/oder Shareholders' Agreement zu Wettbewerbsverboten bzw. erlaubten T&auml;tigkeiten des Vorstands zu beachten.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">The non-competition clause does not apply to interests in companies in the form of bonds traded on the stock exchange and acquired for the purpose of capital investment. In addition, any existing overriding regulation from an Investment Agreement and/or Shareholders' Agreement on restraints of competition or permitted activities of the Board Member must be observed.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 3<BR>
Verg&uuml;tung und Bonus</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 3<BR>
Remuneration and bonus</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand erh&auml;lt f&uuml;r seine T&auml;tigkeit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member receives for its activities</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.15pt">a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ein
festes Jahresgehalt <B>(&bdquo;Grundverg&uuml;tung&quot;) </B>in H&ouml;he von EUR 565,653 brutto, das in 12 gleichen Monatsraten jeweils
nachtr&auml;glich am Monatsletzten ausbezahlt wird. Sofern dieser Vertrag nicht w&auml;hrend der Dauer eines gesamten Kalenderjahres
besteht, wird das Jahresfestgehalt zeitanteilig gezahlt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp; </FONT>a fixed annual salary <B>(&quot;Basic Remuneration&quot;) </B>in the amount of EUR 565,653 gross, paid in 12 equal monthly instalments at the end of each month. If this agreement does not exist for the duration of an entire calendar year, the fixed annual salary shall be paid pro rata temporis.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.15pt">b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">eine
j&auml;hrliche variable Verg&uuml;tung, die bei 100-prozentigem Erreichen der festgelegten Jahresziele maximal EUR 311,573 brutto betr&auml;gt,
also 55 % der j&auml;hrlichen Grundverg&uuml;tung gem&auml;&szlig; Ziffer a) zuvor. Die Einzelheiten, insbesondere zum Verfahren der
Zielfestlegung, zur Feststellung der Zielerreichung und zur F&auml;lligkeit ergeben sich aus dem Rahmenvertrag zur Zielvereinbarung in
seiner jeweils geltenden Fassung. Die Art der Ziele, die Voraussetzungen f&uuml;r ihre Erreichung und ihre Gewichtung zueinander werden
f&uuml;r das jeweilige Gesch&auml;ftsjahr in einer gesonderten Zielfestlegung niedergelegt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp; </FONT>an annual variable remuneration of up to EUR 311,573 gross if the defined annual targets are achieved 100 percent, i.e. 55 % of the annual basic remuneration in accordance with a) above. The details, in particular with regard to the procedure for setting targets, determining the achievement of targets and the due date, are set out in the Framework Agreement regarding the targets (<I>Rahmenvertrag zur Zielvereinbarung</I>) in its current version. The nature of the objectives, the conditions for their achievement and their weighting in relation to each other are laid down for each financial year in a separate target setting.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 40%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt; width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Grundverg&uuml;tung und die variable Verg&uuml;tung werden j&auml;hrlich durch den Aufsichtsrat &uuml;berpr&uuml;ft. Dabei sind die wirtschaftliche Entwicklung der Gesellschaft sowie die pers&ouml;nliche Leistung des Vorstandes zu ber&uuml;cksichtigen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Basic Remuneration and the variable remuneration are reviewed annually by the Supervisory Board. The economic development of the Company and the personal performance of the Board Member must be taken into account.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Sagt eine dritte Person (einschlie&szlig;lich solcher Unternehmen, die mit der Gesellschaft verbunden sind) dem Vorstand Anteile an der Gesellschaft oder an mit der Gesellschaft verbundenen Unternehmen oder diesbez&uuml;gliche Optionen oder Anspr&uuml;che auf Optionen oder sogenannte Stock Appreciation Rights oder Phantom Stocks zu, so werden solche Zusagen weder Bestandteil des Dienstverh&auml;ltnisses zwischen den Parteien dieses Vertrages noch begr&uuml;nden sie Verpflichtungen der Gesellschaft.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event that a third party (including companies which are affiliated with the Company) promises the Board Member shares in the Company or in companies affiliated with the Company or options to acquire such shares or rights to such options or so-called stock appreciation rights or phantom Stocks, such promise shall neither become part of the Service Agreement between the parties to this Agreement nor create any obligations of the Company</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im &Uuml;brigen kann der Aufsichtsrat die Bez&uuml;ge des Vorstands insgesamt auf die angemessene H&ouml;he herabsetzen, wenn sich die Lage der Gesellschaft so verschlechtert, dass die Weitergew&auml;hrung der Bez&uuml;ge unbillig f&uuml;r die Gesellschaft w&auml;re; Ruhegehalt, Hinterbliebenenbez&uuml;ge und Leistungen verwandter Art k&ouml;nnen dabei nur in den ersten drei Jahren nach Ausscheiden aus der Gesellschaft herabgesetzt werden (&sect; 87 (2) AktG). Der Vorstand kann in diesem Fall diesen Dienstvertrag au&szlig;erordentlich mit einer Frist von sechs Wochen zum Schluss des n&auml;chsten Kalendervierteljahres nach Erkl&auml;rung der Herabsetzung k&uuml;ndigen (&sect; 87 (2) Satz 3 AktG). Entf&auml;llt eine verschlechterte Lage der Gesellschaft, ist die Herabstufung wieder r&uuml;ckg&auml;ngig zu machen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Otherwise, the Supervisory Board may reduce the total remuneration of the Board Member to the appropriate amount, if the situation of the Company deteriorates to such an extent that the continued granting of the remuneration would be inequitable for the Company; retirement pension, survivors benefits and benefits of a related kind may only be reduced in the first three years after leaving the Company (Section 87 (2) AktG). In this case, the Board Member may terminate this Service Agreement extraordinarily with six weeks' notice to the end of the next calendar quarter after declaration of the reduction (Section 87 (2) sentence 3 AktG). If a deterioration in the situation of society does not apply, the downgrade shall be reversed.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Ein Anspruch auf Verg&uuml;tung von &Uuml;berstunden, Sonntags-, Feiertags- oder sonstiger Mehrarbeit besteht nicht.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>There is no entitlement to remuneration for overtime, work on Sundays, public holidays or other additional work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 4<BR>
Versicherungen und Nebenleistungen</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 4<BR>
Insurance and Fringe Benefits</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Auch soweit keine gesetzliche Versicherungspflicht besteht, zahlt die Gesellschaft an das Vorstandsmitglied monatliche Zusch&uuml;sse zur Kranken-und Pflegeversicherung des Vorstandsmitglieds. Die einzelnen Zusch&uuml;sse entsprechen in ihrer H&ouml;he der H&auml;lfte der vom Vorstandsmitglied gezahlten Beitr&auml;ge, h&ouml;chstens jedoch dem jeweils unter Ber&uuml;cksichtigung der jeweils geltenden Beitragsbemessungsgrenzen gesetzlich geschuldeten H&ouml;chstbetrag des Arbeitgeberanteils der gesetzlichen Kranken- und Pflegeversicherung. Die von der Gesellschaft geschuldeten Zusch&uuml;sse werden dem Vorstandsmitglied jeweils am Kalendermonatsende gezahlt. Die auf diese Zahlungen etwaig anfallende Einkommensteuer tr&auml;gt das Vorstandsmitglied.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Even if there is no statutory insurance obligation, the Company shall pay the Board Member monthly health and long-term care insurance contributions for the Board Member. The individual contributions are in their amount equivalent to the amount of the contributions paid by the Board Member, but limited to the amount of the employer's contribution to the statutory health and long-term care insurance legally owed in each case, taking into account the applicable contribution assessment thresholds. The contributions owed by the Company are paid to the Board Member at the end of each calendar month. Any income tax payable on these payments shall be borne by the Board Member.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand erh&auml;lt in angemessenem Umfang f&uuml;r die im Gesellschaftsinteresse erforderlichen Aufwendungen Ersatz. Erforderliche Reisekosten werden gegen Einzelnachweis erstattet. Die darin enthaltenen Tage- und &Uuml;bernachtungsgelder k&ouml;nnen im Rahmen der steuerlich zul&auml;ssigen Betr&auml;ge auch pauschal abgerechnet werden.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall be reimbursed to an appropriate extent for the expenses required in the interest of the Company. Required travel expenses will be reimbursed against itemization. The daily and overnight allowances contained therein may also be settled as a lump sum within the limits of the amount permissible for tax purposes.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft kann den Vorstand nach ihrem Ermessen f&uuml;r die Dauer dieses Dienstvertrages im Rahmen einer Risiko-Lebensversicherung in H&ouml;he von EUR 500.000,00 f&uuml;r den Todesfall und im Rahmen einer Unfallversicherung in H&ouml;he von EUR&nbsp;700.000,00 f&uuml;r den Invalidit&auml;tsfall versichern bzw. eine bereits bestehende Versicherung fortf&uuml;hren. Der Vorstand hat das Recht, den/die Bezugsberechtigten zu bestimmen.</FONT></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>At its discretion, the Company may insure the Board Member for the duration of this Service Agreement under a risk life insurance policy in the amount of EUR 500,000.00 in the event of death and under an accident insurance policy in the amount of EUR&nbsp;700,000.00 in the event of disability or continue an existing insurance policy. The Board Member is entitled to determine the beneficiary/beneficiaries.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im Falle der &Uuml;bernahme einer bestehenden Direktversicherung kann diese gem&auml;&szlig; &sect;&nbsp;40 b EStG in ihrer geltenden Fassung weiter gef&uuml;hrt werden. Die pauschale Versteuerung &uuml;bernimmt in diesem Fall die Gesellschaft.</FONT></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event that an existing direct insurance policy is taken over, this insurance policy can be managed in its current version under Section 40 b German Income Tax Act (EStG). In this case, the lump sum taxation is paid by the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft bietet dem Vorstand die M&ouml;glichkeit zur Teilnahme an einer Pensionskasse, Unterst&uuml;tzungskasse oder einer &auml;hnlichen betrieblichen Altersversorgung (BAV) bzw. zur &Uuml;bernahme einer bereits bestehenden BAV. In diesem Zusammenhang kann der Vorstand einen Teil seiner Gehaltsanspr&uuml;che zugunsten einer betrieblichen Altersversorgungszusage umwandeln. Die dem Vorstand gem&auml;&szlig; &sect;&nbsp;3 (1) lit. a) gew&auml;hrte Grundverg&uuml;tung wird dabei mit Wirkung zum Beginn einer betrieblichen Altersversorgungszusage entsprechend um einen monatlichen Bruttobetrag gek&uuml;rzt, um in eine wertgleiche Zusage auf betriebliche Versorgungsleistung umgewandelt zu werden. In H&ouml;he dieses Betrags verringert sich der Anspruch des Vorstands auf Zahlung der Grundverg&uuml;tung. Sollte der Vorstand die Versorgungszusage im weiteren Verlauf ganz oder teilweise wieder k&uuml;ndigen oder ruhen lassen, so lebt der entsprechende Verg&uuml;tungsanspruch wieder auf.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Company offers the Board Member the opportunity to participate in a pension fund, support fund or similar company pension scheme (<I>betriebliche Altersvorsorge</I>, BAV) or to take over an existing BAV. In this context, the Board Member can convert part of its salary entitlements into a company pension commitment. The Basic Remuneration granted to the Board Member pursuant to &sect; 3 (1) lit. a) shall be reduced by a gross monthly amount with effect from the beginning of a company pension commitment to be converted into an equal-value commitment to company pension benefits. The Board Member's entitlement to payment of the Basic Remuneration is reduced by this amount. If the Board Member rescinds or suspends the pension commitment in whole or in part in the further course of the plan, the corresponding entitlement to compensation shall revive.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft schlie&szlig;t f&uuml;r den Vorstand eine Verm&ouml;gensschaden-Haftpflichtversicherung (D&amp;O) f&uuml;r den Fall ab, dass der Vorstand wegen einer in Aus&uuml;bung seiner T&auml;tigkeit begangenen Pflichtverletzung von einem Dritten oder der Gesellschaft aufgrund gesetzlicher Haftpflichtbestimmungen privatrechtlichen Inhalts f&uuml;r einen Verm&ouml;gensschaden in Anspruch genommen wird. Der Vorstand tr&auml;gt dabei eine Selbstbeteiligung in H&ouml;he des Mindestwerts gem&auml;&szlig; &sect;&nbsp;93 (2) AktG (derzeit je Schadensfall 10% des Schadens, maximal aber das 1<SUP>1</SUP>/<SUB>2</SUB>-fache der Grundverg&uuml;tung pro Jahr (j&auml;hrliche H&ouml;chstgrenze). Kommt es zu mehreren Schadensf&auml;llen in einem Jahr, gilt die j&auml;hrliche H&ouml;chstgrenze f&uuml;r alle Schadensf&auml;lle zusammen. Der Selbstbehalt passt sich bei &Auml;nderung der Grundverg&uuml;tung (bzw. bei &Auml;nderung von &sect;&nbsp;93 (2) AktG) automatisch an; der Vorstand ist verpflichtet, die entsprechenden &Auml;nderungen beim Selbstbehalt des D&amp;O Versicherungsvertrages zu veranlassen, und / oder s&auml;mtliche in diesem Zusammenhang erforderlichen Erkl&auml;rungen abzugeben. Das Bezugsjahr f&uuml;r den anzuwendenden Selbstbehalt ist das Jahr des Pflichtversto&szlig;es.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Company enters into a directors' and officers' liability insurance policy (D&amp;O) for the Board Member for the event that a third party or the Company makes a claim against the Board Member for a loss of assets due to a breach of duty committed in the performance of its duties due to statutory liability provisions under private law. The Board Member bears a deductible in the amount of the minimum value pursuant to Section 93 (2) of the German Stock Corporation Act (AktG) (currently 10% of the damage per claim, but not more than one and a half times the basic annual remuneration (annual maximum limit). In case of several loss events in one year, the annual maximum limit applies to all loss events in combination. The deductible is automatically adjusted in the event of a change in the Basic Remuneration (or in the event of a change in Section 93 (2) AktG); the Board Member is obliged to arrange for the corresponding changes to the deductible in the D&amp;O insurance agreement and / or to provide all declarations required in this regard. The reference year for the deductible to be applied is the year of the violation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 5<BR>
Urlaub</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 5<BR>
Holiday</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand hat Anspruch auf einen Jahresurlaub von 30 Arbeitstagen. Arbeitstage sind alle Kalendertage mit Ausnahme von Samstagen, Sonntagen und gesetzlichen Feiertagen am Sitz der Gesellschaft. Bei unterj&auml;hrigem Besch&auml;ftigungsbeginn oder -ende wird der Jahresurlaub in diesem Kalenderjahr zeitanteilig gew&auml;hrt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member is entitled to an annual vacation of 30 working days. Working days are all calendar days except Saturdays, Sundays and public holidays at the registered office of the Company. If employment begins or ends during the course of the year, annual vacation in this calendar year will be granted pro rata temporis.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Urlaubszeit ist unter Ber&uuml;cksichtigung der Gesch&auml;ftslage mit den anderen Vorstandsmitgliedern abzustimmen.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The holiday period shall be coordinated with the other members of the Executive Board, taking into account the business situation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 6<BR>
Bez&uuml;ge bei Krankheit, Arbeitsunf&auml;higkeit oder Tod</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 6<BR>
Beneficiaries in the event of illness, incapacity for work or death</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>lm Fall einer Dienstverhinderung (z.B. infolge Erkrankung) ist das Vorstandsmitglied verpflichtet, den Aufsichtsratsvorsitzenden der Gesellschaft unverz&uuml;glich &uuml;ber Grund und Dauer der Dienstverhinderung zu informieren und auf vordringlich zu erledigende Aufgaben hinzuweisen. Dauert die Dienstverhinderung l&auml;nger als eine Woche, hat das Vorstandsmitglied im Fall einer Erkrankung ein &auml;rztliches Attest oder im Fall einer sonstigen Dienstverhinderung eine schriftliche Erkl&auml;rung vorzulegen, woraus sich der Grund der Arbeitsunf&auml;higkeit sowie deren voraussichtliche Dauer ergeben.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of an unforeseen absence (e.g. due to illness), the Board Member is obliged to inform the Chairman of the Supervisory Board of the Company without undue delay of the reason for and probable duration of the impediment to service and draw the attention on the tasks to be performed urgently. If the absence lasts longer than one week, the Board Member must submit a medical certificate or in the event of any other incapacity or a written declaration in the event of any other disability, stating the reason for the incapacity and its probable duration.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Das Vorstandsmitglied tritt bereits jetzt etwaige (Schadensersatz-)Anspr&uuml;che in H&ouml;he der nach dieser Regelung von der Gesellschaft geleisteten oder zu leistenden Zahlungen an die Gesellschaft ab, die ihm gegen&uuml;ber Dritten wegen der Arbeitsverhinderung zustehen. Das Vorstandsmitglied ist verpflichtet, der Gesellschaft unverz&uuml;glich s&auml;mtliche zur Geltendmachung derartiger (Schadensersatz-)Anspr&uuml;che notwendigen Angaben zu machen sowie hierf&uuml;r notwendige Unterlagen zu &uuml;berlassen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Board Member hereby assigns to the Company any (compensation) claims in the amount of the payments made or to be made by the Company in accordance with this provision to which he is entitled in respect of third parties due to the impediment to work. The Board Member is obligated to provide the Company with all information necessary for asserting such (compensation) claims and to provide the Company with the necessary documents without undue delay.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Bei einer vor&uuml;bergehenden krankheitsbedingten oder sonstigen unverschuldeten Arbeitsunf&auml;higkeit des Vorstandes wird die Grundverg&uuml;tung gem&auml;&szlig; &sect; 3 (1) lit. a) w&auml;hrend der Zeit der Arbeitsunf&auml;higkeit bis zu einer Dauer von sechs Monaten, l&auml;ngstens jedoch bis zur Beendigung dieses Dienstvertrages weitergezahlt. Dauert die Arbeitsunf&auml;higkeit l&auml;nger als ununterbrochen 3 Monate an, kann der Aufsichtsrat die variable Verg&uuml;tung unter Ber&uuml;cksichtigung der Dauer der Arbeitsunf&auml;higkeit angemessen reduzieren.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of a temporary illness or other non-culpable incapacity to work, the basic remuneration pursuant to &sect; 3 (1) lit. a) shall continue to be paid during the period of the incapacity to work up to a period of six months, at the latest until the termination of this Service Agreement. If the incapacity to work lasts longer than three months without interruption, the Supervisory Board may reduce the variable remuneration by a reasonable amount, taking into account the duration of the incapacity to work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Bei einer dauernden Arbeitsunf&auml;higkeit des Vorstandes endet der Dienstvertrag mit dem Ende des Quartals, in dem die dauernde Arbeitsunf&auml;higkeit festgestellt worden ist.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of permanent incapacity to work of the Board Member, the employment agreement ends at the end of the quarter in which the permanent incapacity to work was determined.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ist der Vorstand l&auml;nger als sechs Monate au&szlig;erstande, seiner T&auml;tigkeit nachzugehen, kann der Aufsichtsrat verlangen, dass das Vorliegen einer dauernden Arbeitsunf&auml;higkeit durch einen von ihm ausgew&auml;hlten Arzt auf Kosten der Gesellschaft nachgepr&uuml;ft wird. Nimmt der Vorstand den Termin trotz zweimaliger Aufforderung durch den Aufsichtsrat nicht wahr, gilt der Vorstand als dauernd arbeitsunf&auml;hig. Die Aufforderungen haben mit einer Woche zeitlichen Abstands voneinander zu erfolgen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If the Board Member is unable to carry out its duties for more than six months, the Supervisory Board may demand that the existence of a permanent incapacity to work be reviewed by a doctor of its choice at the Company's expense. If the Board Member fails to meet the demand despite two requests by the Supervisory Board, the Board Member shall be deemed permanently incapacitated for work. The requests shall be made at intervals of one week.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Eine Abfindung ist bei einer Beendigung des Dienstvertrags wegen dauernder Arbeitsunf&auml;higkeit nicht zu leisten.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A severance payment shall not be made in the event of termination of the employment agreement due to permanent incapacity to work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Stirbt der Vorstand w&auml;hrend der Dauer des Dienstvertrages, ist die Grundverg&uuml;tung nach &sect; 3 (1) lit. a) noch f&uuml;r den Sterbemonat und f&uuml;r die zwei darauf folgenden Monate zu zahlen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>If the Board Member dies during the term of this Service Agreement, the Basic Remuneration according to &sect; 3 (1) lit. a) shall still be payable for the month of death and for the following two months.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Die Boni werden entsprechend den vertraglichen Regelungen durch den Aufsichtsrat festgelegt und an den Ehepartner, bei deren Fehlen an die unterhaltsberechtigten Kinder des Vorstands (letztere als Gesamtgl&auml;ubiger) oder seine Erben bezahlt.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">The bonuses pursuant are determined in accordance with the contractual regulations by the Supervisory Board and paid to the spouse, in the event of their absence to the dependent children of the Board Member (the latter as joint creditor) or his heirs.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 7<BR>
Sonderleistungen und Sonderk&uuml;ndigungsrecht bei Kontrollerwerb</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 7<BR>
Special services and special right of termination in the event of acquisition of control</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Kommt es nach der Unterzeichnung dieses Vertrags zu einem Kontrollerwerb im Sinne eines Anteilserwerbs von mehr als 50% durch einen Aktion&auml;r, Dritten oder gemeinsam handelnde Personen oder zu einer wirtschaftlich vergleichbaren Transaktion (z.B. Verkauf des Gesch&auml;ftsbetriebs oder eines wesentlichen Teils davon durch die Gesellschaft, Verkauf von wesentlichen Beteiligungsgesellschaften der Gesellschaft, Verschmelzung auf ein anderes Unternehmen, Verkauf von mehr als 50% der Anteile der Gesellschaft nach einem &bdquo;Delisting&quot; der Gesellschaft, etc.) und will sich die Gesellschaft in diesem Zusammenhang oder in dessen Folge von dem Vorstand durch vorzeitige Vertragsaufl&ouml;sung trennen, ohne hierf&uuml;r einen wichtigen Grund im Sinn des &sect; 626 BGB zu haben, so erh&auml;lt der Vorstand zus&auml;tzlich zu der Verg&uuml;tung und allen Leistungen, die ihm bis zum Trennungszeitpunkt zustehen, eine Abfindung. Die H&ouml;he der Abfindung entspricht der Grundverg&uuml;tung die der Vorstand bis zum Ablauf der in &sect; 10 (1) definierten Dauer gem&auml;&szlig; diesem Vertrag erhalten hatte, w&auml;re der Vertrag nicht vorzeitig beendet, sondern bis zum Ende der vollen Amtszeit erf&uuml;llt worden zuz&uuml;glich eines Erh&ouml;hungsbetrages, der 100 % des Anspruchs auf variable Leistungen im Jahr des Austritts entspricht. Betr&auml;gt die ordentliche Laufzeit dieses Vertrages gem&auml;&szlig; &sect;&nbsp;10 (1) zum Zeitpunkt des Wirksamwerdens der Trennung nach diesem Absatz weniger als 18 Monate, berechnet sich die zu zahlende Abfindung auf Basis einer fiktiven Restlaufzeit von 18 Monaten, d.&nbsp;h. die Abfindung wird berechnet auf Basis einer angenommenen Restlaufzeit von mindestens 18 Monaten. </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>If, after the signing of this Agreement, control is acquired in the sense of a share acquisition of more than 50% by a shareholder, third party or persons acting jointly or in the sense of an economically comparable transaction (e.g. sale of the business operations or a substantial part thereof by the Company, sale of substantial associated companies of the Company, merger with another company, sale of more than 50% of the shares of the Company after a delisting of the Company, etc.) and if the Company wishes to terminate the agreement with the Board Member in this context or as a result thereof by early termination of the agreement without having an important reason within the meaning of Section 626 of the German Civil Code (BGB), the Board Member shall receive a severance payment in addition to the remuneration and all benefits to which it is entitled up to the time of termination. The amount of the severance payment corresponds to the basic remuneration that the Board Member would have received until expiry of the term defined in &sect; 10 (1) of this agreement, if the agreement would not have been terminated prematurely, but would have been fulfilled up until the end of the full term of office, plus an increase amount corresponding to 100 % of the entitlement to variable benefits in the year of departure. If the ordinary term of this agreement pursuant to &sect; 10 (1) is less than 18 months at the time the separation pursuant to this paragraph takes effect, the severance payment to be made shall be calculated on the basis of a fictitious remaining term of 18 months, i.e. the severance payment shall be calculated on the basis of an assumed remaining term of at least 18 months.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">W&auml;hrend der Vertragslaufzeit stattfindende Anhebungen der Verg&uuml;tung gem&auml;&szlig; &sect; 3 (1) werden bei den beschriebenen Berechnungen ber&uuml;cksichtigt.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any increases in remuneration in accordance with &sect; 3 (1) that take place during the term of the agreement shall be taken into account in the calculations described.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soweit der Vorstand im Rahmen dieser Regelung aus den Diensten der Gesellschaft ausscheidet, wird beim Bonus gem&auml;&szlig; &sect; 3 Ziffer 1 b) f&uuml;r das Jahr des Austritts eine Zielerreichung in H&ouml;he von 100 % unterstellt, soweit die tats&auml;chliche Zielerreichung niedriger liegt. </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If the Board Member leaves the services of the Company under this provision, a target achievement of 100% is assumed for the bonus pursuant to Section 3 (1) b) for the year of departure if the actual target achievement is lower.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Abfindung ist in voller H&ouml;he zusammen mit dem Gehalt f&uuml;r den Monat, zu dessen Ende die Trennung nach Absatz (1) wirksam wird, zur Zahlung f&auml;llig.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The severance payment shall be payable in full together with the salary for the month at the end of which the separation referred to in paragraph (1) takes effect.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im Falle dieses Absatzes (1) wird dem Vorstand ein au&szlig;erordentliches Sonderk&uuml;ndigungsrecht zu diesem Dienstvertrag einger&auml;umt. Das Sonderk&uuml;ndigungsrecht kann innerhalb von sechs Wochen ab Kenntnis des Vorstands &uuml;ber den rechtskr&auml;ftigen Vollzug des Kontrollwechsels im Sinne des Absatzes (1) mit einer Frist von drei Monaten zum Monatsende ausge&uuml;bt werden. Dar&uuml;ber hinaus besteht ein Sonderk&uuml;ndigungsrecht des Vorstands auch dann, wenn der Vorstand innerhalb von einem Jahr nach Vollzug des Kontrollwechsels abberufen wird. In diesem Fall betr&auml;gt die Sonderk&uuml;ndigungsfrist zwei Wochen. Die K&uuml;ndigung kann innerhalb von vier Wochen nach Abberufung durch den Vorstand erkl&auml;rt werden.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of this paragraph (1), the Board Member shall be granted an extraordinary right of termination of this Service Agreement. The special right of termination may be exercised within six weeks of the knowledge of the Board Member of the legally binding execution of the change of control within the meaning of paragraph (1) with a notice period of three months to the end of the month. In addition, the Board Member has a special right of termination even if the Board Member is dismissed within one year of the completion of the change of control. In this case, the special notice period is two weeks. The termination may be declared by the Board Member within four weeks after dismissal.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 8<BR>
Diensterfindungen und Schutzrechte</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 8<BR>
Service inventions and industrial property rights</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Erfindungen des Vorstands sowie seine technischen oder organisatorischen Verbesserungsvorschl&auml;ge werden entsprechend den jeweils geltenden Bestimmungen des Gesetzes &uuml;ber Arbeitnehmererfindungen vom 25.7.1957 mit folgender Ma&szlig;gabe behandelt: Der Vorstand wird der Gesellschaft Diensterfindungen, freie Erfindungen und technische wie organisatorische Verbesserungsvorschl&auml;ge unverz&uuml;glich melden und der Gesellschaft zur ausschlie&szlig;lichen, beschr&auml;nkten oder unbeschr&auml;nkten Inanspruchnahme anbieten. Die Erkl&auml;rung der Inanspruchnahme hat seitens der Gesellschaft innerhalb von vier Monaten nach der Meldung zu erfolgen. Die Gesellschaft hat das Recht, jedoch nicht die Verpflichtung, zur Anmeldung von Schutzrechten im In- und Ausland. Im Fall einer Diensterfindung oder eines technischen oder organisatorischen Verbesserungsvorschlags sind sich die Parteien darin einig, dass eine etwaige Verg&uuml;tung f&uuml;r eine von der Gesellschaft in Anspruch genommene Diensterfindung mit der Zahlung der Grundverg&uuml;tung nach &sect; 3 (1) lit. a) dieses Vertrages vollst&auml;ndig abgegolten ist. Im Fall einer freien Erfindung ist dem Vorstandsmitglied eine markt&uuml;bliche Verg&uuml;tung zu zahlen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Inventions by the Board Member and its technical or suggestions for organizational improvements shall be treated in accordance with the applicable provisions of the Act on Employee Inventions of 25 July 1957, subject to the following provisions: The Board Member will immediately notify the Company of job-related inventions, free inventions and technical and organizational suggestions for improvement and offer them to the Company for exclusive, limited or unlimited use. The Company must declare the claim within four months of notification. The Company is entitled, but not obliged, to register intellectual property rights in Germany and abroad. In the case of a job-related invention or a technical or organizational suggestion for improvement, the parties agree that any remuneration for a service invention claimed by the Company shall be paid in full upon payment of the basic remuneration pursuant to &sect; 3 (1) lit. a) of this Agreement. In the case of a free invention, the Board Member shall be paid remuneration in line with market-based conditions.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand &uuml;bertr&auml;gt der Gesellschaft ausschlie&szlig;liche, zeitlich, r&auml;umlich und inhaltlich unbeschr&auml;nkte Nutzungs- und Verwertungsrechte f&uuml;r alle etwaigen nach dem Urhebergesetz schutzf&auml;higen T&auml;tigkeitsergebnisse, die das Vorstandsmitglied w&auml;hrend der Dauer seines Dienstvertrages w&auml;hrend seiner Arbeitszeit oder, sofern sie Bezug zu seinen dienstvertraglichen Aufgaben haben, auch au&szlig;erhalb seiner Arbeitszeit erstellt. Die &Uuml;bertragung der urheberrechtlichen Nutzungs- und Verwertungsrechte umfasst auch etwaige bei Vertragsschluss noch unbekannte Nutzungsarten. Die &Uuml;bertragung der Nutzungs- und Verwertungsrechte umfasst insbesondere auch die Erlaubnis zur Bearbeitung und Lizenzvergabe an Dritte. Das Vorstandsmitglied verzichtet ausdr&uuml;cklich auf sonstige ihm etwa als Urheber zustehende Rechte an den T&auml;tigkeitsergebnissen, insbesondere auf das Recht auf Namensnennung, auf Bearbeitung und auf Zug&auml;nglichmachung des Werkes.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall grant the Company exclusive rights of use and exploitation, unlimited in terms of time, space and content, for any works which may be protected under the Copyright Act and which the Board Member produces during the term of this Service Agreement during his working hours or, if they relate to his duties under the Service Agreement, also outside of his working hours. The transfer of the copyrighted rights of use and exploitation also includes any types of use still unknown at the time of conclusion of the agreement. The transfer of the rights of use and exploitation includes in particular the permission for processing and licensing to third parties. The Board Member expressly waives any other rights to the works, which he is entitled as the author, in particular the right to name, edit and make accessible the work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Soweit T&auml;tigkeitsergebnisse, die der Vorstand w&auml;hrend der Dauer seines Dienstvertrages w&auml;hrend seiner Arbeitszeit oder, sofern sie Bezug zu seinen dienstvertraglichen Aufgaben haben, auch au&szlig;erhalb seiner Arbeitszeit erstellt, nicht bereits nach Absatz (1) und (2) &uuml;bertragen sind, &uuml;bertr&auml;gt der Vorstand der Gesellschaft s&auml;mtliche Rechte an diesen T&auml;tigkeitsergebnissen, insbesondere Marken- und sonstige Kennzeichenrechte sowie eingetragene Designs.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Insofar as works which the Board Member produces during the term of its Service Agreement, during its working hours or, insofar as they relate to its duties under the Service Agreement, also outside its working hours, have not already been transferred in accordance with paragraphs (1) and (2), the Board Member shall transfer to the Company all rights to these works, in particular trademark and other distinctive rights as well as registered designs.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Parteien sind sich einig, dass die Einr&auml;umung dieser Rechte und der Verzicht auf Rechte nach dieser Regelung vollumf&auml;nglich mit der Zahlung der Grundverg&uuml;tung nach &sect;&nbsp;3 (1) lit. a) dieses Vertrages abgegolten sind, soweit dem nicht zwingende gesetzliche Regelungen entgegenstehen. Der Vorstand ist verpflichtet, jedwedes seiner schutzrechtsf&auml;higen T&auml;tigkeitsergebnisse unverz&uuml;glich der Gesellschaft, vertreten durch den Aufsichtsrat, zu meiden und die Gesellschaft im erforderlichen Umfang, auch nach Beendigung dieses Dienstvertrages, bei der Erlangung von Schutzrechten zu unterst&uuml;tzen. Soweit der Vorstand seine Mitwirkungspflichten nach der Beendigung dieses Dienstvertrages erf&uuml;llt, erh&auml;lt der Vorstand hierf&uuml;r einen angemessenen Tagessatz sowie eine Erstattung aller Aufwendungen, die ihm durch seine Mitwirkung entstanden sind.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The parties agree that the granting of these rights and the waiver of rights under this provision are fully covered by the payment of the Basic Remuneration under &sect; 3 (1) lit. a) this agreement, unless otherwise provided for by mandatory legal provisions. The Board Member is obliged to notify any of the works that are capable of being protected by intellectual property rights without delay to the Company, represented by the Supervisory Board, and to support the Company to the necessary extent, even after termination of this Service Agreement, in obtaining intellectual property rights. To the extent that the Board Member fulfils its duties to cooperate after the termination of this Service Agreement, the Board Member shall receive an appropriate daily rate as well as a reimbursement of all expenses incurred by him resulting from his cooperation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 9<BR>
Geheimhaltung und R&uuml;ckgabe von Unterlagen, Interessenkonflikte</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 9<BR>
Confidentiality and return of documents, conflicts of interest</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand verpflichtet sich, &uuml;ber alle ihm im Rahmen seiner T&auml;tigkeit oder sonst zur Kenntnis gelangenden gesch&auml;ftlichen und betrieblichen Angelegenheiten der Gesellschaft und aller Verbundenen Unternehmen strengstes Stillschweigen zu bewahren, einschlie&szlig;lich des Inhalts dieses Dienstvertrages sowie den Vertragsverhandlungen, die dem Abschluss dieses Dienstvertrages zugrunde liegen. Der Vorstand verpflichtet sich weiterhin, diese Informationen nicht f&uuml;r den eigenen oder den Nutzen anderer zu verwenden und alle solche gesch&auml;ftlichen und betrieblichen Angelegenheiten betreffenden Gesch&auml;ftsunterlagen der Gesellschaft und der Verbundenen Unternehmen unter Verschluss zu halten. Unter gesch&auml;ftlichen und betrieblichen Angelegenheiten im Sinne dieser Regelung verstehen die Parteien insbesondere Gesch&auml;fts- und Betriebsgeheimnisse sowie alle Informationen und Daten mit Bezug zu vertraulichen Angelegenheiten und gesch&auml;ftsbezogenem Know-how, s&auml;mtliche Informationen &uuml;ber alle mit dem existenten oder k&uuml;nftigen Gesch&auml;ft der Gesellschaft und der Verbundenen Unternehmen in Zusammenhang stehenden Gesch&auml;ftspl&auml;ne und Gesch&auml;ftsstrategien, Verfahren, Preis- oder Marktstrategien und Produkt-, Dienstleistungs- oder Entwicklungsplanungen, geplante Unternehmenserwerbe oder -ver&auml;u&szlig;erungen, s&auml;mtliche Gesch&auml;ftszahlen und Details der organisatorischen Strukturen sowie die wesentlichen Ideen und Prinzipien, welche diesen Strategien und Planungen zugrunde liegen, und alle Informationen, von denen vern&uuml;nftigerweise erwartet werden kann, dass sie zu solchen Strategien oder Planungen f&uuml;hren w&uuml;rden und die von der Gesellschaft, von Verbundenen Unternehmen oder dem Vorstandsmitglied w&auml;hrend der Dauer dieses Dienstvertrages erdacht, erfunden, &uuml;berarbeitet, entdeckt, entwickelt, erworben, beurteilt, getestet oder angewendet worden sind.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member undertakes to maintain the strictest secrecy with regard to all business and operational matters of the Company and old affiliated companies that come to its attention in the course of its activities or otherwise, including the contents of this Service Agreement and the negotiations on which the conclusion of this Service Agreement is based. The Board Member further undertakes not to use this information for its own benefit or for the benefit of others and to keep all business documents of the Company and its affiliates relating to such business and operational matters under lock and key. For the purposes of this provision, business and operational matters shall mean, in particular, business and trade secrets and all information and data relating to confidential matters and business-related know-how, all information, all business plans and strategies, procedures, price or market strategies and product, service or development plans relating to the existing or future business of the Company and its affiliates, planned corporate acquisitions or disposals, all business figures and details of the organizational structures and the principal ideas and principles underlying such strategies and plans, and all information that can reasonably be expected to result in such strategies or plans and that has been invented, redacted, discovered, developed, assessed, tested or applied by the Company, its affiliates or the Board Member during the term of this Service Agreement.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Geheimhaltungsverpflichtung nach vorstehendem Absatz (1) dauert auch nach Beendigung des Dienstverh&auml;ltnisses fort. Im Rahmen einer von dem Vorstand nach Beendigung dieses Dienstvertrages ausge&uuml;bten beruflichen oder unternehmerischen T&auml;tigkeit kann er sein als Vorstandsmitglied erworbenes Wissen einsetzen, sofern dabei die gesetzlichen Beschr&auml;nkungen &ndash; insbesondere nach &sect;&sect; 3, 17 UWG, &sect;&nbsp;823 (1) und (2) BGB i.V.m. UWG, &sect;&nbsp;826 BGB und den datenschutzrechtlichen Regelungen &ndash; sowie die Beschr&auml;nkungen aus dem nachvertraglichen Wettbewerbsverbot nach &sect;&nbsp;16 dieses Vertrages strikt beachtet werden.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The obligation to maintain secrecy pursuant to paragraph (1) above shall continue even after the termination of the employment relationship. The Board Member may use the knowledge acquired as a Board Member within the scope of a professional or entrepreneurial activity carried out by the Board Member after termination of this Service Agreement, provided that he complies with the statutory restrictions - in particular Sections 3, 17 UWG, Section 823 (1) and (2) BGB in conjunction with Sections 3, 17 UWG, Section 823 (1) and (2) BGB associated with UWG, Section 826 BGB and the data protection regulations.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand ist verpflichtet, in Zweifelsf&auml;llen &uuml;ber den Umfang der Geheimhaltungsverpflichtung nach vorstehenden Abs&auml;tzen (1) und (2) mit dem Aufsichtsrat der Gesellschaft eine Kl&auml;rung herbeizuf&uuml;hren.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In cases of doubt, the Board Member is obliged to reach a clarification with the Supervisory Board of the Company regarding the scope of the confidentiality obligation pursuant to paragraphs (1) and (2) above.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand verpflichtet sich, auf Verlangen der Gesellschaft jederzeit und sp&auml;testens bei Ende seiner Bestellung zum Organ auch ohne gesonderte Aufforderung alle in seinem Besitz befindlichen Unterlagen der Gesellschaft oder Verbundener Unternehmen, insbesondere alle Notizen, Memoranden, Aufzeichnungen, Protokolle und Berichte, Akten sowie alle anderen &auml;hnlichen Dokumente (einschlie&szlig;lich Abschriften, Ablichtungen, Kopien oder sonstiger Reproduktionen), die im Zusammenhang mit seiner T&auml;tigkeit stehen, unverz&uuml;glich und vollst&auml;ndig an die Gesellschaft zur&uuml;ckzugeben. Ein Zur&uuml;ckbehaltungsrecht ist ausgeschlossen. Diese Regelung gilt sinngem&auml;&szlig; f&uuml;r elektronisch gespeicherte Daten sowie die jeweiligen Daten- oder Programmtr&auml;ger.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member undertakes, at the request of the Company at any time and at the latest at the end of its appointment to the board and without separate request, to return to the Company all documents of the Company or affiliated companies in its possession, in particular all notes, memoranda, records, minutes and reports, files as well as all other similar documents (including copies, photocopies or other reproductions) in connection with its activities without delay and in full. A right of retention is excluded. This provision applies to electronically stored data as well as to the respective data or program carriers.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Herausgabeverpflichtung bezieht sich auch auf sonstiges, im Besitz des Vorstands befindliches Eigentum der Gesellschaft oder Verbundener Unternehmen bzw. von der Gesellschaft oder von einem Verbundenen Unternehmen geleaste Gegenst&auml;nde. Diese Herausgabeverpflichtung erstreckt sich insbesondere auch auf ein dem Vorstand etwa &uuml;berlassenes Mobiltelefon, Laptop oder sonstige Ger&auml;te der Datenverarbeitung, bei Ende seiner Bestellung zum Organ auch, wenn insoweit eine private Nutzung gestattet war.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The release obligation also applies to other property of the Company or affiliates or items leased by the Company or an affiliate that is in possession of the Board Member. This release obligation also extends in particular to a mobile phone, laptop or other data processing device left in the possession of the Board Member, at the end of its appointment to the Board even if private use was permitted in this respect.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand hat m&ouml;gliche und tats&auml;chliche Interessenkonflikte unverz&uuml;glich dem Aufsichtsrat gegen&uuml;ber offenzulegen und die anderen Vorstandsmitglieder hier&uuml;ber zu informieren.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member must immediately disclose possible and actual conflicts of interest to the Supervisory Board and inform the other members of the Management Board hereof.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 10<BR>
Vertragsdauer, Beendigung, Abfindung</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 10<BR>
Term of the Agreement, Termination, Severance</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Dienstvertrag beginnt mit dem 01.01.2024 (&bdquo;<B>Stichtagsdatum</B>&ldquo;) und endet zum Ablauf des 31.12.2026 (&bdquo;<B>Beendigungsdatum&ldquo;</B>).</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.15pt; text-align: justify; text-indent: -16.15pt">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;
</FONT>The Service Agreement commences on January 01, 2024 (&ldquo;<B>Effective Date</B>&rdquo;) and ends on December 31, 2026 (&ldquo;<B>Completion
Date</B>&rdquo;).</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Das Recht zur au&szlig;erordentlichen K&uuml;ndigung bleibt unber&uuml;hrt.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The right to extraordinary termination remains unaffected.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im Fall eines Widerrufs der Bestellung, der Amtsniederlegung durch das Vorstandsmitglied oder bei einer sonstigen Beendigung der Organstellung endet dieser Dienstvertrag mit Ablauf von drei Monaten nach dem Ende des Amtes, sp&auml;testens jedoch zum Ende der Laufzeit nach Absatz (1). Eine etwaige fr&uuml;here Beendigung aufgrund Absatz (2) dieses Vertrages bleibt unber&uuml;hrt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of revocation of the appointment, demission by the Board Member or other termination of the position, this Service Agreement shall end at the end of three months after the end of the term of office, at the latest, however, at the end of the term pursuant to paragraph (1). A possible termination due to paragraph (2) of this agreement remains unaffected.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorsitzende des Aufsichtsrats wird dem Vorstand sp&auml;testens drei Monate vor Ablauf dieses Vertrages, also bis zum 30. September 2026, schriftlich mitteilen, ob und unter welchen Bedingungen der Aufsichtsrat den Vorstand erneut zum Vorstandsmitglied bestellen wird und ob er bereit ist, den Dienstvertrag entsprechend der Dauer der neuen Bestellung zu verl&auml;ngern oder einen neuen Dienstvertrag zu mindestens gleichen Bedingungen mit ihm abzuschlie&szlig;en, Der Vorstand wird innerhalb von zwei Monaten ab Zugang des Angebots des Aufsichtsratsvorsitzenden erkl&auml;ren, ob er die erneute Bestellung annimmt und bereit ist, den f&uuml;r die Fortsetzung oder Erneuerung des Dienstvertrages angebotenen Bedingungen zuzustimmen.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Chairman of the Supervisory Board will inform the Board Member in writing no later than three months before the expiry of this agreement, i.e. by 30 September 2026, whether and under what conditions the Supervisory Board will reappoint the Board Member and whether he is willing to extend the Service Agreement for the duration of the new appointment or to conclude a new Service Agreement on at least the same terms. Within two months of receipt of the Supervisory Board Chairman's offer, the Board Member will declare whether it accepts the reappointment and is prepared to agree to the terms and conditions offered for the continuation or renewal of the Service Agreement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft ist berechtigt, den Vorstand nach dem Widerruf seiner Bestellung gem&auml;&szlig; &sect; 84 (3) AktG oder im Zusammenhang mit einer Beendigung des Dienstvertrages, insbesondere nach einer K&uuml;ndigung oder im Anschluss an den Abschluss eines Aufhebungsvertrages, ganz oder teilweise von seiner Pflicht zur Dienstleistung unter Fortzahlung der Grundverg&uuml;tung gem&auml;&szlig; &sect; 3 (1) lit. a) widerruflich oder unwiderruflich freizustellen. Im Fall der unwiderruflichen Freistellung werden offene Urlaubs- und sonstige Freizeitausgleichsanspr&uuml;che angerechnet, die damit erledigt sind. Der Dienstvertrag im &Uuml;brigen wird von der Freistellung nicht ber&uuml;hrt; insoweit bestehen insbesondere die Verschwiegenheitspflicht und das vertragliche Wettbewerbsverbot bis zum Ende des Dienstvertrages fort. Anderweitiger Verdienst w&auml;hrend der Freistellungszeit wird gem&auml;&szlig; &sect; 615 Satz 2 BGB angerechnet. Eine Anrechnung erfolgt nicht, wenn und soweit der anderweitige Verdienst aus einer genehmigten Nebent&auml;tigkeit (&sect; 2 (1) dieses Dienstvertrages) stammt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Company is entitled, after the revocation of its appointment pursuant to Section 84 (3) AktG or in connection with a termination of the Service Agreement, in particular following a termination or following the conclusion of a termination agreement, to release the Board Member in whole or in part from its obligation to provide services with continued payment of the Basic Remuneration pursuant to &sect; 3 (1) a) revocably or irrevocably. In the event of irrevocable release, receivable holiday and other time off compensation claims shall be credited and settled. The rest of the Service Agreement is not affected by the indemnification; in this respect, the obligation to maintain secrecy and the contractual non-competition clause continue to apply until the end of the Service Agreement. Other earnings during the exemption period shall be credited in accordance with Section 615 sentence 2 BGB. Crediting does not take place if and as far as the other earnings originate from an approved secondary activity (&sect; 2 (1) of this Service Agreement).</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Dienstvertrag endet sp&auml;testens am Ende des Kalenderjahres, in dem das Vorstandsmitglied sein 65. Lebensjahr vollendet, sofern dieser Dienstvertrag nicht bereits nach Absatz (1) bis (2) dieses Vertrages vor diesem Zeitpunkt geendet hat.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Service Agreement shall end at the latest at the end of the calendar year in which the Board Member reaches the age of 65, unless this Service Agreement has not already ended before this date in accordance with paragraphs (1) to (2) of this agreement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.35pt; text-align: justify; text-indent: -17.35pt">7.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;
    </FONT>Bei vorzeitiger Beendigung der Vorstandst&auml;tigkeit durch die Gesellschaft ohne wichtigen Grund entsprechen die Zahlungen an
    den Vorstand einschlie&szlig;lich Nebenleistungen maximal dem Wert von zwei Jahresverg&uuml;tungen (Abfindungs-Cap) und &uuml;berschreiten
    nicht die Gesamtverg&uuml;tung (Grundverg&uuml;tung, variable Verg&uuml;tung sowie Nebenleistungen) f&uuml;r die Restlaufzeit des Dienstvertrages.
    Bei einem Kontrollerwerb nach &sect; 7 gilt ein Abfindungs-Cap von maximal drei Jahresverg&uuml;tungen.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.35pt; text-align: justify; text-indent: -17.35pt">&nbsp;</P></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.9pt; text-align: justify; text-indent: -12.9pt">7.<FONT STYLE="font-size: 10pt">&nbsp;
    </FONT>In the event of premature termination of the board activity by the Company without good cause, payments to the Board Member including
    fringe benefits shall not exceed the value of two years' remuneration (severance payment cap) and shall not exceed the total remuneration
    (Basic Remuneration, variable remuneration and fringe benefits) for the remaining term of the Service Agreement. In the case of an acquisition
    of control pursuant to &sect; 7, a severance payment cap of a maximum of three years' remuneration applies.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.9pt; text-align: justify; text-indent: -12.9pt">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 17.35pt; text-align: justify; text-indent: -17.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Sofern der Dienstvertrag nicht &uuml;ber das Beendigungsdatum nach dieser &Auml;nderungsvereinbarung (oder ein sp&auml;ter vereinbartes Beendigungsdatum nach abermaliger Wiederbestellung) hinaus fortgesetzt wird, erh&auml;lt der Vorstand eine Brutto-Abfindung in H&ouml;he von 12 Monatsgrundgeh&auml;ltern gem&auml;&szlig; &sect; 3, Die Abfindung ist zahlbar zum Beendigungsdatum. Der Abfindungsanspruch entf&auml;llt, wenn der Vorstand ein Angebot auf Wiederbestellung f&uuml;r eine Dauer von mindestens 12 Monaten im unmittelbaren Anschluss an das hiesige Beendigungsdatum zu mindestens gleichwertigen dienstvertraglichen Bedingungen und bei mindestens 12-monatiger Laufzeit in &Uuml;bereinstimmung mit den Fristen gem&auml;&szlig; &sect; 10 Ziffer 4 erh&auml;lt und dieses nicht annimmt. Erh&auml;lt der Vorstand ein solches Angebot im Sinne von &sect; 10 Ziffer 4 versp&auml;tet oder zu nicht gleichwertigen Bedingungen, oder wird ihm mitgeteilt, dass eine Wiederbestellung nicht erfolgen soll, so werden die Zahlungen gem&auml;&szlig; &sect; 3 die dem Zeitraum von der Angebotsunterbreitung bzw. Mitteilung der nicht erfolgenden Wiederstellung bis zum Beendigungsdatum zuzuordnen sind, vom Abfindungsanspruch abgezogen, aber nur den Zeitraum, f&uuml;r den eine Freistellung nach &sect; 10 Ziffer 5 erfolgt ist. </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 12.9pt; text-align: justify; text-indent: -12.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.<FONT STYLE="font-size: 10pt">&nbsp; </FONT>If the Service Agreement is not continued beyond the Completion Date under this Amendment Agreement (or a later termination date agreed upon after reappointment), the Board Member shall receive gross severance payment equal to 12 monthly basic remuneration pursuant to &sect; 3 The severance payment is payable on the Completion Date. The severance payment claim shall lapse if the Board member receives and does not accept an offer of reappointment for a term of at least 12 months immediately following the Completion Date here under at least equivalent terms and conditions of the Service Agreement and for a term of at least 12 months in accordance with the time limits pursuant to &sect; 10 clause 4. If the Board Member receives such an offer within the meaning of &sect; 10 clause 4 belatedly or on non-equivalent terms, or is informed that a reappointment is not to take place, the payments pursuant to &sect; 3, which are attributable to the period from the submission of the offer or notification of the non-occurrence of the reappointment until the Completion Date, shall be deducted from the severance payment claim but only for the period for which a release has occurred pursuant to &sect; 10 clause 5.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 17.35pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Der Abfindungsanspruch entf&auml;llt, sofern die Nichtverl&auml;ngerung des Dienstverh&auml;ltnisses auf einem vom Vorstand zu vertretenen wichtigen Grund beruht.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 12.9pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">The severance payment claim shall lapse if the non-extension of the employment relationship is due to a serious cause for which the Board Member is responsible.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 17.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Der Abfindungsanspruch besteht auch dann, wenn das Dienstverh&auml;ltnis mindestens 12 Monate vor dem Beendigungsdatum aufgrund Abberufung / K&uuml;ndigung der Gesellschaft gem&auml;&szlig; &sect; 10 Ziffer 3 endet (vorzeitiges Beendigungsdatum), jedoch nur, soweit das Dienstverh&auml;ltnis nicht aus einem vom Vorstand zu vertretenen wichtigen Grund vorzeitig beendet worden ist. Endet das Dienstverh&auml;ltnisses infolge einer K&uuml;ndigung gem&auml;&szlig; vorstehenden Satz weniger als 12 Monate vor dem Beendigungsdatum, so werden die Zahlungen gem&auml;&szlig; &sect; 3, die dem Zeitraum von dem vorzeitigen Beendigungsdatum bis zum Beendigungsdatum zuzuordnen sind, vom Abfindungsanspruch abgezogen. Die Abfindung ist dann zum vorzeitigen Beendigungsdatum zahlbar.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 12.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The severance payment claim also exists if the employment relationship ends at least 12 months before the Completion Date due to removal from office / termination of the Company pursuant to &sect; 10 clause 3 (Early Completion Date), but only to the extent that the employment relationship has not been prematurely terminated for serious cause for which the Board Member is responsible. If the employment relationship ends less than 12 months prior to the Completion Date as a result of a termination pursuant to the preceding sentence, the payments pursuant to &sect; 3 as amended by this Amendment Agreement, which are attributable to the period from the Early Completion Date to the Completion Date, shall be deducted from the severance payment claim. The severance payment shall then be payable on the Early Completion Date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 11<BR>
Ausschlussfristen</B></FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 11<BR>
Cut-off Periods</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Anspr&uuml;che der Gesellschaft und des Vorstands aus dem Dienstverh&auml;ltnis oder im Zusammenhang mit diesem Dienstverh&auml;ltnis verfallen, ungeachtet ihres Rechtsgrundes, wenn die bzw. der Anspruchsberechtigte den Anspruch nicht innerhalb einer Frist von sechs Monaten, berechnet ab dem Zeitpunkt der F&auml;lligkeit und der Kenntnis oder grob fahrl&auml;ssigen Unkenntnis des Anspruchsberechtigten von den anspruchsbegr&uuml;ndenden Umstanden, durch Erkl&auml;rung in Textform gegen&uuml;ber der jeweils anderen Vertragspartei geltend macht. F&uuml;r die Beurteilung der Rechtzeitigkeit der Geltendmachung ist der Zugang der Erkl&auml;rung ma&szlig;geblich. Dies gilt nicht f&uuml;r die Geltendmachung von Anspr&uuml;chen wegen Verletzung des Lebens, des K&ouml;rpers oder der Gesundheit sowie bei vors&auml;tzlichen Pflichtverletzungen. Diese Ausschlussfrist gilt auch nicht f&uuml;r Anspr&uuml;che auf den gesetzlichen Mindestlohn sowie f&uuml;r gesetzliche Fristen, die keiner Ausschlussfrist unterliegen d&uuml;rfen. Die Vers&auml;umung der Ausschlussfrist f&uuml;hrt zum Verlust des Anspruchs.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>. Claims of the Company and the Board Member arising from or in connection with the service relationship expire, irrespective of their legal basis, if the claimant does not assert the claim within a period of six months, calculated from the due date and the knowledge or grossly negligent ignorance of the claimant of the circumstances giving rise to the claim, by declaration in text form against the respective other contracting party. For the assessment of the timeliness of the assertion, the receipt of the declaration is decisive. This does not apply to the assertion of claims due to injury to life, bodily injury or health as well as to intentional breaches of duty. The aforementioned preclusive period shall also not apply to claims regarding the statutory minimum wage as well as to statutory time limits that are no subject to limitation periods. Failure to observe the limitation period shall result in the loss of the claim.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Etwaige Anspr&uuml;che der Gesellschaft nach &sect; 93 (2) und (3) AktG gegen das Vorstandsmitglied bleiben gem&auml;&szlig; &sect; 93 (4) Satz 3 AktG von vorstehendem Absatz (1) unber&uuml;hrt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Any claims of the Company pursuant to Section 93 (2) and (3) AktG against the Board Member shall remain unaffected by the above paragraph (1) pursuant to Section 93 (4) sentence 3 AktG.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 12<BR>
Schlussbestimmungen</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 12<BR>
Final Provisions</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dieser Vertrag enth&auml;lt die gesamte Vereinbarung zwischen den Parteien. Bereits getroffene Vereinbarungen zwischen den Parteien werden hiermit ausdr&uuml;cklich mit Wirkung ab dem Stichtagsdatum aufgehoben.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>This agreement contains the entire agreement between the parties. Prior agreements between the parties are hereby expressly cancelled with effect as of the Effective Date.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>&Auml;nderungen oder Erg&auml;nzungen dieses Vertrages einschlie&szlig;lich dieser Schriftformklausel bed&uuml;rfen zu ihrer Wirksamkeit der Schriftform.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Changes or additions to this agreement, including this written form clause, must be made in writing to be effective.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dieser Vertrag unterliegt dem Recht der Bundesrepublik Deutschland.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>This agreement is subject to the law of the Federal Republic of Germany.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Erf&uuml;llungsort ist der Sitz der Gesellschaft, Gerichtsstand f&uuml;r Streitigkeiten aus diesem Vertrag ist der Sitz der Gesellschaft.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Place of performance is the seat of the Company, place of jurisdiction for disputes from this agreement is the seat of the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die deutsche Fassung dieser Vereinbarung ist ma&szlig;geblich.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The German version of this Amendment Agreement is authoritative.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Sollte eine Bestimmung dieses Vertrages ganz oder teilweise rechtsunwirksam oder undurchf&uuml;hrbar sein oder werden, so wird die G&uuml;ltigkeit der &uuml;brigen Bestimmungen dieses Vertrages nicht ber&uuml;hrt. Vielmehr ist die ganz oder teilweise rechtsunwirksame oder undurchf&uuml;hrbare Bestimmung durch eine Bestimmung zu ersetzen, die den mit der unwirksamen Bestimmung angestrebten wirtschaftlichen Erfolg soweit wie m&ouml;glich erreicht. Das gleiche gilt im Fall von L&uuml;cken dieses Vertrages.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Should any provision of this agreement be or become invalid or unenforceable in whole or in part, the validity of the remaining provisions of this agreement shall not be affected. Rather, the invalid or unenforceable provision, in whole or in part, shall be replaced by a provision that achieves as far as possible the economic purpose intended by the invalid provision. The same shall apply in the event of any gaps in this agreement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Martinsried, den</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Martinsried, den</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12/19/2023</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12/18/2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Immunic AG,<BR>
vertreten durch den Aufsichtsratsvorsitzenden<BR>
/s/ Dr. J&ouml;rg Neermann</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">/s/ Daniel Vitt</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Anlagenverzeichnis</B></FONT></TD>
    <TD STYLE="width: 3%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 48%; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Schedule of Annexes</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Anlage 1:&#9;AR-Beschluss</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Annex 1:&#9;SB resolution</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Anlage 2:&#9;Genehmigte Nebent&auml;tigkeiten des Vorstands</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Annex 2:&#9;Approved ancillary activity of the Board Member</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Anlage 1:</B> AR-Beschluss / <B>Annex 1:</B> SB resolution</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Anlage 2:</B> Genehmigte Nebent&auml;tigkeiten des Vorstands / <B>Annex
2:</B> Approved ancillary activity of the Board Member</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 53.45pt"></TD><TD STYLE="width: 18pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nebent&auml;tigkeit / Side Activity f&uuml;r/for
Brauhaus GermeringNebent&auml;tigkeit / Side Activity als/as Berater/Advisor Bayern Kapital Investment Committee </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>e619130_ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DIENSTVERTRAG</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SERVICE AGREEMENT</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">zwischen</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">between</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Immunic AG, <BR>
vertreten durch den Vorsitzenden des Aufsichtsrates</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Immunic AG, <BR>
represented by the Chairman of the Supervisory Board</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- nachfolgend &bdquo;Gesellschaft&quot; genannt -</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- hereinafter referred to as the &quot;Company&quot; -</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">und</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Herrn Dr. med. Andreas Rolf M&uuml;hler, </B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Dr. med. Andreas Rolf M&uuml;hler,</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- nachfolgend &bdquo;Vorstand&quot; genannt -</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- hereinafter referred to as the &quot;Board Member&quot; -</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Pr&auml;ambel</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-align: center; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Preamble</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Der Vorstand ist erstmalig mit Wirkung ab dem 23.03.2016 zum Mitglied des Vorstandes der Gesellschaft bestellt worden. Die letztmalige Bestellung zum Mitglied des Vorstandes endet mit Ablauf des 31.12.2023. Die dienstvertraglichen Beziehungen zwischen den Parteien werden durch den Dienstvertrag vom 22.&nbsp;August 2016 sowie diverser &Auml;nderungsvereinbarungen geregelt (&bdquo;Dienstvertrag&ldquo;). Der Vorstand ist mit <B>beigef&uuml;gten Aufsichtsratsbeschluss</B> erneut zum Mitglied des Vorstand der Gesellschaft bestellt worden, diesmal f&uuml;r den Zeitraum vom 01.01.2024 bis zum 31.12.2026 (&bdquo;Laufzeit&ldquo;). Dies vorausgeschickt, vereinbaren die Parteien den Dienstvertrag (einschlie&szlig;lich aller &Auml;nderungsvereinbarungen) mit Wirkung zum Ablauf des 31.12.2023 aufzuheben und durch den nachfolgenden neuen Dienstvertrag insgesamt f&uuml;r die Dauer der Laufzeit zu ersetzen. Diese Pr&auml;ambel ist integraler Bestandteil dieser Vereinbarung.</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board Member was appointed to the company's
Board for the first time with effect from March 23, 2016. The last appointment as a member of the Board ends at the end of December 31,
2023. The service contract between the parties is governed by the service contract dated August 22,&nbsp;2016 and various amendment agreements
(&quot;Service Contract&quot;). The Board Member was reappointed to the company's Executive Board by the attached Supervisory Board resolution,
this time for the period from January 1, 2024 to December 31, 2026 (&quot;Term&quot;). With this in mind, the parties agree to terminate
the Service Contract (including all amendment agreements) with effect from the end of December 31, 2023, and to replace it with the following
new service contract in its entirety for the duration of the Term. This preamble is an integral part of this agreement.</P></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 1<BR>
Aufgabenbereich und Pflichten</B></FONT></TD>
    <TD STYLE="width: 5%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 1<BR>
Responsibilities and Obligations</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Herr Dr. Andreas Rolf M&uuml;hler wird f&uuml;r die Laufzeit als Vorstand f&uuml;r den Bereich Medical (Chief Medical Officer, CMO) der Gesellschaft bestellt und vertritt die Gesellschaft gemeinsam mit einem Vorstand oder einem Prokuristen. Der Aufsichtsrat kann dem Vorstand Einzelvertretungsbefugnis erteilen sowie von den Beschr&auml;nkungen des &sect;&nbsp;181 Alt. 2 BGB befreien.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Dr. Andreas Rolf M&uuml;hler is appointed as Chief Medical Officer (CMO) of the Company for the Term and represents the Company together with a member of the Management Board or an authorized signatory. The Supervisory Board may grant the Board Member sole power of representation as well as exemption from the restrictions of &sect; 181 Alt. 2 of the German Civil Code (BGB).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand f&uuml;hrt die Gesch&auml;fte der Gesellschaft nach Ma&szlig;gabe der Gesetze, der Satzung, der Gesch&auml;ftsordnung f&uuml;r den Vorstand und dieses Dienstvertrages. Der Vorstand hat insbesondere f&uuml;r die laut einer Gesch&auml;ftsordnung des Vorstands unter Zustimmungsvorbehalt stehenden Gesch&auml;fte und Ma&szlig;nahmen die Zustimmung des Aufsichtsrats einzuholen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall conduct the business of the Company in accordance with the law, the Articles of Association, the rules of procedure for the Management Board and this Service Agreement. In particular, the Board Member shall obtain the approval of the Supervisory Board for transactions and measures subject to approval in accordance with the rules of procedure of the Management Board.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dem Vorstand obliegen insbesondere die Aufgaben, die im Sinne des jeweiligen Gesch&auml;ftsverteilungsplans zum Gesch&auml;ftsbereich des Medicalvorstands (CMO) geh&ouml;ren.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In particular, the Board Member is responsible for the tasks that belong to the business area of the Chief Medical Officer (CMO) within the meaning of the respective schedule of responsibilities.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand &uuml;bernimmt auf Wunsch der Gesellschaft ohne weitere Verg&uuml;tung auch Positionen oder &Auml;mter bei mit der Gesellschaft verbundenen Unternehmen (&sect;&nbsp;15 AktG). Ebenso &uuml;bernimmt der Vorstand Positionen oder &Auml;mter bei Verb&auml;nden, Berufsvereinigungen oder sonstigen Organisationen, in denen die Gesellschaft oder ein verbundenes Unternehmen Mitglied ist. Ihm von dritter Seite diesbez&uuml;glich gew&auml;hrte Verg&uuml;tungen oder Aufwandsentsch&auml;digungen f&uuml;hrt der Vorstand an die Gesellschaft ab. Auf Wunsch der Gesellschaft legt der Vorstand im Interesse der Gesellschaft oder verbundener Unternehmen &uuml;bernommene Positionen oder &Auml;mter nieder und setzt sich nach besten Kr&auml;ften daf&uuml;r ein, dass von der Gesellschaft benannte Nachfolger in die Positionen oder &Auml;mter nachr&uuml;cken.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall, upon the Company's request, without any additional remuneration, also accept positions or offices in companies affiliated with the Company (Section&nbsp;15 Stock Corporation Act - <I>AktG</I>). In the same way, the Board Member shall also accept positions or offices in associations and professional or other organizations of which the Company or an affiliated Company is a member. The Board Member shall transfer to the Company any remuneration or allowances he receives from third parties in this respect. Upon the Company's request, the Board Member shall resign from any position or office accepted in the interests of the Company or an affiliated Company and he shall do his utmost to ensure that the person nominated by the Company shall succeed him in the position or office.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; padding-left: 16.05pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Unber&uuml;hrt bleibt die T&auml;tigkeit des Vorstands f&uuml;r die Immunic Inc. im Rahmen eines mit dieser Gesellschaft bestehenden Vertragsverh&auml;ltnisses, die verg&uuml;tet wird. Die dort erhaltene Verg&uuml;tung ist nicht an die Gesellschaft abzuf&uuml;hren.&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="width: 5%; padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The remunerated activities of the Board Member for Immunic Inc. in accordance with the contractual relationships agreed on with this company shall remain unaffected. Remuneration received in the context of this contractual relationship shall not be transferred to the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dienstort ist Gr&auml;felfing. Sofern die Pflichten nach diesem Vertrag es zulassen, ist der Vorstand frei in der Wahl des Ortes der Aus&uuml;bung seiner T&auml;tigkeit.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The place of work is Gr&auml;felfing. If the obligations according to this agreement allow it, the Board Member is free in the choice of the place of the exercise of its activity.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 2<BR>
Umfang der Dienste, Nebent&auml;tigkeiten</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 2<BR>
Scope of Service and Side Activity</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand stellt 50 % seiner Arbeitskraft und all sein Wissen und K&ouml;nnen in den Dienst der Gesellschaft. In der Bestimmung seiner T&auml;tigkeitszeiten ist der Vorstand im Rahmen der betrieblichen Erfordernisse frei. Es besteht Einvernehmen, dass der Vorstand die verbleibenden 50 % seiner Arbeitskraft der Immunic Inc. zur Verf&uuml;gung zu stellen hat. Hinsichtlich der Verteilung der Arbeitszeiten ist auf die Interessen der Gesellschaft und der Immunic Inc. R&uuml;cksicht zu nehmen.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall devote 50 % of his working capacity, knowledge and skills into the services of the Company. He shall be able to schedule his working hours, subject to business requirements. It is agreed that the Board Member shall devote the remaining 50 % of his working capacity to Immunic Inc. The Board Member shall reasonably take into account the interests of the Company as well as Immunic Inc. with regard to the distribution of his working time.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die &Uuml;bernahme einer entgeltlichen Nebent&auml;tigkeit sowie von Aufsichts-rats-, Beirats- oder &auml;hnlichen Mandanten bedarf der vorherigen Zustimmung durch den Aufsichtsratsvorsitzenden.</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The assumption of an ancillary commercial activity as well as mandates in a supervisory board or advisory board or similar mandates require the prior consent of the Chairman of the Supervisory Board.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dem Aufsichtsratsgremium ist bekannt, dass der Vorstand zum Zeitpunkt der Unterzeichnung dieses Vertrages die in <B>Anlage 2 </B>aufgelisteten Mandate innehat und erteilt zu deren Fortf&uuml;hrung seine Zustimmung.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Supervisory Board is aware that the Board Member holds the mandates listed in <B>Annex 2 </B>at the time of signing of this agreement and grants its approval to their continuation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>F&uuml;r den Vorstand gilt das Wettbewerbsverbot des &sect;&nbsp;88 AktG. W&auml;hrend der Dauer dieses Vertrages wird sich der Vorstand auch nicht an Unternehmen beteiligen, die mit der Gesellschaft in Wettbewerb stehen oder mit denen die Gesellschaft Gesch&auml;ftsverbindungen unterh&auml;lt, es sei denn, der Aufsichtsrat hat vorher seine schriftliche Zustimmung erteilt.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member is subject to the non-competition clause of Section 88 of the German Stock Corporations Act (AktG). During the term of this agreement, the Board Member will also not invest in companies that compete with the Company or with which the Company has business relationships, unless the Supervisory Board has given its prior written consent.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Das Wettbewerbsverbot gilt nicht f&uuml;r Beteiligungen an Unternehmen in Gestalt von Wertpapieren, die an B&ouml;rsen gehandelt und zum Zwecke der Kapitalanlage erworben werden. Dar&uuml;ber hinaus sind etwaig bestehende, vorrangige Regelungen aus einem Investment Agreement und/oder Shareholders' Agreement zu Wettbewerbsverboten bzw. erlaubten T&auml;tigkeiten des Vorstands zu beachten.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The non-competition clause does not apply to interests in companies in the form of bonds traded on the stock exchange and acquired for the purpose of capital investment. In addition, any existing overriding regulation from an Investment Agreement and/or Shareholders' Agreement on restraints of competition or permitted activities of the Board Member must be observed.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 3<BR>
Verg&uuml;tung und Bonus</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 3<BR>
Remuneration and bonus</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand erh&auml;lt f&uuml;r seine T&auml;tigkeit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member receives for its activities</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a)&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ein festes Jahresgehalt <B>(&bdquo;Grundverg&uuml;tung&quot;) </B>in H&ouml;he von EUR 231,825 brutto, das in 12 gleichen Monatsraten jeweils nachtr&auml;glich am Monatsletzten ausbezahlt wird. Sofern dieser Vertrag nicht w&auml;hrend der Dauer eines gesamten Kalenderjahres besteht, wird das Jahresfestgehalt zeitanteilig gezahlt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp; </FONT>a fixed annual salary <B>(&quot;Basic Remuneration&quot;) </B>in the amount of EUR 231,825 gross, paid in 12 equal monthly instalments at the end of each month. If this agreement does not exist for the duration of an entire calendar year, the fixed annual salary shall be paid pro rata temporis.</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 36.05pt; width: 40%; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b)&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">eine j&auml;hrliche variable Verg&uuml;tung, die bei 100-prozentigem Erreichen der festgelegten Jahresziele maximal EUR 92,730 brutto betr&auml;gt, also 40 % der j&auml;hrlichen Grundverg&uuml;tung gem&auml;&szlig; Ziffer a) zuvor. Die Einzelheiten, insbesondere zum Verfahren der Zielfestlegung, zur Feststellung der Zielerreichung und zur F&auml;lligkeit ergeben sich aus dem Rahmenvertrag zur Zielvereinbarung in seiner jeweils geltenden Fassung. Die Art der Ziele, die Voraussetzungen f&uuml;r ihre Erreichung und ihre Gewichtung zueinander werden f&uuml;r das jeweilige Gesch&auml;ftsjahr in einer gesonderten Zielfestlegung niedergelegt.</FONT></TD>
    <TD STYLE="width: 5%; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 40%; padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp; </FONT>an annual variable remuneration of up to EUR 92,730 gross if the defined annual targets are achieved 100 percent, i.e. 40 % of the annual basic remuneration in accordance with a) above. The details, in particular with regard to the procedure for setting targets, determining the achievement of targets and the due date, are set out in the Framework Agreement regarding the targets (<I>Rahmenvertrag zur Zielvereinbarung</I>) in its current version. The nature of the objectives, the conditions for their achievement and their weighting in relation to each other are laid down for each financial year in a separate target setting.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Grundverg&uuml;tung und die variable Verg&uuml;tung werden j&auml;hrlich durch den Aufsichtsrat &uuml;berpr&uuml;ft. Dabei sind die wirtschaftliche Entwicklung der Gesellschaft sowie die pers&ouml;nliche Leistung des Vorstandes zu ber&uuml;cksichtigen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Basic Remuneration and the variable remuneration are reviewed annually by the Supervisory Board. The economic development of the Company and the personal performance of the Board Member must be taken into account.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Sagt eine dritte Person (einschlie&szlig;lich solcher Unternehmen, die mit der Gesellschaft verbunden sind) dem Vorstand Anteile an der Gesellschaft oder an mit der Gesellschaft verbundenen Unternehmen oder diesbez&uuml;gliche Optionen oder Anspr&uuml;che auf Optionen oder sogenannte Stock Appreciation Rights oder Phantom Stocks zu, so werden solche Zusagen weder Bestandteil des Dienstverh&auml;ltnisses zwischen den Parteien dieses Vertrages noch begr&uuml;nden sie Verpflichtungen der Gesellschaft.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event that a third party (including companies which are affiliated with the Company) promises the Board Member shares in the Company or in companies affiliated with the Company or options to acquire such shares or rights to such options or so-called stock appreciation rights or phantom Stocks, such promise shall neither become part of the Service Agreement between the parties to this Agreement nor create any obligations of the Company</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im &Uuml;brigen kann der Aufsichtsrat die Bez&uuml;ge des Vorstands insgesamt auf die angemessene H&ouml;he herabsetzen, wenn sich die Lage der Gesellschaft so verschlechtert, dass die Weitergew&auml;hrung der Bez&uuml;ge unbillig f&uuml;r die Gesellschaft w&auml;re; Ruhegehalt, Hinterbliebenenbez&uuml;ge und Leistungen verwandter Art k&ouml;nnen dabei nur in den ersten drei Jahren nach Ausscheiden aus der Gesellschaft herabgesetzt werden (&sect; 87 (2) AktG). Der Vorstand kann in diesem Fall diesen Dienstvertrag au&szlig;erordentlich mit einer Frist von sechs Wochen zum Schluss des n&auml;chsten Kalendervierteljahres nach Erkl&auml;rung der Herabsetzung k&uuml;ndigen (&sect; 87 (2) Satz 3 AktG). Entf&auml;llt eine verschlechterte Lage der Gesellschaft, ist die Herabstufung wieder r&uuml;ckg&auml;ngig zu machen.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Otherwise, the Supervisory Board may reduce the total remuneration of the Board Member to the appropriate amount, if the situation of the Company deteriorates to such an extent that the continued granting of the remuneration would be inequitable for the Company; retirement pension, survivors benefits and benefits of a related kind may only be reduced in the first three years after leaving the Company (Section 87 (2) AktG). In this case, the Board Member may terminate this Service Agreement extraordinarily with six weeks' notice to the end of the next calendar quarter after declaration of the reduction (Section 87 (2) sentence 3 AktG). If a deterioration in the situation of society does not apply, the downgrade shall be reversed.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Ein Anspruch auf Verg&uuml;tung von &Uuml;berstunden, Sonntags-, Feiertags- oder sonstiger Mehrarbeit besteht nicht.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>There is no entitlement to remuneration for overtime, work on Sundays, public holidays or other additional work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 4<BR>
Versicherungen und Nebenleistungen</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 4<BR>
Insurance and Fringe Benefits</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Auch soweit keine gesetzliche Versicherungspflicht besteht, zahlt die Gesellschaft an das Vorstandsmitglied monatliche Zusch&uuml;sse zur Kranken-und Pflegeversicherung des Vorstandsmitglieds. Die einzelnen Zusch&uuml;sse entsprechen in ihrer H&ouml;he der H&auml;lfte der vom Vorstandsmitglied gezahlten Beitr&auml;ge, h&ouml;chstens jedoch dem jeweils unter Ber&uuml;cksichtigung der jeweils geltenden Beitragsbemessungsgrenzen gesetzlich geschuldeten H&ouml;chstbetrag des Arbeitgeberanteils der gesetzlichen Kranken- und Pflegeversicherung. Die von der Gesellschaft geschuldeten Zusch&uuml;sse werden dem Vorstandsmitglied jeweils am Kalendermonatsende gezahlt. Die auf diese Zahlungen etwaig anfallende Einkommensteuer tr&auml;gt das Vorstandsmitglied.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Even if there is no statutory insurance obligation, the Company shall pay the Board Member monthly health and long-term care insurance contributions for the Board Member. The individual contributions are in their amount equivalent to the amount of the contributions paid by the Board Member, but limited to the amount of the employer's contribution to the statutory health and long-term care insurance legally owed in each case, taking into account the applicable contribution assessment thresholds. The contributions owed by the Company are paid to the Board Member at the end of each calendar month. Any income tax payable on these payments shall be borne by the Board Member.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft zahlt an das Vorstandsmitglied monatliche Zusch&uuml;sse zur Bayerischen &Auml;rzteversorgung des Vorstandsmitglieds. Die einzelnen Zusch&uuml;sse entsprechen in ihrer H&ouml;he der H&auml;lfte der vom Vorstandsmitglied gezahlten Beitr&auml;ge. Die von der Gesellschaft geschuldeten Zusch&uuml;sse werden dem Vorstandsmitglied jeweils am Kalendermonatsende gezahlt. Die auf diese Zahlungen etwaig anfallende Einkommensteuer tr&auml;gt das Vorstandsmitglied.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Company pays the Board Member monthly contributions for <I>Bayerische &Auml;rzteversorgung</I> of the Board Member. The individual contributions correspond in their amount to half of the contributions paid by the Board Member. The contributions owed by the Company are paid to the Board Member at the end of each calendar month. Any income tax payable on these payments shall be borne by the Board Member.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand erh&auml;lt in angemessenem Umfang f&uuml;r die im Gesellschaftsinteresse erforderlichen Aufwendungen Ersatz. Erforderliche Reisekosten werden gegen Einzelnachweis erstattet. Die darin enthaltenen Tage- und &Uuml;bernachtungsgelder k&ouml;nnen im Rahmen der steuerlich zul&auml;ssigen Betr&auml;ge auch pauschal abgerechnet werden.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall be reimbursed to an appropriate extent for the expenses required in the interest of the Company. Required travel expenses will be reimbursed against itemization. The daily and overnight allowances contained therein may also be settled as a lump sum within the limits of the amount permissible for tax purposes.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft kann den Vorstand nach ihrem Ermessen f&uuml;r die Dauer dieses Dienstvertrages im Rahmen einer Risiko-Lebensversicherung in H&ouml;he von EUR 500.000,00 f&uuml;r den Todesfall und im Rahmen einer Unfallversicherung in H&ouml;he von EUR&nbsp;700.000,00 f&uuml;r den Invalidit&auml;tsfall versichern bzw. eine bereits bestehende Versicherung fortf&uuml;hren. Der Vorstand hat das Recht, den/die Bezugsberechtigten zu bestimmen.</FONT></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>At its discretion, the Company may insure the Board Member for the duration of this Service Agreement under a risk life insurance policy in the amount of EUR 500,000.00 in the event of death and under an accident insurance policy in the amount of EUR&nbsp;700,000.00 in the event of disability or continue an existing insurance policy. The Board Member is entitled to determine the beneficiary/beneficiaries.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im Falle der &Uuml;bernahme einer bestehenden Direktversicherung kann diese gem&auml;&szlig; &sect;&nbsp;40 b EStG in ihrer geltenden Fassung weiter gef&uuml;hrt werden. Die pauschale Versteuerung &uuml;bernimmt in diesem Fall die Gesellschaft.</FONT></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event that an existing direct insurance policy is taken over, this insurance policy can be managed in its current version under Section 40 b German Income Tax Act (EStG). In this case, the lump sum taxation is paid by the Company.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft bietet dem Vorstand die M&ouml;glichkeit zur Teilnahme an einer Pensionskasse, Unterst&uuml;tzungskasse oder einer &auml;hnlichen betrieblichen Altersversorgung (BAV) bzw. zur &Uuml;bernahme einer bereits bestehenden BAV. In diesem Zusammenhang kann der Vorstand einen Teil seiner Gehaltsanspr&uuml;che zugunsten einer betrieblichen Altersversorgungszusage umwandeln. Die dem Vorstand gem&auml;&szlig; &sect;&nbsp;3 (1) lit. a) gew&auml;hrte Grundverg&uuml;tung wird dabei mit Wirkung zum Beginn einer betrieblichen Altersversorgungszusage entsprechend um einen monatlichen Bruttobetrag gek&uuml;rzt, um in eine wertgleiche Zusage auf betriebliche Versorgungsleistung umgewandelt zu werden. In H&ouml;he dieses Betrags verringert sich der Anspruch des Vorstands auf Zahlung der Grundverg&uuml;tung. Sollte der Vorstand die Versorgungszusage im weiteren Verlauf ganz oder teilweise wieder k&uuml;ndigen oder ruhen lassen, so lebt der entsprechende Verg&uuml;tungsanspruch wieder auf.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Company offers the Board Member the opportunity to participate in a pension fund, support fund or similar company pension scheme (<I>betriebliche Altersvorsorge</I>, BAV) or to take over an existing BAV. In this context, the Board Member can convert part of its salary entitlements into a company pension commitment. The Basic Remuneration granted to the Board Member pursuant to &sect; 3 (1) lit. a) shall be reduced by a gross monthly amount with effect from the beginning of a company pension commitment to be converted into an equal-value commitment to company pension benefits. The Board Member's entitlement to payment of the Basic Remuneration is reduced by this amount. If the Board Member rescinds or suspends the pension commitment in whole or in part in the further course of the plan, the corresponding entitlement to compensation shall revive.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft schlie&szlig;t f&uuml;r den Vorstand eine Verm&ouml;gensschaden-Haftpflichtversicherung (D&amp;O) f&uuml;r den Fall ab, dass der Vorstand wegen einer in Aus&uuml;bung seiner T&auml;tigkeit begangenen Pflichtverletzung von einem Dritten oder der Gesellschaft aufgrund gesetzlicher Haftpflichtbestimmungen privatrechtlichen Inhalts f&uuml;r einen Verm&ouml;gensschaden in Anspruch genommen wird. Der Vorstand tr&auml;gt dabei eine Selbstbeteiligung in H&ouml;he des Mindestwerts gem&auml;&szlig; &sect;&nbsp;93 (2) AktG (derzeit je Schadensfall 10% des Schadens, maximal aber das 1<SUP>1</SUP>/<SUB>2</SUB>-fache der Grundverg&uuml;tung pro Jahr (j&auml;hrliche H&ouml;chstgrenze). Kommt es zu mehreren Schadensf&auml;llen in einem Jahr, gilt die j&auml;hrliche H&ouml;chstgrenze f&uuml;r alle Schadensf&auml;lle zusammen. Der Selbstbehalt passt sich bei &Auml;nderung der Grundverg&uuml;tung (bzw. bei &Auml;nderung von &sect;&nbsp;93 (2) AktG) automatisch an; der Vorstand ist verpflichtet, die entsprechenden &Auml;nderungen beim Selbstbehalt des D&amp;O Versicherungsvertrages zu veranlassen, und / oder s&auml;mtliche in diesem Zusammenhang erforderlichen Erkl&auml;rungen abzugeben. Das Bezugsjahr f&uuml;r den anzuwendenden Selbstbehalt ist das Jahr des Pflichtversto&szlig;es.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Company enters into a directors' and officers' liability insurance policy (D&amp;O) for the Board Member for the event that a third party or the Company makes a claim against the Board Member for a loss of assets due to a breach of duty committed in the performance of its duties due to statutory liability provisions under private law. The Board Member bears a deductible in the amount of the minimum value pursuant to Section 93 (2) of the German Stock Corporation Act (AktG) (currently 10% of the damage per claim, but not more than one and a half times the basic annual remuneration (annual maximum limit). In case of several loss events in one year, the annual maximum limit applies to all loss events in combination. The deductible is automatically adjusted in the event of a change in the Basic Remuneration (or in the event of a change in Section 93 (2) AktG); the Board Member is obliged to arrange for the corresponding changes to the deductible in the D&amp;O insurance agreement and / or to provide all declarations required in this regard. The reference year for the deductible to be applied is the year of the violation.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 40%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 5<BR>
Urlaub</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 5<BR>
Holiday</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand hat Anspruch auf einen Jahresurlaub von 30 Arbeitstagen. Arbeitstage sind alle Kalendertage mit Ausnahme von Samstagen, Sonntagen und gesetzlichen Feiertagen am Sitz der Gesellschaft. Bei unterj&auml;hrigem Besch&auml;ftigungsbeginn oder -ende wird der Jahresurlaub in diesem Kalenderjahr zeitanteilig gew&auml;hrt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member is entitled to an annual vacation of 30 working days. Working days are all calendar days except Saturdays, Sundays and public holidays at the registered office of the Company. If employment begins or ends during the course of the year, annual vacation in this calendar year will be granted pro rata temporis.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Urlaubszeit ist unter Ber&uuml;cksichtigung der Gesch&auml;ftslage mit den anderen Vorstandsmitgliedern abzustimmen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The holiday period shall be coordinated with the other members of the Executive Board, taking into account the business situation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Urlaubsanspruch wird entsprechend angepasst, wenn der Vorstand regelm&auml;&szlig;ig an weniger als f&uuml;nf Tagen in der Woche arbeitet. Es besteht Einvernehmen, dass der im Rahmen des Vertragsverh&auml;ltnisses mit der Immunic Inc. gew&auml;hrte Urlaub auf die Urlaubsanspr&uuml;che im Rahmen dieses Dienstvertrages anzurechnen ist (sowie umgekehrt), so dass dem Vorstand im Rahmen beider Vertr&auml;ge insgesamt ein Jahresurlaub von 30 Tagen zusteht.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The vacation entitlement will be adapted accordingly if the Board Member regularly works less than five days per week. It is agreed that vacation granted under the contractual relationship with Immunic Inc. will be offset against vacation entitlements deriving from this Service Agreement (and vice versa). As a result, the Board Member shall be able to take 30 days of vacation in total in the addition of these two contracts.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 6<BR>
Bez&uuml;ge bei Krankheit, Arbeitsunf&auml;higkeit oder Tod</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 6<BR>
Beneficiaries in the event of illness, incapacity for work or death</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>lm Fall einer Dienstverhinderung (z.B. infolge Erkrankung) ist das Vorstandsmitglied verpflichtet, den Aufsichtsratsvorsitzenden der Gesellschaft unverz&uuml;glich &uuml;ber Grund und Dauer der Dienstverhinderung zu informieren und auf vordringlich zu erledigende Aufgaben hinzuweisen. Dauert die Dienstverhinderung l&auml;nger als eine Woche, hat das Vorstandsmitglied im Fall einer Erkrankung ein &auml;rztliches Attest oder im Fall einer sonstigen Dienstverhinderung eine schriftliche Erkl&auml;rung vorzulegen, woraus sich der Grund der Arbeitsunf&auml;higkeit sowie deren voraussichtliche Dauer ergeben.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of an unforeseen absence (e.g. due to illness), the Board Member is obliged to inform the Chairman of the Supervisory Board of the Company without undue delay of the reason for and probable duration of the impediment to service and draw the attention on the tasks to be performed urgently. If the absence lasts longer than one week, the Board Member must submit a medical certificate or in the event of any other incapacity or a written declaration in the event of any other disability, stating the reason for the incapacity and its probable duration.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Das Vorstandsmitglied tritt bereits jetzt etwaige (Schadensersatz-)Anspr&uuml;che in H&ouml;he der nach dieser Regelung von der Gesellschaft geleisteten oder zu leistenden Zahlungen an die Gesellschaft ab, die ihm gegen&uuml;ber Dritten wegen der Arbeitsverhinderung zustehen. Das Vorstandsmitglied ist verpflichtet, der Gesellschaft unverz&uuml;glich s&auml;mtliche zur Geltendmachung derartiger (Schadensersatz-)Anspr&uuml;che notwendigen Angaben zu machen sowie hierf&uuml;r notwendige Unterlagen zu &uuml;berlassen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Board Member hereby assigns to the Company any (compensation) claims in the amount of the payments made or to be made by the Company in accordance with this provision to which he is entitled in respect of third parties due to the impediment to work. The Board Member is obligated to provide the Company with all information necessary for asserting such (compensation) claims and to provide the Company with the necessary documents without undue delay.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Bei einer vor&uuml;bergehenden krankheitsbedingten oder sonstigen unverschuldeten Arbeitsunf&auml;higkeit des Vorstandes wird die Grundverg&uuml;tung gem&auml;&szlig; &sect; 3 (1) lit. a) w&auml;hrend der Zeit der Arbeitsunf&auml;higkeit bis zu einer Dauer von sechs Monaten, l&auml;ngstens jedoch bis zur Beendigung dieses Dienstvertrages weitergezahlt. Dauert die Arbeitsunf&auml;higkeit l&auml;nger als ununterbrochen 3 Monate an, kann der Aufsichtsrat die variable Verg&uuml;tung unter Ber&uuml;cksichtigung der Dauer der Arbeitsunf&auml;higkeit angemessen reduzieren.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of a temporary illness or other non-culpable incapacity to work, the basic remuneration pursuant to &sect; 3 (1) lit. a) shall continue to be paid during the period of the incapacity to work up to a period of six months, at the latest until the termination of this Service Agreement. If the incapacity to work lasts longer than three months without interruption, the Supervisory Board may reduce the variable remuneration by a reasonable amount, taking into account the duration of the incapacity to work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Bei einer dauernden Arbeitsunf&auml;higkeit des Vorstandes endet der Dienstvertrag mit dem Ende des Quartals, in dem die dauernde Arbeitsunf&auml;higkeit festgestellt worden ist.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of permanent incapacity to work of the Board Member, the employment agreement ends at the end of the quarter in which the permanent incapacity to work was determined.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ist der Vorstand l&auml;nger als sechs Monate au&szlig;erstande, seiner T&auml;tigkeit nachzugehen, kann der Aufsichtsrat verlangen, dass das Vorliegen einer dauernden Arbeitsunf&auml;higkeit durch einen von ihm ausgew&auml;hlten Arzt auf Kosten der Gesellschaft nachgepr&uuml;ft wird. Nimmt der Vorstand den Termin trotz zweimaliger Aufforderung durch den Aufsichtsrat nicht wahr, gilt der Vorstand als dauernd arbeitsunf&auml;hig. Die Aufforderungen haben mit einer Woche zeitlichen Abstands voneinander zu erfolgen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If the Board Member is unable to carry out its duties for more than six months, the Supervisory Board may demand that the existence of a permanent incapacity to work be reviewed by a doctor of its choice at the Company's expense. If the Board Member fails to meet the demand despite two requests by the Supervisory Board, the Board Member shall be deemed permanently incapacitated for work. The requests shall be made at intervals of one week.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Eine Abfindung ist bei einer Beendigung des Dienstvertrags wegen dauernder Arbeitsunf&auml;higkeit nicht zu leisten.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A severance payment shall not be made in the event of termination of the employment agreement due to permanent incapacity to work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Stirbt der Vorstand w&auml;hrend der Dauer des Dienstvertrages, ist die Grundverg&uuml;tung nach &sect; 3 (1) lit. a) noch f&uuml;r den Sterbemonat und f&uuml;r die zwei darauf folgenden Monate zu zahlen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>If the Board Member dies during the term of this Service Agreement, the Basic Remuneration according to &sect; 3 (1) lit. a) shall still be payable for the month of death and for the following two months.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Die Boni werden entsprechend den vertraglichen Regelungen durch den Aufsichtsrat festgelegt und an den Ehepartner, bei deren Fehlen an die unterhaltsberechtigten Kinder des Vorstands (letztere als Gesamtgl&auml;ubiger) oder seine Erben bezahlt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The bonuses) are determined in accordance with the contractual regulations by the Supervisory Board and paid to the spouse, in the event of their absence to the dependent children of the Board Member (the latter as joint creditor) or his heirs.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 7<BR>
Sonderleistungen und Sonderk&uuml;ndigungsrecht bei Kontrollerwerb</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 7<BR>
Special services and special right of termination in the event of acquisition of control</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Kommt es nach der Unterzeichnung dieses Vertrags zu einem Kontrollerwerb im Sinne eines Anteilserwerbs von mehr als 50% durch einen Aktion&auml;r, Dritten oder gemeinsam handelnde Personen oder zu einer wirtschaftlich vergleichbaren Transaktion (z.B. Verkauf des Gesch&auml;ftsbetriebs oder eines wesentlichen Teils davon durch die Gesellschaft, Verkauf von wesentlichen Beteiligungsgesellschaften der Gesellschaft, Verschmelzung auf ein anderes Unternehmen, Verkauf von mehr als 50% der Anteile der Gesellschaft nach einem &bdquo;Delisting&quot; der Gesellschaft, etc.) und will sich die Gesellschaft in diesem Zusammenhang oder in dessen Folge von dem Vorstand durch vorzeitige Vertragsaufl&ouml;sung trennen, ohne hierf&uuml;r einen wichtigen Grund im Sinn des &sect; 626 BGB zu haben, so erh&auml;lt der Vorstand zus&auml;tzlich zu der Verg&uuml;tung und allen Leistungen, die ihm bis zum Trennungszeitpunkt zustehen, eine Abfindung. Die H&ouml;he der Abfindung entspricht der Grundverg&uuml;tung, die der Vorstand bis zum Ablauf der in &sect; 10 (1) definierten Dauer gem&auml;&szlig; diesem Vertrag erhalten hatte, w&auml;re der Vertrag nicht vorzeitig beendet, sondern bis zum Ende der vollen Amtszeit erf&uuml;llt worden zuz&uuml;glich eines Erh&ouml;hungsbetrages, der 100 % des Anspruchs auf variable Leistungen im Jahr des Austritts entspricht. Betr&auml;gt die ordentliche Laufzeit dieses Vertrages gem&auml;&szlig; &sect;&nbsp;10 (1) zum Zeitpunkt des Wirksamwerdens der Trennung nach diesem Absatz ) weniger als 12 Monate, berechnet sich die zu zahlende Abfindung auf Basis einer fiktiven Restlaufzeit von 12 Monaten, d.&nbsp;h. die Abfindung wird berechnet auf Basis einer angenommenen Restlaufzeit von mindestens 12 Monaten. </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>If, after the signing of this Agreement, control is acquired in the sense of a share acquisition of more than 50% by a shareholder, third party or persons acting jointly or in the sense of an economically comparable transaction (e.g. sale of the business operations or a substantial part thereof by the Company, sale of substantial associated companies of the Company, merger with another company, sale of more than 50% of the shares of the Company after a delisting of the Company, etc.) and if the Company wishes to terminate the agreement with the Board Member in this context or as a result thereof by early termination of the agreement without having an important reason within the meaning of Section 626 of the German Civil Code (BGB), the Board Member shall receive a severance payment in addition to the remuneration and all benefits to which it is entitled up to the time of termination. The amount of the severance payment corresponds to the basic remuneration that the Board Member would have received until expiry of the term defined in &sect; 10 (1) of this agreement, if the agreement would not have been terminated prematurely, but would have been fulfilled up until the end of the full term of office plus an increase amount corresponding to 100 % of the entitlement to variable benefits in the year of departure.. If the ordinary term of this agreement pursuant to &sect; 10 (1) is less than 12 months at the time the separation pursuant to this paragraph&nbsp;&nbsp;takes effect, the severance payment to be made shall be calculated on the basis of a fictitious remaining term of 12 months, i.e. the severance payment shall be calculated on the basis of an assumed remaining term of at least 12 months.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">W&auml;hrend der Vertragslaufzeit stattfindende Anhebungen der Verg&uuml;tung gem&auml;&szlig; &sect; 3 (1) werden bei den beschriebenen Berechnungen ber&uuml;cksichtigt.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any increases in remuneration in accordance with &sect; 3 (1) that take place during the term of the agreement shall be taken into account in the calculations described.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soweit der Vorstand im Rahmen dieser Regelung aus den Diensten der Gesellschaft ausscheidet, wird beim Bonus gem&auml;&szlig; &sect; 3 Ziffer 1 b) f&uuml;r das Jahr des Austritts eine Zielerreichung in H&ouml;he von 100 % unterstellt, soweit die tats&auml;chliche Zielerreichung niedriger liegt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If the Board Member leaves the services of the Company under this provision, a target achievement of 100% is assumed for the bonus pursuant to Section 3 (1) b) for the year of departure if the actual target achievement is lower</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Abfindung ist in voller H&ouml;he zusammen mit dem Gehalt f&uuml;r den Monat, zu dessen Ende die Trennung nach Absatz (1) wirksam wird, zur Zahlung f&auml;llig.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The severance payment shall be payable in full together with the salary for the month at the end of which the separation referred to in paragraph (1) takes effect.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im Falle dieses Absatzes (1) wird dem Vorstand ein au&szlig;erordentliches Sonderk&uuml;ndigungsrecht zu diesem Dienstvertrag einger&auml;umt. Das Sonderk&uuml;ndigungsrecht kann innerhalb von sechs Wochen ab Kenntnis des Vorstands &uuml;ber den rechtskr&auml;ftigen Vollzug des Kontrollwechsels im Sinne des Absatzes (1) mit einer Frist von drei Monaten zum Monatsende ausge&uuml;bt werden. Dar&uuml;ber hinaus besteht ein Sonderk&uuml;ndigungsrecht des Vorstands auch dann, wenn der Vorstand innerhalb von einem Jahr nach Vollzug des Kontrollwechsels abberufen wird. In diesem Fall betr&auml;gt die Sonderk&uuml;ndigungsfrist zwei Wochen. Die K&uuml;ndigung kann innerhalb von vier Wochen nach Abberufung durch den Vorstand erkl&auml;rt werden.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of this paragraph (1), the Board Member shall be granted an extraordinary right of termination of this Service Agreement. The special right of termination may be exercised within six weeks of the knowledge of the Board Member of the legally binding execution of the change of control within the meaning of paragraph (1) with a notice period of three months to the end of the month. In addition, the Board Member has a special right of termination even if the Board Member is dismissed within one year of the completion of the change of control. In this case, the special notice period is two weeks. The termination may be declared by the Board Member within four weeks after dismissal.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 8<BR>
Diensterfindungen und Schutzrechte</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 8<BR>
Service inventions and industrial property rights</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Erfindungen des Vorstands sowie seine technischen oder organisatorischen Verbesserungsvorschl&auml;ge werden entsprechend den jeweils geltenden Bestimmungen des Gesetzes &uuml;ber Arbeitnehmererfindungen vom 25.7.1957 mit folgender Ma&szlig;gabe behandelt: Der Vorstand wird der Gesellschaft Diensterfindungen, freie Erfindungen und technische wie organisatorische Verbesserungsvorschl&auml;ge unverz&uuml;glich melden und der Gesellschaft zur ausschlie&szlig;lichen, beschr&auml;nkten oder unbeschr&auml;nkten Inanspruchnahme anbieten. Die Erkl&auml;rung der Inanspruchnahme hat seitens der Gesellschaft innerhalb von vier Monaten nach der Meldung zu erfolgen. Die Gesellschaft hat das Recht, jedoch nicht die Verpflichtung, zur Anmeldung von Schutzrechten im In- und Ausland. Im Fall einer Diensterfindung oder eines technischen oder organisatorischen Verbesserungsvorschlags sind sich die Parteien darin einig, dass eine etwaige Verg&uuml;tung f&uuml;r eine von der Gesellschaft in Anspruch genommene Diensterfindung mit der Zahlung der Grundverg&uuml;tung nach &sect; 3 (1) lit. a) dieses Vertrages vollst&auml;ndig abgegolten ist. Im Fall einer freien Erfindung ist dem Vorstandsmitglied eine markt&uuml;bliche Verg&uuml;tung zu zahlen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Inventions by the Board Member and its technical or suggestions for organizational improvements shall be treated in accordance with the applicable provisions of the Act on Employee Inventions of 25 July 1957, subject to the following provisions: The Board Member will immediately notify the Company of job-related inventions, free inventions and technical and organizational suggestions for improvement and offer them to the Company for exclusive, limited or unlimited use. The Company must declare the claim within four months of notification. The Company is entitled, but not obliged, to register intellectual property rights in Germany and abroad. In the case of a job-related invention or a technical or organizational suggestion for improvement, the parties agree that any remuneration for a service invention claimed by the Company shall be paid in full upon payment of the basic remuneration pursuant to &sect; 3 (1) lit. a) of this Agreement. In the case of a free invention, the Board Member shall be paid remuneration in line with market-based conditions.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand &uuml;bertr&auml;gt der Gesellschaft ausschlie&szlig;liche, zeitlich, r&auml;umlich und inhaltlich unbeschr&auml;nkte Nutzungs- und Verwertungsrechte f&uuml;r alle etwaigen nach dem Urhebergesetz schutzf&auml;higen T&auml;tigkeitsergebnisse, die das Vorstandsmitglied w&auml;hrend der Dauer seines Dienstvertrages w&auml;hrend seiner Arbeitszeit oder, sofern sie Bezug zu seinen dienstvertraglichen Aufgaben haben, auch au&szlig;erhalb seiner Arbeitszeit erstellt. Die &Uuml;bertragung der urheberrechtlichen Nutzungs- und Verwertungsrechte umfasst auch etwaige bei Vertragsschluss noch unbekannte Nutzungsarten. Die &Uuml;bertragung der Nutzungs- und Verwertungsrechte umfasst insbesondere auch die Erlaubnis zur Bearbeitung und Lizenzvergabe an Dritte. Das Vorstandsmitglied verzichtet ausdr&uuml;cklich auf sonstige ihm etwa als Urheber zustehende Rechte an den T&auml;tigkeitsergebnissen, insbesondere auf das Recht auf Namensnennung, auf Bearbeitung und auf Zug&auml;nglichmachung des Werkes.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall grant the Company exclusive rights of use and exploitation, unlimited in terms of time, space and content, for any works which may be protected under the Copyright Act and which the Board Member produces during the term of this Service Agreement during his working hours or, if they relate to his duties under the Service Agreement, also outside of his working hours. The transfer of the copyrighted rights of use and exploitation also includes any types of use still unknown at the time of conclusion of the agreement. The transfer of the rights of use and exploitation includes in particular the permission for processing and licensing to third parties. The Board Member expressly waives any other rights to the works, which he is entitled as the author, in particular the right to name, edit and make accessible the work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Soweit T&auml;tigkeitsergebnisse, die der Vorstand w&auml;hrend der Dauer seines Dienstvertrages w&auml;hrend seiner Arbeitszeit oder, sofern sie Bezug zu seinen dienstvertraglichen Aufgaben haben, auch au&szlig;erhalb seiner Arbeitszeit erstellt, nicht bereits nach Absatz (1) und (2) &uuml;bertragen sind, &uuml;bertr&auml;gt der Vorstand der Gesellschaft s&auml;mtliche Rechte an diesen T&auml;tigkeitsergebnissen, insbesondere Marken- und sonstige Kennzeichenrechte sowie eingetragene Designs.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Insofar as works which the Board Member produces during the term of its Service Agreement, during its working hours or, insofar as they relate to its duties under the Service Agreement, also outside its working hours, have not already been transferred in accordance with paragraphs (1) and (2), the Board Member shall transfer to the Company all rights to these works, in particular trademark and other distinctive rights as well as registered designs.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Parteien sind sich einig, dass die Einr&auml;umung dieser Rechte und der Verzicht auf Rechte nach dieser Regelung vollumf&auml;nglich mit der Zahlung der Grundverg&uuml;tung nach &sect;&nbsp;3 (1) lit. a) dieses Vertrages abgegolten sind, soweit dem nicht zwingende gesetzliche Regelungen entgegenstehen. Der Vorstand ist verpflichtet, jedwedes seiner schutzrechtsf&auml;higen T&auml;tigkeitsergebnisse unverz&uuml;glich der Gesellschaft, vertreten durch den Aufsichtsrat, zu meiden und die Gesellschaft im erforderlichen Umfang, auch nach Beendigung dieses Dienstvertrages, bei der Erlangung von Schutzrechten zu unterst&uuml;tzen. Soweit der Vorstand seine Mitwirkungspflichten nach der Beendigung dieses Dienstvertrages erf&uuml;llt, erh&auml;lt der Vorstand hierf&uuml;r einen angemessenen Tagessatz sowie eine Erstattung aller Aufwendungen, die ihm durch seine Mitwirkung entstanden sind.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The parties agree that the granting of these rights and the waiver of rights under this provision are fully covered by the payment of the Basic Remuneration under &sect; 3 (1) lit. a) this agreement, unless otherwise provided for by mandatory legal provisions. The Board Member is obliged to notify any of the works that are capable of being protected by intellectual property rights without delay to the Company, represented by the Supervisory Board, and to support the Company to the necessary extent, even after termination of this Service Agreement, in obtaining intellectual property rights. To the extent that the Board Member fulfils its duties to cooperate after the termination of this Service Agreement, the Board Member shall receive an appropriate daily rate as well as a reimbursement of all expenses incurred by him resulting from his cooperation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 9<BR>
Geheimhaltung und R&uuml;ckgabe von Unterlagen, Interessenkonflikte</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 9<BR>
Confidentiality and return of documents, conflicts of interest</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand verpflichtet sich, &uuml;ber alle ihm im Rahmen seiner T&auml;tigkeit oder sonst zur Kenntnis gelangenden gesch&auml;ftlichen und betrieblichen Angelegenheiten der Gesellschaft und aller Verbundenen Unternehmen strengstes Stillschweigen zu bewahren, einschlie&szlig;lich des Inhalts dieses Dienstvertrages sowie den Vertragsverhandlungen, die dem Abschluss dieses Dienstvertrages zugrunde liegen. Der Vorstand verpflichtet sich weiterhin, diese Informationen nicht f&uuml;r den eigenen oder den Nutzen anderer zu verwenden und alle solche gesch&auml;ftlichen und betrieblichen Angelegenheiten betreffenden Gesch&auml;ftsunterlagen der Gesellschaft und der Verbundenen Unternehmen unter Verschluss zu halten. Unter gesch&auml;ftlichen und betrieblichen Angelegenheiten im Sinne dieser Regelung verstehen die Parteien insbesondere Gesch&auml;fts- und Betriebsgeheimnisse sowie alle Informationen und Daten mit Bezug zu vertraulichen Angelegenheiten und gesch&auml;ftsbezogenem Know-how, s&auml;mtliche Informationen &uuml;ber alle mit dem existenten oder k&uuml;nftigen Gesch&auml;ft der Gesellschaft und der Verbundenen Unternehmen in Zusammenhang stehenden Gesch&auml;ftspl&auml;ne und Gesch&auml;ftsstrategien, Verfahren, Preis- oder Marktstrategien und Produkt-, Dienstleistungs- oder Entwicklungsplanungen, geplante Unternehmenserwerbe oder -ver&auml;u&szlig;erungen, s&auml;mtliche Gesch&auml;ftszahlen und Details der organisatorischen Strukturen sowie die wesentlichen Ideen und Prinzipien, welche diesen Strategien und Planungen zugrunde liegen, und alle Informationen, von denen vern&uuml;nftigerweise erwartet werden kann, dass sie zu solchen Strategien oder Planungen f&uuml;hren w&uuml;rden und die von der Gesellschaft, von Verbundenen Unternehmen oder dem Vorstandsmitglied w&auml;hrend der Dauer dieses Dienstvertrages erdacht, erfunden, &uuml;berarbeitet, entdeckt, entwickelt, erworben, beurteilt, getestet oder angewendet worden sind.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member undertakes to maintain the strictest secrecy with regard to all business and operational matters of the Company and old affiliated companies that come to its attention in the course of its activities or otherwise, including the contents of this Service Agreement and the negotiations on which the conclusion of this Service Agreement is based. The Board Member further undertakes not to use this information for its own benefit or for the benefit of others and to keep all business documents of the Company and its affiliates relating to such business and operational matters under lock and key. For the purposes of this provision, business and operational matters shall mean, in particular, business and trade secrets and all information and data relating to confidential matters and business-related know-how, all information, all business plans and strategies, procedures, price or market strategies and product, service or development plans relating to the existing or future business of the Company and its affiliates, planned corporate acquisitions or disposals, all business figures and details of the organizational structures and the principal ideas and principles underlying such strategies and plans, and all information that can reasonably be expected to result in such strategies or plans and that has been invented, redacted, discovered, developed, assessed, tested or applied by the Company, its affiliates or the Board Member during the term of this Service Agreement.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Geheimhaltungsverpflichtung nach vorstehendem Absatz (1) dauert auch nach Beendigung des Dienstverh&auml;ltnisses fort. Im Rahmen einer von dem Vorstand nach Beendigung dieses Dienstvertrages ausge&uuml;bten beruflichen oder unternehmerischen T&auml;tigkeit kann er sein als Vorstandsmitglied erworbenes Wissen einsetzen, sofern dabei die gesetzlichen Beschr&auml;nkungen &ndash; insbesondere nach &sect;&sect; 3, 17 UWG, &sect;&nbsp;823 (1) und (2) BGB i.V.m. UWG, &sect;&nbsp;826 BGB und den datenschutzrechtlichen Regelungen &ndash; sowie die Beschr&auml;nkungen aus dem nachvertraglichen Wettbewerbsverbot nach &sect;&nbsp;16 dieses Vertrages strikt beachtet werden.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The obligation to maintain secrecy pursuant to paragraph (1) above shall continue even after the termination of the employment relationship. The Board Member may use the knowledge acquired as a Board Member within the scope of a professional or entrepreneurial activity carried out by the Board Member after termination of this Service Agreement, provided that he complies with the statutory restrictions - in particular Sections 3, 17 UWG, Section 823 (1) and (2) BGB in conjunction with Sections 3, 17 UWG, Section 823 (1) and (2) BGB associated with UWG, Section 826 BGB and the data protection regulations.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand ist verpflichtet, in Zweifelsf&auml;llen &uuml;ber den Umfang der Geheimhaltungsverpflichtung nach vorstehenden Abs&auml;tzen (1) und (2) mit dem Aufsichtsrat der Gesellschaft eine Kl&auml;rung herbeizuf&uuml;hren.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In cases of doubt, the Board Member is obliged to reach a clarification with the Supervisory Board of the Company regarding the scope of the confidentiality obligation pursuant to paragraphs (1) and (2) above.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand verpflichtet sich, auf Verlangen der Gesellschaft jederzeit und sp&auml;testens bei Ende seiner Bestellung zum Organ auch ohne gesonderte Aufforderung alle in seinem Besitz befindlichen Unterlagen der Gesellschaft oder Verbundener Unternehmen, insbesondere alle Notizen, Memoranden, Aufzeichnungen, Protokolle und Berichte, Akten sowie alle anderen &auml;hnlichen Dokumente (einschlie&szlig;lich Abschriften, Ablichtungen, Kopien oder sonstiger Reproduktionen), die im Zusammenhang mit seiner T&auml;tigkeit stehen, unverz&uuml;glich und vollst&auml;ndig an die Gesellschaft zur&uuml;ckzugeben. Ein Zur&uuml;ckbehaltungsrecht ist ausgeschlossen. Diese Regelung gilt sinngem&auml;&szlig; f&uuml;r elektronisch gespeicherte Daten sowie die jeweiligen Daten- oder Programmtr&auml;ger.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member undertakes, at the request of the Company at any time and at the latest at the end of its appointment to the board and without separate request, to return to the Company all documents of the Company or affiliated companies in its possession, in particular all notes, memoranda, records, minutes and reports, files as well as all other similar documents (including copies, photocopies or other reproductions) in connection with its activities without delay and in full. A right of retention is excluded. This provision applies to electronically stored data as well as to the respective data or program carriers.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Herausgabeverpflichtung bezieht sich auch auf sonstiges, im Besitz des Vorstands befindliches Eigentum der Gesellschaft oder Verbundener Unternehmen bzw. von der Gesellschaft oder von einem Verbundenen Unternehmen geleaste Gegenst&auml;nde. Diese Herausgabeverpflichtung erstreckt sich insbesondere auch auf ein dem Vorstand etwa &uuml;berlassenes Mobiltelefon, Laptop oder sonstige Ger&auml;te der Datenverarbeitung, bei Ende seiner Bestellung zum Organ auch, wenn insoweit eine private Nutzung gestattet war.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The release obligation also applies to other property of the Company or affiliates or items leased by the Company or an affiliate that is in possession of the Board Member. This release obligation also extends in particular to a mobile phone, laptop or other data processing device left in the possession of the Board Member, at the end of its appointment to the Board even if private use was permitted in this respect.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand hat m&ouml;gliche und tats&auml;chliche Interessenkonflikte unverz&uuml;glich dem Aufsichtsrat gegen&uuml;ber offenzulegen und die anderen Vorstandsmitglieder hier&uuml;ber zu informieren.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member must immediately disclose possible and actual conflicts of interest to the Supervisory Board and inform the other members of the Management Board hereof.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 10<BR>
Vertragsdauer, Beendigung, Abfindung</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 10<BR>
Term of the Agreement, Termination, Severance</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Dienstvertrag beginnt mit dem 01.01.2024 (&bdquo;<B>Stichtagsdatum</B>&ldquo;) und endet zum Ablauf des 31.12.2026 (&bdquo;<B>Beendigungsdatum&ldquo;</B>).</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Service Agreement commences on January 01, 2024 (&ldquo;<B>Effective Date</B>&rdquo;) and ends on December 31, 2026 (&ldquo;<B>Completion Date</B>&rdquo;).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Das Recht zur au&szlig;erordentlichen K&uuml;ndigung bleibt unber&uuml;hrt.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The right to extraordinary termination remains unaffected.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im Fall eines Widerrufs der Bestellung, der Amtsniederlegung durch das Vorstandsmitglied oder bei einer sonstigen Beendigung der Organstellung endet dieser Dienstvertrag mit Ablauf von drei Monaten nach dem Ende des Amtes, sp&auml;testens jedoch zum Ende der Laufzeit nach Absatz (1). Eine etwaige fr&uuml;here Beendigung aufgrund Absatz (2) dieses Vertrages bleibt unber&uuml;hrt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of revocation of the appointment, demission by the Board Member or other termination of the position, this Service Agreement shall end at the end of three months after the end of the term of office, at the latest, however, at the end of the term pursuant to paragraph (1). A possible termination due to paragraph (2) of this agreement remains unaffected.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorsitzende des Aufsichtsrats wird dem Vorstand sp&auml;testens drei Monate vor Ablauf dieses Vertrages, also bis zum 30. September 2026, schriftlich mitteilen, ob und unter welchen Bedingungen der Aufsichtsrat den Vorstand erneut zum Vorstandsmitglied bestellen wird und ob er bereit ist, den Dienstvertrag entsprechend der Dauer der neuen Bestellung zu verl&auml;ngern oder einen neuen Dienstvertrag zu mindestens gleichen Bedingungen mit ihm abzuschlie&szlig;en, Der Vorstand wird innerhalb von zwei Monaten ab Zugang des Angebots des Aufsichtsratsvorsitzenden erkl&auml;ren, ob er die erneute Bestellung annimmt und bereit ist, den f&uuml;r die Fortsetzung oder Erneuerung des Dienstvertrages angebotenen Bedingungen zuzustimmen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Chairman of the Supervisory Board will inform the Board Member in writing no later than three months before the expiry of this agreement, i.e. by 30 September 2026, whether and under what conditions the Supervisory Board will reappoint the Board Member and whether he is willing to extend the Service Agreement for the duration of the new appointment or to conclude a new Service Agreement on at least the same terms. Within two months of receipt of the Supervisory Board Chairman's offer, the Board Member will declare whether it accepts the reappointment and is prepared to agree to the terms and conditions offered for the continuation or renewal of the Service Agreement.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft ist berechtigt, den Vorstand nach dem Widerruf seiner Bestellung gem&auml;&szlig; &sect; 84 (3) AktG oder im Zusammenhang mit einer Beendigung des Dienstvertrages, insbesondere nach einer K&uuml;ndigung oder im Anschluss an den Abschluss eines Aufhebungsvertrages, ganz oder teilweise von seiner Pflicht zur Dienstleistung unter Fortzahlung der Grundverg&uuml;tung gem&auml;&szlig; &sect; 3 (1) lit. a) widerruflich oder unwiderruflich freizustellen. Im Fall der unwiderruflichen Freistellung werden offene Urlaubs- und sonstige Freizeitausgleichsanspr&uuml;che angerechnet, die damit erledigt sind. Der Dienstvertrag im &Uuml;brigen wird von der Freistellung nicht ber&uuml;hrt; insoweit bestehen insbesondere die Verschwiegenheitspflicht und das vertragliche Wettbewerbsverbot bis zum Ende des Dienstvertrages fort. Anderweitiger Verdienst w&auml;hrend der Freistellungszeit wird gem&auml;&szlig; &sect; 615 Satz 2 BGB angerechnet. Eine Anrechnung erfolgt nicht, wenn und soweit der anderweitige Verdienst aus einer genehmigten Nebent&auml;tigkeit (&sect; 2 (1) dieses Dienstvertrages) stammt.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Company is entitled, after the revocation of its appointment pursuant to Section 84 (3) AktG or in connection with a termination of the Service Agreement, in particular following a termination or following the conclusion of a termination agreement, to release the Board Member in whole or in part from its obligation to provide services with continued payment of the Basic Remuneration pursuant to &sect; 3 (1) a) revocably or irrevocably. In the event of irrevocable release, receivable holiday and other time off compensation claims shall be credited and settled. The rest of the Service Agreement is not affected by the indemnification; in this respect, the obligation to maintain secrecy and the contractual non-competition clause continue to apply until the end of the Service Agreement. Other earnings during the exemption period shall be credited in accordance with Section 615 sentence 2 BGB. Crediting does not take place if and as far as the other earnings originate from an approved secondary activity (&sect; 2 (1) of this Service Agreement).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Dienstvertrag endet sp&auml;testens am Ende des Kalenderjahres, in dem das Vorstandsmitglied sein 65. Lebensjahr vollendet, sofern dieser Dienstvertrag nicht bereits nach Absatz (1) bis (2) dieses Vertrages vor diesem Zeitpunkt geendet hat.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Service Agreement shall end at the latest at the end of the calendar year in which the Board Member reaches the age of 65, unless this Service Agreement has not already ended before this date in accordance with paragraphs (1) to (2) of this agreement.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Bei vorzeitiger Beendigung der Vorstandst&auml;tigkeit durch die Gesellschaft ohne wichtigen Grund entsprechen die Zahlungen an den Vorstand einschlie&szlig;lich Nebenleistungen maximal dem Wert von zwei Jahresverg&uuml;tungen (Abfindungs-Cap) und &uuml;berschreiten nicht die Gesamtverg&uuml;tung (Grundverg&uuml;tung, variable Verg&uuml;tung sowie Nebenleistungen) f&uuml;r die Restlaufzeit des Dienstvertrages. Bei einem Kontrollerwerb nach &sect; 7 gilt ein Abfindungs-Cap von maximal drei Jahresverg&uuml;tungen.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">7.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of premature termination of the board activity by the Company without good cause, payments to the Board Member including fringe benefits shall not exceed the value of two years' remuneration (severance payment cap) and shall not exceed the total remuneration (Basic Remuneration, variable remuneration and fringe benefits) for the remaining term of the Service Agreement. In the case of an acquisition of control pursuant to &sect; 7, a severance payment cap of a maximum of three years' remuneration applies.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Sofern der Dienstvertrag nicht &uuml;ber das Beendigungsdatum nach dieser &Auml;nderungsvereinbarung (oder ein sp&auml;ter vereinbartes Beendigungsdatum nach abermaliger Wiederbestellung) hinaus fortgesetzt wird, erh&auml;lt der Vorstand eine Brutto-Abfindung in H&ouml;he von 9 Monatsgrundgeh&auml;ltern gem&auml;&szlig; &sect; 3. Die Abfindung ist zahlbar zum Beendigungsdatum. Der Abfindungsanspruch entf&auml;llt, wenn der Vorstand ein Angebot auf Wiederbestellung f&uuml;r eine Dauer von mindestens 12 Monaten im unmittelbaren Anschluss an das hiesige Beendigungsdatum zu mindestens gleichwertigen dienstvertraglichen Bedingungen und bei mindestens 12-monatiger Laufzeit in &Uuml;bereinstimmung mit den Fristen gem&auml;&szlig; &sect; 10 Ziffer 4 erh&auml;lt und dieses nicht annimmt. Erh&auml;lt der Vorstand ein solches Angebot im Sinne von &sect; 10 Ziffer 4 versp&auml;tet oder zu nicht gleichwertigen Bedingungen, oder wird ihm mitgeteilt, dass eine Wiederbestellung nicht erfolgen soll, so werden die Zahlungen gem&auml;&szlig; &sect; 3 die dem Zeitraum von der Angebotsunterbreitung bzw. Mitteilung der nicht erfolgenden Wiederstellung bis zum Beendigungsdatum zuzuordnen sind, vom Abfindungsanspruch abgezogen, aber nur den Zeitraum, f&uuml;r den eine Freistellung nach &sect; 10 Ziffer 5 erfolgt ist.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>If the Service Agreement is not continued beyond the Completion Date under this Amendment Agreement (or a later termination date agreed upon after reappointment), the Board Member shall receive gross severance payment equal to 9 monthly basic remuneration pursuant to &sect; 3. The severance payment is payable on the Completion Date. The severance payment claim shall lapse if the Board member receives and does not accept an offer of reappointment for a term of at least 12 months immediately following the Completion Date here under at least equivalent terms and conditions of the Service Agreement and for a term of at least 12 months in accordance with the time limits pursuant to &sect; 10 clause 4. If the Board Member receives such an offer within the meaning of &sect; 10 clause 4 belatedly or on non-equivalent terms, or is informed that a reappointment is not to take place, the payments pursuant to &sect; 3, which are attributable to the period from the submission of the offer or notification of the non-occurrence of the reappointment until the Completion Date, shall be deducted from the severance payment claim but only for the period for which a release has occurred pursuant to &sect; 10 clause 5.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 17.35pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Der Abfindungsanspruch entf&auml;llt, sofern die Nichtverl&auml;ngerung des Dienstverh&auml;ltnisses auf einem vom Vorstand zu vertretenen wichtigen Grund beruht.</FONT></TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 20pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">The severance payment claim shall lapse if the non-extension of the employment relationship is due to a serious cause for which the Board Member is responsible. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 17.35pt; text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 20pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 17.6pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Der Abfindungsanspruch besteht auch dann, wenn das Dienstverh&auml;ltnis mindestens 9 Monate vor dem Beendigungsdatum aufgrund Abberufung / K&uuml;ndigung der Gesellschaft gem&auml;&szlig; &sect; 10 Ziffer 4 endet (vorzeitiges Beendigungsdatum), jedoch nur, soweit das Dienstverh&auml;ltnis nicht aus einem vom Vorstand zu vertretenen wichtigen Grund vorzeitig beendet worden ist. Endet das Dienstverh&auml;ltnisses infolge einer K&uuml;ndigung gem&auml;&szlig; vorstehenden Satz weniger als 9 Monate vor dem Beendigungsdatum, so werden die Zahlungen gem&auml;&szlig; &sect; 3, die dem Zeitraum von dem vorzeitigen Beendigungsdatum bis zum Beendigungsdatum zuzuordnen sind, vom Abfindungsanspruch abgezogen. Die Abfindung ist dann zum vorzeitigen Beendigungsdatum zahlbar.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 20.05pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The severance payment claim also exists if the employment relationship ends at least 9 months before the Completion Date due to removal from office / termination of the Company pursuant to &sect; 10 clause 3 (Early Completion Date), but only to the extent that the employment relationship has not been prematurely terminated for serious cause for which the Board Member is responsible. If the employment relationship ends less than 9 months prior to the Completion Date as a result of a termination pursuant to the preceding sentence, the payments pursuant to &sect; 3 as amended by this Amendment Agreement, which are attributable to the period from the Early Completion Date to the Completion Date, shall be deducted from the severance payment claim. The severance payment shall then be payable on the Early Completion Date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 11<BR>
Ausschlussfristen</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 11<BR>
Cut-off Periods</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Anspr&uuml;che der Gesellschaft und des Vorstands aus dem Dienstverh&auml;ltnis oder im Zusammenhang mit diesem Dienstverh&auml;ltnis verfallen, ungeachtet ihres Rechtsgrundes, wenn die bzw. der Anspruchsberechtigte den Anspruch nicht innerhalb einer Frist von sechs Monaten, berechnet ab dem Zeitpunkt der F&auml;lligkeit und der Kenntnis oder grob fahrl&auml;ssigen Unkenntnis des Anspruchsberechtigten von den anspruchsbegr&uuml;ndenden Umstanden, durch Erkl&auml;rung in Textform gegen&uuml;ber der jeweils anderen Vertragspartei geltend macht. F&uuml;r die Beurteilung der Rechtzeitigkeit der Geltendmachung ist der Zugang der Erkl&auml;rung ma&szlig;geblich. Dies gilt nicht f&uuml;r die Geltendmachung von Anspr&uuml;chen wegen Verletzung des Lebens, des K&ouml;rpers oder der Gesundheit sowie bei vors&auml;tzlichen Pflichtverletzungen. Diese Ausschlussfrist gilt auch nicht f&uuml;r Anspr&uuml;che auf den gesetzlichen Mindestlohn sowie f&uuml;r gesetzliche Fristen, die keiner Ausschlussfrist unterliegen d&uuml;rfen. Die Vers&auml;umung der Ausschlussfrist f&uuml;hrt zum Verlust des Anspruchs</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>. Claims of the Company and the Board Member arising from or in connection with the service relationship expire, irrespective of their legal basis, if the claimant does not assert the claim within a period of six months, calculated from the due date and the knowledge or grossly negligent ignorance of the claimant of the circumstances giving rise to the claim, by declaration in text form against the respective other contracting party. For the assessment of the timeliness of the assertion, the receipt of the declaration is decisive. This does not apply to the assertion of claims due to injury to life, bodily injury or health as well as to intentional breaches of duty. The aforementioned preclusive period shall also not apply to claims regarding the statutory minimum wage as well as to statutory time limits that are no subject to limitation periods. Failure to observe the limitation period shall result in the loss of the claim</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Etwaige Anspr&uuml;che der Gesellschaft nach &sect; 93 (2) und (3) AktG gegen das Vorstandsmitglied bleiben gem&auml;&szlig; &sect; 93 (4) Satz 3 AktG von vorstehendem Absatz (1) unber&uuml;hrt.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Any claims of the Company pursuant to Section 93 (2) and (3) AktG against the Board Member shall remain unaffected by the above paragraph (1) pursuant to Section 93 (4) sentence 3 AktG.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 12<BR>
Schlussbestimmungen</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 12<BR>
Final Provisions</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dieser Vertrag enth&auml;lt die gesamte Vereinbarung zwischen den Parteien. Bereits getroffene Vereinbarungen zwischen den Parteien werden hiermit ausdr&uuml;cklich mit Wirkung ab dem Stichtagsdatum aufgehoben.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>This agreement contains the entire agreement between the parties. Prior agreements between the parties are hereby expressly cancelled with effect as of the Effective Date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>&Auml;nderungen oder Erg&auml;nzungen dieses Vertrages einschlie&szlig;lich dieser Schriftformklausel bed&uuml;rfen zu ihrer Wirksamkeit der Schriftform.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Changes or additions to this agreement, including this written form clause, must be made in writing to be effective.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dieser Vertrag unterliegt dem Recht der Bundesrepublik Deutschland.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>This agreement is subject to the law of the Federal Republic of Germany.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Erf&uuml;llungsort ist der Sitz der Gesellschaft, Gerichtsstand f&uuml;r Streitigkeiten aus diesem Vertrag ist der Sitz der Gesellschaft.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Place of performance is the seat of the Company, place of jurisdiction for disputes from this agreement is the seat of the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die deutsche Fassung dieser Vereinbarung ist ma&szlig;geblich.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The German version of this Amendment Agreement is authoritative.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Sollte eine Bestimmung dieses Vertrages ganz oder teilweise rechtsunwirksam oder undurchf&uuml;hrbar sein oder werden, so wird die G&uuml;ltigkeit der &uuml;brigen Bestimmungen dieses Vertrages nicht ber&uuml;hrt. Vielmehr ist die ganz oder teilweise rechtsunwirksame oder undurchf&uuml;hrbare Bestimmung durch eine Bestimmung zu ersetzen, die den mit der unwirksamen Bestimmung angestrebten wirtschaftlichen Erfolg soweit wie m&ouml;glich erreicht. Das gleiche gilt im Fall von L&uuml;cken dieses Vertrages.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Should any provision of this agreement be or become invalid or unenforceable in whole or in part, the validity of the remaining provisions of this agreement shall not be affected. Rather, the invalid or unenforceable provision, in whole or in part, shall be replaced by a provision that achieves as far as possible the economic purpose intended by the invalid provision. The same shall apply in the event of any gaps in this agreement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Martinsried, den</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Martinsried, den</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2in">12/19/2023</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2in">&nbsp;</P></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12/18/2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Immunic AG,<BR>
vertreten durch den Aufsichtsratsvorsitzenden<BR>
/s/ Dr. J&ouml;rg Neermann</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif">Dr. Andreas M&uuml;hler</FONT></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Anlagenverzeichnis</B></FONT></TD>
    <TD STYLE="width: 3%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 48%; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Schedule of Annexes</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Anlage 1:&#9;AR-Beschluss</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Annex 1:&#9;SB resolution</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Anlage 2:&#9;Genehmigte Nebent&auml;tigkeiten des Vorstands</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Annex 2:&#9;Approved ancillary activity of the Board Member</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Anlage 1:</B> AR-Beschluss / <B>Annex 1:</B> SB resolution</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Anlage 2:</B> Genehmigte Nebent&auml;tigkeiten des Vorstands / <B>Annex
2:</B> Approved ancillary activity of the Board Member</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 14.15pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Takeda Group, einschlie&szlig;lich der 100%-igen
Tochtergesellschaft Takeda Pharmaceuticals International, vormals Millennium Pharmaceuticals (durchschnittlicher Aufwand beschr&auml;nkt
auf maximal 8 Stunden pro Woche) / </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 21.3pt"></TD><TD STYLE="width: 14.15pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Takeda Group, including its wholly owned subsidiary
Takeda Pharmaceuticals International, formerly Millennium Pharmaceuticals (average effort limited to a maximum of 8 hours per week)</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt">&nbsp;</P>

<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>e619130_ex10-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EMPLOYMENT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 5.05pt; text-align: justify; text-indent: 35pt">This Employment
Agreement (the &ldquo;<B><I>Agreement</I></B>&rdquo;) is entered into on December 18, 2023 and effective as of January 1, 2024 (the &ldquo;<B><I>Effective
Date</I></B>&rdquo;), by and between <B>IMMUNIC, INC.</B>, a Delaware corporation (the &ldquo;<B><I>Company</I></B>&rdquo;), and <B>ANDREAS
ROLF MUEHLER</B> (the &ldquo;<B><I>Executive</I></B>&rdquo;), with residential address of <FONT STYLE="font-family: Times New Roman, Times, Serif">[</FONT><FONT STYLE="font-family: Wingdings">l</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">]</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in 0pt 5.05pt; text-align: justify; text-indent: 35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.55pt 0pt 5.05pt; text-align: justify; text-indent: 35pt">WHEREAS, the
Company desires that the Executive be retained to continue to serve in the capacity of Chief Medical Officer of the Company, and the Executive
has agreed to continue to serve in such position in accordance with the terms and conditions of this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.55pt 0pt 5.05pt; text-align: justify; text-indent: 35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.55pt 0pt 5.05pt; text-align: justify; text-indent: 35pt">NOW, THEREFORE,
in consideration of the premises and mutual covenants contained herein, and for other valuable consideration, the Company and the Executive
hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.55pt 0pt 5.05pt; text-align: justify; text-indent: 35pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Certain Definitions</U>. Capitalized terms shall have the meanings set forth on <B>Exhibit A</B> attached hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Term of Employment</U>. The Company shall continue to employ the Executive, and the Executive shall continue to accept employment,
upon the terms and conditions set forth in this Agreement for the period commencing on the Effective Date and ending on the earlier of:
(a) December 31, 2026 and (b) the Executive&rsquo;s Date of Termination as provided in <U>Section 6</U> (such period shall be referred
to as the &ldquo;<B><I>Initial Term of Employment</I></B>&rdquo;). The Company shall provide written notice of non-renewal at least three
(3) months, or the Executive shall provide written notice of non-renewal at least six (6) months, before the end of Initial Term of Employment,
if such negotiation in good faith for an extension to this Agreement will no longer be sought. In the event the parties negotiate an extension
of this Agreement, the extended period, together with the Initial Term of Employment shall be referred to in this Agreement as the &ldquo;<B><I>Term
of Employment</I></B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">3.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Executive&rsquo;s Duties and Obligations.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Duties</U>. The Executive shall serve as the Company&rsquo;s Chief Medical Officer. The Executive shall be responsible for all
duties customarily associated with the Chief Medical Officer of a publicly-traded company. The Executive shall report directly to the
Company&rsquo;s Chief Executive Officer (&ldquo;<B><I>CEO</I></B>&rdquo;) and shall be subject to reasonable policies established by the
CEO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Location of Employment</U>. The Executive&rsquo;s principal place of business shall be primarily his home office, to the extent
it does not interfere with work assignments, or at the headquarters of the Company to be located in New York, New York. In addition, the
Executive acknowledges and agrees that the performance by the Executive of the Executive&rsquo;s duties shall require frequent travel
including, without limitation, overseas travel from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Confidential Information, Assignment of Rights, Non-Solicitation and Non-Competition Agreement</U>. In consideration of the
covenants contained herein, the Executive has executed and agrees to be bound by the Confidential Information, Assignment of Rights, Non-Solicitation
and Non-Competition Agreement (the &ldquo;<B><I>Confidentiality Agreement</I></B>&rdquo;) attached to this Agreement as <B><U>Exhibit
B</U></B>. The Executive shall comply at all times with the covenants (including covenants not to compete or solicit employees, consultants
and independent contractors) and other terms and conditions of the Confidentiality Agreement and all other reasonable policies of the
Company governing its confidential and proprietary information. The Executive&rsquo;s obligations under the Confidentiality Agreement
shall survive the Term of Employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Devotion of Time to the Company&rsquo;s Business</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Efforts</U>. During the Term of Employment, the Executive shall devote fifty percent (50%) of his business time, attention and
effort to the affairs of the Company, excluding any periods of disability, vacation, or sick leave to which the Executive is entitled,
and shall use his reasonable best efforts to perform the duties properly assigned to him hereunder and to promote the interests of the
Company. It is agreed the Executive shall devote the remaining fifty percent (50%) of his business time to Immunic AG.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Other Activities</U>. The Executive may serve on corporate, civic or charitable boards or committees, deliver lectures, fulfill
speaking engagements and may manage personal investments; provided that such activities do not individually or in the aggregate significantly
interfere with the performance of his duties under this Agreement. In addition, Executive may engage in certain limited consulting agreements
as provided in the Service Agreement effective as of January 1, 2024 with Immunic AG.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">5.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compensation and Benefits</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Base Salary</U>. The Company shall pay to the Executive in accordance with its normal payroll practices (but not less frequently
than monthly) an annual salary at a rate of two hundred and fifty thousand dollars ($250,000) per annum (&ldquo;<B><I>Base Salary</I></B>&rdquo;).
The Executive&rsquo;s Base Salary shall be reviewed at least annually for the purpose of determining increases, if any, based on the Executive&rsquo;s
performance, the performance of the Company, then prevailing salary scales for comparable positions, inflation and other relevant factors.
Effective as of the date of any increase in the Executive&rsquo;s Base Salary, Base Salary as so increased shall be considered the new
Base Salary for all purposes of this Agreement and may not thereafter be reduced. Any increase in Base Salary shall not limit or reduce
any other obligation of the Company to the Executive under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Annual Bonus</U>. During the Term of Employment, the Executive shall be eligible to receive an annual cash incentive award (&ldquo;<B><I>Annual
Bonus</I></B>&rdquo;) pursuant to the bonus plan then in effect for executive employees of the Company (the &ldquo;<B><I>Bonus Plan</I></B>&rdquo;).
All Annual Bonuses are subject to the terms and conditions of then-current Bonus Plan adopted by the Company. If the Executive achieves
his target performance goals for a Fiscal Year, which goals shall be determined by the Compensation Committee of the Board on an annual
or more frequent basis, the Annual Bonus shall be not less than forty percent (40%) of his Base Salary. To be eligible to receive an Annual
Bonus, the Executive must be actively employed by the Company at the time the Annual Bonus, if any, is paid; provided, however, that if
the Executive&rsquo;s employment is terminated by the Company without Cause, by the Executive for Good Reason, or upon non-renewal by
the Executive as provided in <U>Section 2</U>, Executive shall be entitled to receive a pro-rated Annual Bonus for such Fiscal Year, subject
to his achievement of his target performance goals prior to such termination. Any such pro-rated bonus shall be paid within thirty (30)
days of the Executive&rsquo;s termination of employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Benefits</U>. During the Term of Employment, the Executive shall be entitled to participate in all employee benefit plans, programs
and arrangements made available generally to the Company&rsquo;s senior executives or to other full-time employees on substantially the
same basis that such benefits are provided to such senior executives of a similar level or to other full-time employees (including, without
limitation profit-sharing, savings and other retirement plans or programs (e.g., a 401(k) plan)), long-term cash incentive plan, program
or arrangement, medical, dental, hospitalization, vision, short- term and long-term disability and life insurance plans or programs, accidental
death and dismemberment protection, travel accident insurance, and any other fringe benefit or employee welfare benefit plans or programs
that may be sponsored by the Company from time to time, including any plans or programs that supplement the above-listed types of plans
or programs (whether funded or unfunded); provided, however, that during the Term of Employment, the Executive shall not be eligible to
participate in any generally available severance benefit plan, program or arrangement sponsored or maintained by the Company. Nothing
in this Agreement shall be construed to require the Company to establish or maintain any such fringe or employee benefit plans, programs
or arrangements. If a conflict should exist between similar benefits afforded under any Company policy and the benefits afforded under
this Agreement, to the extent that this Agreement shall provide for greater benefits, the terms of this Agreement shall control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Vacations</U>. During the Term of Employment, the Executive shall be entitled to an annual aggregate maximum of thirty (30)
days&rsquo; vacation under this Agreement and his Service Agreement with Immunic AG.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Reimbursement of Expenses</U>. During the Term of Employment, the Executive shall be entitled to receive prompt reimbursement
for all reasonable business-related or employment-related expenses incurred by the Executive upon the receipt by the Company of reasonable
documentation in accordance with standard practices, policies and procedures applicable to other senior executives of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">6.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination of Employment</U>. The Term of Employment shall be automatically terminated upon the first to occur of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Death</U>. The Executive&rsquo;s employment shall terminate immediately upon the Executive&rsquo;s death.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Disability</U>. If the Executive is Disabled, either party may terminate the Executive&rsquo;s employment due to such Disability
upon delivery of written notice to the other party. The effective date of such termination of employment will be the Date of Termination
set forth in such written notice or immediately upon delivery of such written notice if no effective date is specified in the written
notice. For avoidance of doubt, if the Executive&rsquo;s employment is terminated pursuant to this <U>Section 6(b)</U>, his employment
will not constitute a termination of employment by the Company without Cause or by the Executive for Good Reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination by the Executive Without Good Reason</U>. The Executive may terminate his employment for any reason other than Good
Reason upon his delivery of written notice to the Company at least thirty (30) days prior to his Date of Termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination by the Executive for Good Reason</U>. The Executive may terminate his employment for Good Reason if (i) not later
than ninety (90) days after the occurrence of any act or omission that constitutes Good Reason, the Executive provides the Company with
a written notice setting forth in reasonable detail the acts or omissions that constitute Good Reason, (ii) the Company fails to correct
or cure the acts or omissions within thirty (30) days after it receives such written notice, and (iii) the Executive terminates his employment
with the Company after the expiration of such cure period but not later than sixty (60) days after the expiration of such cure period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination by the Company Without Cause</U>. The Company may terminate the Executive&rsquo;s employment without Cause upon
delivery of written notice to the Executive at least thirty (30) days prior to his Date of Termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination Upon Non-Renewal</U>. Unless otherwise agreed to by the parties, the Executive&rsquo;s employment shall terminate
on the last day of the Initial Term of Employment if either the Company or the Executive provides the other party with a written notice
of non-renewal of this Agreement in accordance with <U>Section 2</U> and the parties do not extend this Agreement prior to the expiration
of the Initial Term of Employment (&ldquo;<B><I>Non-Renewal</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination by the Company for Cause</U>. Upon the occurrence of any act or omission that constitutes Cause, the Company may
terminate the Executive&rsquo;s employment upon delivery of written notice to the Executive at least fifteen (15) days prior to his Date
of Termination, unless the Executive cures such acts or omissions constituting Cause to the satisfaction of the Company prior to the expiration
of such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">7.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Compensation and Benefits Payable Upon of Termination of Employment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Payment of Accrued But Unpaid Compensation and Benefits</U>. Upon the Executive&rsquo;s termination of employment for any reason,
the Executive (or his Beneficiary following the Executive&rsquo;s death) shall receive (i) a lump sum payment on the Date of Termination
in an amount equal to the sum of the Executive&rsquo;s earned but unpaid Base Salary through his Date of Termination plus his accrued
but unused vacation days at the Executive&rsquo;s Base Salary in effect as of his Date of Termination; plus (ii) any other benefits or
rights the Executive has accrued or earned through his Date of Termination in accordance with the terms of the applicable fringe or employee
benefit plans and programs of the Company. Except as provided in <U>Section 7(b)</U> or <U>Section 7(c)</U> below or as expressly provided
pursuant to the terms of any employee benefit plan, the Executive will not be entitled to earn or accrue any additional compensation or
benefits for any period following his Date of Termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination of Employment Due to Death or Disability</U>. In addition to the compensation and benefits payable under <U>Section
7(a)</U> above, if the Executive&rsquo;s employment is terminated due to his death or Disability, the Executive (or his Beneficiary following
the Executive&rsquo;s death) shall receive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Executive&rsquo;s accrued but unpaid Annual Bonus, if any, for the Fiscal Year ended prior to his Date of Termination payable
at the same time annual bonuses for such Fiscal Year are paid to other key executives of the Company pursuant to the terms of the Bonus
Plan; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>one hundred percent (100%) of the Executive&rsquo;s outstanding Equity Awards as of the Date of Termination will be fully vested
and exercisable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Termination of Employment by the Company Without Cause, by the Executive for Good Reason or Upon Non-Renewal by the Company</U>.
In addition to the compensation and benefits payable under <U>Section 7(a)</U> above, if the Executive&rsquo;s employment is terminated
by the Company without Cause, by the Executive for Good Reason or upon Non-Renewal in accordance with <U>Section 2</U> where it is the
Company that provided written notice of non-renewal of this Agreement in accordance with <U>Section 2</U>, and the Executive returns an
executed Release to the Company, which becomes final, binding and irrevocable within sixty (60) days following the Executive&rsquo;s Date
of Termination in accordance with <U>Section 8</U>, the Executive (or his Beneficiary following the Executive&rsquo;s death) shall receive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>the Executive&rsquo;s accrued but unpaid Annual Bonus, if any, for the Fiscal Year ended prior to his Date of Termination payable
at the same time annual bonuses for such Fiscal Year are paid to other key executives of the Company pursuant to the terms of the Bonus
Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>one hundred percent (100%) of the Executive&rsquo;s outstanding Equity Awards as of the Date of Termination will be fully vested
and exercisable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>a severance payment payable in a single lump sum within five (5) business days after the Executive&rsquo;s Release becomes final,
binding and irrevocable in accordance with <U>Section 8</U>, in an amount equal to nine (9) months of Base Salary; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>reimbursement of the COBRA premiums, if any, paid by the Executive for continuation coverage for the Executive, his spouse and
dependents under the Company&rsquo;s group health, dental and vision plans for the period such individuals have COBRA continuation coverage.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding the foregoing,
if the Executive materially breaches this Agreement or the Executive&rsquo;s Confidentiality Agreement, then the Company&rsquo;s continuing
obligations under this <U>Section 7(c)</U> shall cease as of the date of the breach and the Executive shall be entitled to no further
payments hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Release</U>. As a condition of receiving the compensation and benefits described in <U>Section 7(c)</U>, the Executive must
execute a release of any and all claims arising out of the Executive&rsquo;s employment with the Company or the Executive&rsquo;s separation
from such employment (including, without limitation, claims relating to age, disability, sex or race discrimination to the extent permitted
by law), excepting (i) claims for benefits under any employee benefit plan in accordance with the terms of such employee benefit plan,
(ii) any right to exercise Equity Awards that are vested on the Date of Termination pursuant to the terms of such Equity Awards (as modified
by the Employment Agreement), (iii) claims based on breach of the Company&rsquo;s obligations to pay the compensation and benefits described
in <U>Section 5</U>, <U>Section 7(a)</U> or <U>Section 7(c)</U> of this Employment Agreement, (iv) claims arising under the Age Discrimination
in Employment Act after the date the Executive signs such release, and (v) any right to indemnification by the Company or to coverage
under directors and officers liability insurance to which the Executive is otherwise entitled in accordance with this Agreement and the
Company&rsquo;s articles of incorporation or by laws or other agreement between the Executive and the Company (the &ldquo;<B><I>Release</I></B>&rdquo;).
Such Release shall be in a form tendered to the Executive by the Company within five (5) business days following the termination of the
Executive&rsquo;s employment by the Company without Cause or by the Executive for Good Reason, which shall comply with any applicable
legislation or judicial requirements, including, but not limited to, the Older Workers Benefit Protection Act, and shall be substantially
in the form of release attached as <B>Exhibit C</B>. The compensation and benefits described in <U>Section 7(c)</U> will not be paid to
the Executive if the Executive fails to execute the Release within the time frame specified in such Release, if the Executive revokes
the Release within the applicable revocation period set forth in such Release or if the revocation period expires more than sixty (60)
days following the Executive&rsquo;s Date of Termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">9.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Excess Parachute Excise Tax.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Anything in this Agreement to the contrary notwithstanding, in the event it shall be determined that any payment, award, benefit
or distribution (including any acceleration) by the Company or any entity which effectuates a transaction described in Section 280G(b)(2)(A)(i)
of the Code to or for the benefit of the Executive (whether pursuant to the terms of this Agreement or otherwise, but determined before
application of any reductions required pursuant to this <U>Section 9</U>) (a &ldquo;<B><I>Payment</I></B>&rdquo;) would be subject to
the excise tax imposed by Section 4999 of the Code or any interest or penalties are incurred with respect to such excise tax by the Executive
(such excise tax, together with any such interest and penalties, are hereinafter collectively referred to as the &ldquo;<B><I>Excise Tax</I></B>&rdquo;),
the Company will automatically reduce such Payments to the extent, but only to the extent, necessary so that no portion of the remaining
Payments will be subject to the Excise Tax, unless the amount of such Payments that the Executive would retain after payment of the Excise
Tax and all applicable Federal, state and local income taxes without such reduction would exceed the amount of such Payments that the
Executive would retain after payment of all applicable Federal, state and local taxes after applying such reduction. Unless otherwise
elected by the Executive, to the extent permitted under Code Section 409A, such reduction shall first be applied to any severance payments
payable to the Executive under this Agreement, then to the accelerated vesting on any Equity Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>All determinations required to be made under this <U>Section 9</U>, including the assumptions to be utilized in arriving at such
determination, shall be made by the Company&rsquo;s independent auditors or such other certified public accounting firm of national standing
reasonably acceptable to the Executive as may be designated by the Company (the &ldquo;<B><I>Accounting Firm</I></B>&rdquo;) which shall
provide detailed supporting calculations both to the Company and the Executive within fifteen (15) business days of the receipt of notice
from the Executive that there has been a Payment, or such earlier time as is requested by either the Company or the Executive. All fees
and expenses of the Accounting Firm shall be borne solely by the Company. If the Accounting Firm determines that no Excise Tax is payable
by the Executive, it shall furnish the Executive with a written opinion to such effect. Any determination by the Accounting Firm shall
be binding upon the Company and the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">10.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Legal Fees</U>. All reasonable legal fees and related expenses (including costs of experts, evidence and counsel) paid or incurred
by the Executive pursuant to any claim, dispute or question of interpretation relating to this Agreement shall be paid or reimbursed by
the Company if the Executive is successful on the merits pursuant to a legal judgment or arbitration. Except as provided in this <U>Section
10</U>, each party shall be responsible for its own legal fees and expenses in connection with any claim or dispute relating to this Agreement.
The Company will reimburse the Executive for all legal fees associated with the negotiation and execution of this agreement, up to a maximum
amount of five thousand dollars ($5,000 USD).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">11.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Beneficiary</U>. If the Executive dies prior to receiving all of the amounts payable to him in accordance with the terms of
this Agreement, such amounts shall be paid to one or more beneficiaries (each, a &ldquo;<B><I>Beneficiary</I></B>&rdquo;) designated by
the Executive in writing to the Company during his lifetime, or if no such Beneficiary is designated, to the Executive&rsquo;s estate.
Such payments shall be made in accordance with the terms of this Agreement. The Executive, without the consent of any prior Beneficiary,
may change his designation of Beneficiary or Beneficiaries at any time or from time to time by a submitting to the Company a new designation
in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">12.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Notices</U>. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have
been duly given if delivered by hand, email or mailed within the continental United States by first class certified mail, return receipt
requested, postage prepaid, addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45in 0pt 75.15pt; text-align: justify; text-indent: -35.05pt">If to
the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 3.45in 0pt 75.15pt; text-align: justify; text-indent: -35.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in">Immunic, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in">c/o Immunic AG</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in">Lochhamer Schlag
21</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in">82166 Gr&auml;felfing,
Germany</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in">Attn: Chief Legal
Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in">Email: inderpal.singh@imux.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.9pt 0pt 40.1pt; text-align: justify">If to the Executive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7.9pt 0pt 40.1pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in">Andreas Rolf
Muehler</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif">[</FONT><FONT STYLE="font-family: Wingdings">l</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">]</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in">Email: <FONT STYLE="font-family: Times New Roman, Times, Serif">[</FONT><FONT STYLE="font-family: Wingdings">l</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">]</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 7pt 0pt 75.15pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Addresses may be changed by
written notice sent to the other party at the last recorded address of that party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">13.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Withholding</U>. The Company shall be entitled to withhold from payments due hereunder any required federal, state or local
withholding or other taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">14.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Arbitration</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If the parties are unable to resolve any dispute or claim relating directly or indirectly to this agreement or any dispute or claim
between the Executive and the Company or its officers, directors, agents, or employees (a &ldquo;<B><I>Dispute</I></B>&rdquo;), then either
party may require the matter to be settled by final and binding arbitration by sending written notice of such election to the other party
clearly marked &ldquo;Arbitration Demand.&rdquo; Thereupon such Dispute shall be arbitrated in accordance with the terms and conditions
of this <U>Section 14</U>. Notwithstanding the foregoing, either party may apply to a court of competent jurisdiction for a temporary
restraining order, a preliminary injunction, or other equitable relief to preserve the status quo or prevent irreparable harm or to enforce
the terms of the Confidentiality Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The Dispute shall be resolved by a single arbitrator in an arbitration administered by the American Arbitration Association in
accordance with its Employment Arbitration Rules and judgment upon the award rendered by the arbitrator may be entered in any court having
jurisdiction thereof. The decision of the arbitrator shall be final and binding on the parties, and specific performance giving effect
to the decision of the arbitrator may be ordered by any court of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Nothing contained herein shall operate to prevent either party from asserting counterclaim(s) in any arbitration commenced in accordance
with this Agreement, and any such party need not comply with the procedural provisions of this <U>Section 14</U> in order to assert such
counterclaim(s).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The arbitration shall be filed with the office of the American Arbitration Association (&ldquo;<B><I>AAA</I></B>&rdquo;) located
in New York or such other AAA office as the parties may agree upon (without any obligation to so agree). The arbitration shall be conducted
pursuant to the Employment Arbitration Rules of AAA as in effect at the time of the arbitration hearing, such arbitration to be completed
in a sixty (60)-day period. In addition, the following rules and procedures shall apply to the arbitration:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The arbitrator shall have the sole authority to decide whether or not any Dispute between the parties is arbitrable and whether
the party presenting the issues to be arbitrated has satisfied the conditions precedent to such party&rsquo;s right to commence arbitration
as required by this <U>Section 14</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The decision of the arbitrator, which shall be in writing and state the findings, the facts and conclusions of law upon which the
decision is based, shall be final and binding upon the parties, who shall forthwith comply after receipt thereof. Judgment upon the award
rendered by the arbitrator may be entered by any competent court. Each party submits itself to the jurisdiction of any such court, but
only for the entry and enforcement to judgment with respect to the decision of the arbitrator hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The arbitrator shall have the power to grant all legal and equitable remedies (including, without limitation, specific performance)
and award compensatory and punitive damages if authorized by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as otherwise provided in <U>Section 10</U> or by law, the parties shall bear their own costs in preparing for and participating
in the resolution of any Dispute pursuant to this <U>Section 14</U>, and the costs of the arbitrator(s) shall be equally divided between
the parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Except as provided in the last sentence of <U>Section 14(a)</U>, the provisions of this <U>Section 14</U> shall be a complete defense
to any suit, action or proceeding instituted in any federal, state or local court or before any administrative tribunal with respect to
any Dispute arising in connection with this Agreement. Any party commencing a lawsuit in violation of this <U>Section 14</U> shall pay
the costs of the other party, including, without limitation, reasonable attorney&rsquo;s fees and defense costs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">15.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Recoupment.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Policy</U>. Any incentive-based compensation received by the Executive including Annual Bonus and Equity Awards, whether pursuant
to this Agreement or otherwise, that is granted, earned or vested based in any part on attainment of a financial reporting measure, shall
be subject to the terms and conditions of the Company&rsquo;s Claw Back Compensation Policy, if any (the &ldquo;<B><I>Recoupment Policy</I></B>&rdquo;),
and any other policy of recoupment of compensation as shall be adopted from time to time by the Board or its Compensation Committee as
it deems necessary or appropriate to comply with the requirements of Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection
Act, Section 304 of the Sarbanes-Oxley Act of 2002, and any implementing rules and regulations of the U.S. Securities and Exchange Commission
and applicable listing standards of a national securities exchange adopted in accordance with any of the foregoing. The terms and conditions
of the Recoupment Policy, including any changes to the Recoupment Policy adopted from time to time by the Company, are hereby incorporated
by reference into this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Non-Indemnification and Advancement for Recoupment</U>. The Company shall not be obligated to indemnify or advance funds to
the Executive for any payment or reimbursement by the Executive to the Company of any bonus or other incentive-based or equity-based compensation
previously received by the Executive or payment of any profits realized by the Executive from the sale of securities of the Company, as
required in each case under the Securities Exchange Act of 1934 or under the rules of the stock exchange on which the common stock of
the Company is listed (including any such payments or reimbursements under Section 304 and 306 of the Sarbanes-Oxley Act of 2002, or pursuant
to Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act and any implementing rules and regulations of the U.S.
Securities and Exchange Commission and applicable listing standards of a national securities exchange adopted in accordance with any of
the foregoing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">16.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Miscellaneous</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Governing Law</U>. This Agreement shall be interpreted, construed, governed and enforced according to the laws of the State
of New York without regard to the application of choice of law rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Entire Agreement</U>. This Agreement contains the entire agreement between the parties with respect to the subject matter hereof
and supersedes any and all other prior agreements, promises, understandings and representations regarding the Executive&rsquo;s employment,
compensation, severance or other payments contingent upon the Executive&rsquo;s termination of employment, whether written or otherwise,
other than the Executive&rsquo;s Service Agreement with Immunic AG.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Amendments</U>. No amendment or modification of the terms or conditions of this Agreement shall be valid unless in writing and
signed by the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Severability</U>. If one or more provisions of this Agreement are held to be invalid or unenforceable under applicable law,
such provisions shall be construed, if possible, so as to be enforceable under applicable law, or such provisions shall be excluded from
this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable in
accordance with its terms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Binding Effect</U>. This Agreement shall be binding upon and inure to the benefit of the beneficiaries, heirs and representatives
of the Executive (including the Beneficiary) and the successors and assigns of the Company. The Company shall require any successor (whether
direct or indirect, by purchase, merger, reorganization, consolidation, acquisition of property or stock, liquidation, or otherwise) to
all or substantially all of its assets, by agreement in form and substance satisfactory to the Executive, expressly to assume and agree
to perform this Agreement in the same manner and to the same extent that the Company would be required to perform this Agreement if no
such succession had taken place. Regardless whether such agreement is executed, this Agreement shall be binding upon any successor of
the Company in accordance with the operation of law and such successor shall be deemed the Company for purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Successors and Assigns; Nonalienation of Benefits</U>. Except as provided in <U>Section 16(e)</U> in the case of the Company,
or to the Beneficiary in the case of the death of the Executive, this Agreement is not assignable by any party. Compensation and benefits
payable to the Executive under this Agreement shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment,
pledge, encumbrance, charge, garnishment, execution or levy of any kind, either voluntary or involuntary, prior to actually being received
by the Executive or a Beneficiary, as applicable, and any such attempt to dispose of any right to benefits payable hereunder shall be
void and no payment to be made hereunder shall be subject to anticipation, alienation, sale, transfer, assignment, pledge, encumbrance
or other charge.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Remedies Cumulative; No Waiver</U>. No remedy conferred upon either party by this Agreement is intended to be exclusive of any
other remedy, and each and every such remedy shall be cumulative and shall be in addition to any other remedy given hereunder or now or
hereafter existing at law or in equity. No delay or omission by either party in exercising any right, remedy or power hereunder or existing
at law or in equity shall be construed as a waiver thereof, and any such right, remedy or power may be exercised by such party from time
to time and as often as may be deemed expedient or necessary by such party in such party&rsquo;s sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Survivorship</U>. Notwithstanding anything in this Agreement to the contrary, all terms and provisions of this Agreement that
by their nature extend beyond the Date of Termination shall survive termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Counterparts</U>. This Agreement may be executed in two or more counterparts, each of which shall constitute an original, but
all of which, when taken together, shall constitute one document.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">17.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>No Contract of Employment</U>. Nothing contained in this Agreement will be construed as a right of the Executive to be continued
in the employment of the Company, or as a limitation of the right of the Company to discharge the Executive with or without Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">18.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Section 409A of the Code.</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>The intent of the parties is that payments and benefits under this Agreement comply with, or be exempt from, Section 409A of the
Code and, accordingly, to the maximum extent permitted, this Agreement shall be construed and interpreted in accordance with such intent.
The Executive&rsquo;s termination of employment (or words to similar effect) shall not be deemed to have occurred for purposes of this
Agreement unless such termination of employment constitutes a &ldquo;separation from service&rdquo; within the meaning of Code Section
409A and the regulations and other guidance promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>Notwithstanding any provision in this Agreement to the contrary, if the Executive is deemed on the date of the Executive&rsquo;s
separation from service to be a &ldquo;specified employee&rdquo; within the meaning of that term under Code Section 409A(a)(2)(B) and
using the identification methodology selected by the Company from time to time, or if none, the default methodology set forth in Code
Section 409A, then with regard to any payment or the providing of any benefit that constitutes &ldquo;non-qualified deferred compensation&rdquo;
pursuant to Code Section 409A and the regulations issued thereunder that is payable due to the Executive&rsquo;s separation from service,
to the extent required to be delayed in compliance with Code Section 409A(a)(2)(B), such payment or benefit shall not be made or provided
to the Executive prior to the earlier of (i) the expiration of the six (6)-month period measured from the date of the Executive&rsquo;s
separation from service, and (ii) the date of the Executive&rsquo;s death (the &ldquo;<B><I>Delay Period</I></B>&rdquo;). On the first
day of the seventh (7<SUP>th</SUP>) month following the date of the Executive&rsquo;s separation from service or, if earlier, on the date
of the Executive&rsquo;s death, all payments delayed pursuant to this <U>Section 18</U> shall be paid or reimbursed to the Executive in
a lump sum, and any remaining payments and benefits due to the Executive under this Agreement shall be paid or provided in accordance
with the normal payment dates specified for them herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>To the extent any reimbursement of costs and expenses (including reimbursement of COBRA premiums pursuant to <U>Section 7(c)(iv)</U>)
provided for under this Agreement constitutes taxable income to the Executive for Federal income tax purposes, such reimbursements shall
be made as soon as practicable after the Executive provides proper documentation supporting reimbursement but in no event later than December
31 of the calendar year next following the calendar year in which the expenses to be reimbursed are incurred. With regard to any provision
herein that provides for reimbursement of expenses or in-kind benefits, except as permitted by Code Section 409A, (i) the right to reimbursement
or in-kind benefits is not subject to liquidation or exchange for another benefit, and (ii) the amount of expenses eligible for reimbursement,
or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits to
be provided, in any other taxable year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT>If under this Agreement, any amount is to be paid in two (2) or more installments, each such installment shall be treated as a
separate payment for purposes of Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">19.<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</FONT><U>Executive Acknowledgement</U>. The Executive hereby acknowledges that the Executive has read and understands the provisions
of this Agreement, that the Executive has been given the opportunity for the Executive&rsquo;s legal counsel to review this Agreement,
that the provisions of this Agreement are reasonable and that the Executive has received a copy of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 11.65pt 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF,
the parties hereto have caused this Employment Agreement to be executed as of the dates set forth below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 11.65pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMMUNIC, INC.</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 6%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 35%">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By: </FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Daniel Vitt</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Daniel Vitt</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: <U>12/18/2023&#9;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 41%; text-align: justify; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXECUTIVE</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Andreas Rolf Muehler</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andreas Rolf Muehler</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 3in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: <U>12/18/2023&#9;</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Signature Page</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 39.75pt 0pt 39.5pt; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 39.75pt 0pt 39.5pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Annual Bonus&rdquo;
shall have the meaning set forth in <U>Section 5(b)</U> of the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Base Salary&rdquo;
shall have the meaning set forth in <U>Section 5(a)</U> of the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Beneficiary&rdquo;
shall have the meaning set forth in <U>Section 11</U> of the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Board&rdquo; means
the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Bonus Plan&rdquo; shall
have the meaning set forth in <U>Section 5(b)</U> of the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Cause&rdquo; means
one or more of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Executive&rsquo;s willful failure to perform his duties hereunder (other than as a result of illness or injury) that directly, materially
and demonstrably impairs or damages the property, goodwill, reputation, business or finances of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Executive&rsquo;s willful misconduct or gross negligence in the performance of his duties hereunder that directly, materially and demonstrably
impairs or damages the property, goodwill, reputation, business or finances of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
conviction of, or plea of <I>nolo contendere </I>by, the Executive to, a felony or a crime involving moral turpitude that materially and
demonstrably impairs or damages the property, goodwill, reputation, business or finances of the Company; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Executive&rsquo;s commission of any willful acts of personal dishonesty in connection with his responsibilities as an employee of the
Company that directly, materially and demonstrably impairs or damages the property, goodwill, reputation, business or finances of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Code&rdquo; means the
Internal Revenue Code of 1986, as amended and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Competing Business&rdquo;
shall have the meaning set forth in Section 10(a) of Exhibit B to the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Confidentiality Agreement&rdquo;
means the Confidential Information, Assignment of Rights, Non-Solicitation and Non-Competition Agreement between the Company and the Executive,
a copy of which is attached to this Agreement as Exhibit B, pursuant to which the Executive has agreed to abide by certain covenants (including
covenants not to disclose confidential information, compete with the Company or solicit employees, consultants or independent contractors
of the Company).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Date of Termination&rdquo;
means the date specified in a written notice of termination delivered pursuant to Section 6 hereof, or the Executive&rsquo;s last date
as an active employee of the Company before a termination of employment due to his death or Non-Renewal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Exhibit A - Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Disabled&rdquo; or
&ldquo;Disability&rdquo; means a mental or physical condition that renders the Executive substantially incapable of performing his duties
and obligations under this Agreement, after taking into account provisions for reasonable accommodation, as determined by a medical doctor
(such doctor to be mutually determined in good faith by the parties) for four (4) or more consecutive months or for a total of four (4)
months during any twelve (12) consecutive months.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Fiscal Year&rdquo;
means the fiscal year of the Company, which is the calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Good Reason&rdquo;
means, unless the Executive has consented in writing thereto, the occurrence of any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
assignment to the Executive of any duties materially inconsistent with the Executive&rsquo;s position, including any change in status,
title, authority, duties or responsibilities or any other action which results in a material diminution in such status, title, authority,
duties or responsibilities;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
material reduction in the Executive&rsquo;s Base Salary by the Company or any breach by the Company of its obligations pursuant to <U>Section
5(c)</U> with respect to the Executive&rsquo;s benefits;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the
relocation of the Executive&rsquo;s office to a location more than fifty (50) miles from New York, New York; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a
material breach of this Agreement by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Non-Renewal&rdquo;
shall have the meaning set forth in <U>Section 6(f)</U> of the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Release&rdquo; shall
have the meaning set forth in <U>Section 8</U> of the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;Term of Employment&rdquo;
shall have the meaning set forth in <U>Section 2</U> of the Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">Exhibit A - Page <!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CONFIDENTIAL INFORMATION, ASSIGNMENT OF RIGHTS,<BR>
NON-SOLICITATION AND NON-COMPETITION AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration of my employment
with Immunic, Inc., or any of its subsidiaries, in connection with the performance of my duties as an employee of the Immunic, Inc. or
any of its subsidiaries (&ldquo;<B><I>Company</I></B>&rdquo;) (hereinafter, my &ldquo;<B><I>Employment</I></B>&rdquo;), I hereby agree
and acknowledge, effective as of _____________, 2021, that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Confidential Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">As a result of my Employment, I may come to possess Confidential Information, and the Company has informed
me that it will not retain me unless I agree to the terms of this Agreement and abide by them. As used in this Agreement, &ldquo;Confidential
Information&rdquo; includes, without limitation, information, whether or not in tangible form, which has not been publicly disclosed regarding
Company, any of Company&rsquo;s customers, remarketing and/or support agreements made between Company and its business partners which
disclose product data, commission rates, territories, quotas, and terms of licenses; the identities and locations of vendors and consultants
furnishing materials and services to Company and the terms of such arrangements (including prices) negotiated by Company with such vendors
and consultants; data relating to sales and license volumes, by customer, by location or by product; data relating to consulting agreements
between Company and its customers which disclose billing rates, budgets, deliverables, time schedules and staff assignments; customer
and product licensee and prospective product licensee lists; financial information that has not been released to the public by Company;
employee lists of Company; future business plans, licensing strategies, advertising campaigns and the like; data provided to you which
is marked as confidential or proprietary to Company, one of Company&rsquo;s customers or business partners; proposed or actual acquisitions
of stock or assets by Company; and/or any other information concerning or used in Company&rsquo;s business, its manner of operations,
its plan, processes or other data.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The definition of Confidential Information
also shall include &ldquo;Trade Secrets&rdquo;, which are defined as the whole or any portion or phase of any scientific or technical
information, design, process, procedure, formula, data-processing technique, computer program, or improvement that is valuable and secret
(in the sense that it is not generally known to competitors of Company or competitors of its business partners). To the extent consistent
with the foregoing, Trade Secrets include, without limitation, the specialized information and technology embodied in computer program
material, including source and object code, system and user documentation, and program and system designs that provide Company or its
business partners with an advantage over their competitors in the development, sales, implementation and support of their application
software and products.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">I acknowledge that Company has developed
its Confidential Information through its own efforts and at great expense. I further acknowledge that Company has a legitimate interest
in protecting its Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">EXHIBIT B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">I will not at any time, except as required by my duties at Company, duplicate, remove, transfer, use,
disclose or communicate, or knowingly allow any other person to duplicate, remove, transfer, use, disclose or communicate, any Confidential
Information. I will safeguard all Confidential Information at all times so that it is not exposed to, or taken by, unauthorized persons
and will exercise my best efforts to assure its safekeeping. I understand that the maintenance of the confidentiality of Confidential
Information is material and essential to Company and its disclosure would have a severe adverse effect on the conduct of Company&rsquo;s
business, and Company&rsquo;s competitive position and goodwill.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">Upon termination of my Employment, whether voluntary or involuntary, or upon Company&rsquo;s request at
any time during the term of my Employment, I will deliver to Company all written and other materials which contain or relate to Confidential
Information, whether formal or informal, whether prepared by me or by others and whether required by my employment or for my personal
use, including, without limitation, all documents, notes, computer programs and data prepared for or stored in or obtained from any automated
information system, all of which materials shall be and remain the property of Company. In addition, I shall also provide any information,
such as passwords or codes, necessary to allow Company to fully utilize its property.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">I will not make any unauthorized disclosure of trade secrets or confidential information to any third
person, including any such information which is subject to a confidentiality agreement between Company and such third person, to which
I gain access as a result of my Employment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">My obligations under this Agreement will remain in effect both during the term of my Employment and thereafter,
whatever the reason for termination of my Employment, and shall survive any termination of this Agreement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Assignment of Right</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">6.</TD>
    <TD STYLE="width: 0.5in">(a)&#9;</TD><TD STYLE="text-align: justify">All intellectual property in whatever form including, without limitation, inventions, discoveries,
ideas, computer programs, programs based upon or developed from computer programs, improvements, codes, methods, algorithms, trade secrets,
know-how, system documentation, technical data, drawings, flow charts, prototypes, design specifications, and any other documentation,
notes and materials related to the foregoing (whether or not patentable or copyrightable) that are conceived or made by me, either alone
or with others, during the course of or derived from my Employment by Company and in any way related to my Employment or to any business
in which Company is engaged at any time during the term of my Employment or (if it should reasonably be known by me) is considering in
engaging (&ldquo;Discoveries&rdquo;), shall be deemed to be &ldquo;works made for hire&rdquo; if permitted by applicable law and shall
belong to Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">I will promptly disclose all Discoveries to Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">To the extent that any Discovery does not constitute a work made for hire pursuant to applicable law,
I hereby transfer, grant, convey, assign and relinquish exclusively to Company all of my rights to, title to and interest in all Discoveries,
in perpetuity (or for the longest period of time otherwise permitted by law), including:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">EXHIBIT B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">all of my rights, title, interest, and benefit (including the right to make, use, or sell under patent
law; to copy, adapt, distribute, display, and perform under copyright law; and to use and disclose under trade secret law) in and to all
United States and foreign patents and patent applications, patent license rights, patentable inventions, trade secrets, trademarks, service
marks, trade names (including, in the case of trademarks, service marks and trade names, all goodwill pertaining thereto), copyrights,
technology licenses, know-how, confidential information, shop rights, and all other intellectual property rights owned or claimed or acquired
in the future by me as embodied in the Discoveries; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">all of my rights, title, interest, and benefit and all powers and privileges, in, to, and under all technical
data, drawings, prototypes, engineering files, system documentation, flow charts, and design specifications developed by, owned, or acquired
previously or in the future by me in connection with the development of the programming, inventions, processes, and apparatus entailed
by the Discoveries.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">I will execute and deliver, from time to time after the date hereof, upon Company&rsquo;s request, such
further conveyance instruments, and take such further actions, as may be necessary or desirable to evidence more fully the transfer of
ownership of all the Discoveries to Company, or the original ownership of all the Discoveries on the part of Company, to the fullest extent
possible. I therefore agree to:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">execute, acknowledge, and deliver any affidavits or documents of assignment and conveyance regarding the
Discoveries.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">provide testimony in connection with any proceeding affecting the right, title, interest, or benefit of
Company in or to the Discoveries.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">perform any other acts deemed necessary to carry out the intent of this Agreement including, without limitation,
assisting in the application, perfection, maintenance and enforcement of the Discoveries and all rights relating thereto.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">In furtherance of this Agreement, I hereby acknowledge that, from this date forward, or a previous date
if rights were earlier transferred, Company has succeeded to all of my rights, title, and standing to:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">receive all rights and benefits pertaining to the Discoveries.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">institute and prosecute all suits and proceedings and take all actions that Company, in its sole discretion
may deem necessary or proper to collect, assert, or enforce any claim, right, or title of any kind in and to any and all of the Discoveries.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">EXHIBIT B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">defend and compromise any and all such actions, suits, or proceedings relating to such transferred and
assigned rights, title, interest, and benefits, and do all other such acts and things in relation thereto as Company, in its sole discretion,
deems advisable.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">Upon termination of my Employment, I will immediately surrender to Company all materials and work product
in my possession or within my control (including all copies thereof) relating in any way to the Discoveries.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">To effectuate the terms of this paragraph 6, I hereby name and irrevocably constitute and appoint Company,
with the full power of substitution therein, as my true and lawful attorney-in-fact to exercise the rights assigned hereby.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">I represent and warrant that no consents of any other parties are necessary or appropriate under any agreements
concerning any of the Discoveries in order for the transfer and assignment of any of the Discoveries under this Agreement to be legally
effective.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">I represent and warrant that, to the best of my knowledge, upon consummation of this Agreement, Company
will have good and marketable title to the Discoveries, free and clear of any and all liens, mortgages, encumbrances, pledges, security
interests, or charges of any nature whatsoever.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">I have listed on the Schedule attached to this Agreement all inventions, if any, conceived or made by
me prior to my Employment by Company and which are to be excluded from this Agreement, as well as any restrictions on any work for Company
or any obligations under this Agreement arising from any prior employment or other agreement. I am not required to list on the Schedule
any inventions conceived or made by me prior to my Employment by Company that (i) are unrelated to the business, operations, services
or products of Company or (ii) are solely related to my personal hobbies and not to the business, operations, service or products of Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Non-Solicitation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify">I agree that all Company relationships, whether or not contractual, including but not limited to, relationships
with employees, contractors, consultants, partners (collectively &ldquo;Relationships&rdquo;) are the sole property of Company. I agree
that, during and after my Employment with Company, unless Company provides written consent, I will not directly or indirectly provide
information, including but not limited to, employee lists, resumes, independent contractor agreements, employment information and contact
information, to other entities or individuals. I agree not to interfere with these Relationships by hiring or soliciting for hire individuals
or entities, directly or indirectly, to work with or for any person or entity external to Company without the written consent of Company,
during, and for a period of twenty-four (24) months after the termination of, my Employment with Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify">I agree that all Company relationships with customers, partners, resellers, vendors and suppliers and
all information, whether or not in writing, are and shall be the exclusive property of Company (collectively &ldquo;<B><I>Customer Information</I></B>&rdquo;).
Customer Information shall not be used outside the duties of my Employment with Company without the written consent of Company, either
during or after the termination of my Employment with Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">EXHIBIT B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.35in"><B>Non-Competition</B></TD><TD STYLE="text-align: justify"></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">10.</TD>
    <TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">I further agree that, during the term of my Employment with Company, and for a period of twelve
(12) months following the termination (whether voluntary or involuntary) of such Employment, I will not engage in any capacity (including
without limitation, as an employee, officer, director, consultant or shareholder (other than as an owner of one percent (1%) or less of
the outstanding shares of any publicly-traded company)), in any Competing Business in any geographical area in which Company (or any of
Company&rsquo;s affiliates) transacts such business. For purposes of this Agreement a &ldquo;Competing Business&rdquo; means a pharmaceutical
or biotech company for which their commercial business or their development portfolio based on number of development projects (for a non-commercial
company) comprises at least 50% of oral drugs to be used in non-oncology immunological diseases.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The covenants contained in this Section 10 shall be enforced to the fullest extent permissible under the
laws of each jurisdiction in which enforcement is sought. Accordingly, I agree that if any of the provisions of this Section 10 shall
be adjudicated to be invalid or unenforceable for any reason whatsoever, said provision shall be construed (only with respect to the operation
thereof in the particular jurisdiction in which such adjudication is made) by limiting and reducing it so as to be enforceable to the
fullest extent permissible, without invalidating the remaining provisions of this Agreement or affecting the validity or enforceability
of said provision in any other jurisdiction.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify">Breach by me of any provision of this Agreement will cause Company irreparable injury and damage for which
money damages may not be adequate. In addition to all other remedies that are available to it, Company shall be entitled to preliminary
and permanent injunctive and equitable relief to prevent or remedy a breach of this Agreement by me.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify">This Agreement:</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">shall bind my heirs, executors, administrators, legal representatives and assigns, and supersedes any
prior agreements concerning Confidential Information executed by me with or in favor of Company, if any.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">constitutes the entire understanding between Company and me concerning Confidential Information and no
waiver or amendment of any provision of this Agreement shall be valid or effective unless in writing and signed by the party against whom
enforcement thereof is sought.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">shall be enforceable by Company or any of its successors or assigns.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">shall be enforced and construed in accordance with the laws of the State of New York, without giving effect
to the choice of laws principles of New York that would result in the application of the laws of any other jurisdiction.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">EXHIBIT B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13</TD><TD STYLE="text-align: justify">Should any part of this Agreement for any reason be declared by any court of competent jurisdiction to
be invalid, that decision shall not affect the validity of the remaining portion, which shall continue in full force and effect as if
this Agreement had been executed with the invalid portion eliminated, provided, however, that this Agreement shall be interpreted to carry
out to the greatest extent possible the intent of the parties and to provide to Company substantially the same benefits as Company would
have received under this Agreement if such invalid part of this Agreement had been enforceable.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify">I represent that I am not a party to, or bound by, any confidentiality agreements, non-compete agreements,
restrictive covenants, non-solicitation agreements, invention and assignment agreements, or any other agreements or obligations to any
former employer or other entity that will prevent me from performing, or impede me in performance of service for Company. I also represent
that I have disclosed to Company all contracts or agreements that could prevent me from carrying out my responsibilities for Company.
I further acknowledge that I have not and will not take or remove from my prior employment the originals or copies of any documents maintained
as confidential or proprietary information by my prior employer, and that I have not and will not disclose any confidential or proprietary
information of my prior employer. Therefore, I am &ldquo;free and clear&rdquo; to be employed by Company. I acknowledge that Company is
relying on my representation in making its offer of employment, in employing me, or in continuing my employment with Company. I further
agree not to enter into any agreement either written or oral in conflict with my Employment with Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify">I further agree that this Agreement does not constitute a contract of employment, and that I have the
right to resign and Company has the right to terminate my employment at any time, for any reason, with or without cause, subject to the
provisions of any written employment agreement between Company and me. I hereby acknowledge that I have read this Agreement, understand
it and agree to be bound by its restrictions.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 35%; text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANDREAS ROLF MUEHLER</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Date Signed)</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCEPTED AND DATED AS OF ___________________</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMMUNIC, INC.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">EXHIBIT B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Immunic, Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">c/o Immunic AG</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Lochhamer Schlag 21</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">82166 Gr&auml;felfing, Germany</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Attn: Chief Legal Counsel</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Email: inderpal.singh@imux.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
following is a complete list of all inventions or improvements relevant to the subject matter of my employment by Immunic, Inc. (the &ldquo;Company&rdquo;)
that have been made or conceived or first reduced to practice by me, alone or jointly with others, prior to my employment by the Company
that I desire to remove from the operation of the Company&rsquo;s Confidential Information, Assignment of Rights, Non-Solicitation and
Non-Competition Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">______ No inventions or
improvements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">______ See below:
Any and all inventions regarding</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">______ Additional
sheets attached.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I
propose to bring to my employment the following materials and documents of a former employer:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">______ No materials
or documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">______ See below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Andreas Rolf Muehler</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">_______________________________</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Date</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">EXHIBIT B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT C</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>WAIVER AND RELEASE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This is a Waiver and Release
(&ldquo;<B><I>Release</I></B>&rdquo;) between Andreas Rolf Muehler (&ldquo;<B><I>Executive</I></B>&rdquo;) and Immunic, Inc. (the &ldquo;<B><I>Company</I></B>&rdquo;).
The Company and the Executive agree that they have entered into this Release voluntarily, and that it is intended to be a legally binding
commitment between them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In consideration for and contingent
upon the Executive&rsquo;s right to receive the benefits described in the Employment Agreement between the Company and the Executive (the
&ldquo;<B><I>Employment Agreement</I></B>&rdquo;) and this Release, the Executive hereby agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>General
Waiver and Release</U>. Except as provided in Paragraph (e) below, the Executive and any person acting through or under the Executive
hereby release, waive and forever discharge the Company, its past and present subsidiaries and affiliates, and their respective successors
and assigns, and their respective past and present officers, trustees, directors, shareholders, executives and agents of each of them,
from any and all claims, demands, actions, liabilities and other claims for relief and remuneration whatsoever (including without limitation
attorneys&rsquo; fees and expenses), whether known or unknown, absolute, contingent or otherwise (each, a &ldquo;<B><I>Claim</I></B>&rdquo;),
arising or which could have arisen up to and including the date of his execution of this Release, including without limitation those arising
out of or relating to the Executive&rsquo;s employment or cessation and termination of employment, or any other written or oral agreement,
any change in the Executive&rsquo;s employment status, any benefits or compensation, any tortious injury, breach of contract, wrongful
discharge (including any Claim for constructive discharge), infliction of emotional distress, slander, libel or defamation of character,
and any Claims arising under Title VII of the Civil Rights Act of 1964 (as amended by the Civil Rights Act of 1991), the Americans With
Disabilities Act, the Rehabilitation Act of 1973, the Equal Pay Act, the Older Workers Benefits Protection Act, the Age Discrimination
in Employment Act, the Employee Retirement Income Security Act of 1974, or any other federal, state or local statute, law, ordinance,
regulation, rule or executive order, any tort or contract claims, and any of the claims, matters and issues which could have been asserted
by the Executive against the Company or its subsidiaries and affiliates in any legal, administrative or other proceeding. the Executive
agrees that if any action is brought in his name before any court or administrative body, the Executive will not accept any payment of
monies in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Miscellaneous</U>.
the Executive agrees that Section 7(c) of the Employment Agreement (which is specifically incorporated herein by reference) specifies
payments from the Company to himself, the total of which meets or exceeds any and all funds due him by the Company, and that he will not
seek to obtain any additional funds from the Company with the exception of non-reimbursed business expenses. (This covenant does not preclude
the Executive from seeking workers&rsquo; compensation, unemployment compensation, or benefit payments from the Company&rsquo;s insurance
carriers that could be due him.)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Non-Solicitation,
Confidentiality and Non-Solicitation Covenants</U>. the Executive warrants that the Executive has, and will continue to comply fully with
Section 3(c) of the Employment Agreement and the provisions of the Confidential Information, Assignment of Rights, Non-Solicitation and
Non-Competition Agreement by and between the Company and the Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">EXHIBIT C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THE
COMPANY AND THE EXECUTIVE AGREE THAT THE BENEFITS DESCRIBED IN SECTION 7(C) OF THE EMPLOYMENT AGREEMENT AS SUBJECT TO EXECUTIVE&rsquo;S
COMPLIANCE WITH SECTION 8 THEREOF ARE CONTINGENT UPON THE EXECUTIVE SIGNING THIS RELEASE. THE EXECUTIVE FURTHER UNDERSTANDS AND AGREES
THAT IN SIGNING THIS RELEASE, EXECUTIVE IS RELEASING POTENTIAL LEGAL CLAIMS AGAINST THE COMPANY. THE EXECUTIVE UNDERSTANDS AND AGREES
THAT IF HE DECIDES NOT TO SIGN THIS RELEASE, OR IF HE REVOKES THIS RELEASE, THAT HE WILL IMMEDIATELY REFUND TO THE COMPANY ANY AND ALL
SEVERANCE PAYMENTS AND OTHER BENEFITS HE MAY HAVE ALREADY RECEIVED.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
waiver contained in Paragraph (a) and (b) above does not apply to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">Any claims for benefits under employee benefit plans in accordance with the terms of the applicable employee
benefit plan, including the Executive&rsquo;s right to elect continuation coverage under the Company&rsquo;s group health, dental and/or
visions plans pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (COBRA),</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">Any right to exercise stock options or stock appreciation rights that were vested and exercisable on the
Date of Termination or the end of the Term of Employment in accordance with the terms thereof (as modified by the Employment Agreement);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">Any Claim under or based on a breach of the Company&rsquo;s obligations to pay the compensation and benefits
described in Sections 5 or 7(a) or (c) of the Employment Agreement,</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">Rights or Claims that may arise under the Age Discrimination in Employment Act after the date that the
Executive signs this Release, and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">Any right to indemnification by the Company or to coverage under directors and officers liability insurance
to which the Executive is otherwise entitled in accordance with Section 12 of Employment or the Company&rsquo;s articles of incorporation
or by-laws or other agreement between the Executive and the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EXECUTIVE
ACKNOWLEDGES THAT HE HAS READ AND IS VOLUNTARILY SIGNING THIS RELEASE. EXECUTIVE ALSO ACKNOWLEDGES THAT HE IS HEREBY ADVISED TO CONSULT
WITH AN ATTORNEY, HE HAS BEEN GIVEN AT LEAST <B><I>[21][45]</I></B> DAYS TO CONSIDER THIS RELEASE BEFORE THE DEADLINE FOR SIGNING IT;
<B><I>[HE HAS RECEIVED A RECEIVED A WRITTEN DESCRIPTION OF THE JOB TITLES AND AGES ALL INDIVIDUALS SELECTED FOR THIS JOB ELIMINATION PROGRAM
AND THE AGES OF ANY INDIVIDUALS IN THE SAME JOB CLASSIFICATIONS WHO ARE NOT SELECTED FOR THIS JOB ELIMINATION PROGRAM AS PROVIDED BY THE
ADEA (SUCH DESCRIPTION ATTACHED AS EXHIBIT A HERETO)]</I></B>; AND HE UNDERSTANDS THAT HE MAY REVOKE THE RELEASE WITHIN SEVEN (7) DAYS
AFTER SIGNING IT. IF NOT REVOKED WITHIN SUCH PERIOD, THIS RELEASE WILL BECOME EFFECTIVE ON THE EIGHTH (8) DAY AFTER IT IS SIGNED BY EXECUTIVE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">EXHIBIT C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt; text-align: right; font-size: 8pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">BY SIGNING BELOW, BOTH THE
COMPANY AND EXECUTIVE AGREE THAT THEY UNDERSTAND AND ACCEPT EACH PART OF THIS RELEASE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 6%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 35%; text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANDREAS ROLF MUEHLER</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Date Signed)</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ACCEPTED AND DATED AS OF ___________________</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IMMUNIC, INC.</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT C-3</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>e619130_ex10-4.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 5%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>DIENSTVERTRAG</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>SERVICE AGREEMENT</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">zwischen</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">between</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Immunic AG, <BR>
vertreten durch den Vorsitzenden des Aufsichtsrates</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Immunic AG, <BR>
represented by the Chairman of the Supervisory Board</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- nachfolgend &bdquo;Gesellschaft&quot; genannt -</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- hereinafter referred to as the &quot;Company&quot; -</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">und</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Frau Dr. Hella Kohlhof, </B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Ms. Dr. Hella Kohlhof,</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- nachfolgend &bdquo;Vorstand&quot; genannt -</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>- hereinafter referred to as the &quot;Board Member&quot; -</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Pr&auml;ambel</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-align: center; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Preamble</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Der Vorstand ist erstmalig mit Wirkung ab dem 01.01.2017 zum Mitglied des Vorstandes der Gesellschaft bestellt worden. Die letztmalige Bestellung zum Mitglied des Vorstandes endet mit Ablauf des 31.12.2023. Die dienstvertraglichen Beziehungen zwischen den Parteien werden durch den Dienstvertrag vom 29. September 2016 sowie diverser &Auml;nderungsvereinbarungen geregelt (&bdquo;Dienstvertrag&ldquo;). Der Vorstand ist mit <B>beigef&uuml;gten Aufsichtsratsbeschluss</B> erneut zum Mitglied des Vorstand der Gesellschaft bestellt worden, diesmal f&uuml;r den Zeitraum vom 01.01.2024 bis zum 31.12.2026 (&bdquo;Laufzeit&ldquo;). Dies vorausgeschickt, vereinbaren die Parteien den Dienstvertrag (einschlie&szlig;lich aller &Auml;nderungsvereinbarungen) mit Wirkung zum Ablauf des 31.12.2023 aufzuheben und durch den nachfolgenden neuen Dienstvertrag insgesamt f&uuml;r die Dauer der Laufzeit zu ersetzen. Diese Pr&auml;ambel ist integraler Bestandteil dieser Vereinbarung.</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board Member was appointed to the company's
    Board for the first time with effect from January 1, 2017. The last appointment as a member of the Board ends at the end of December 31,
    2023. The service contract between the parties is governed by the service contract dated September 29, 2016 and various amendment agreements
    (&quot;Service Contract&quot;). The Board Member was reappointed to the company's Executive Board by the <B>attached Supervisory Board
    resolution</B>, this time for the period from January 1, 2024 to December 31, 2026 (&quot;Term&quot;). With this in mind, the parties
    agree to terminate the Service Contract (including all amendment agreements) with effect from the end of December 31, 2023, and to replace
    it with the following new service contract in its entirety for the duration of the Term. This preamble is an integral part of this agreement.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 1<BR>
Aufgabenbereich und Pflichten</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 1<BR>
Responsibilities and Obligations</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Frau Dr. Kohlhof wird f&uuml;r die Laufzeit als Vorstandsmitglied f&uuml;r die wissenschaftliche Gesch&auml;ftsleitung (CSO) der Gesellschaft bestellt und vertritt die Gesellschaft gemeinsam mit einem Vorstand oder einem Prokuristen. Der Aufsichtsrat kann dem Vorstand Einzelvertretungsbefugnis erteilen sowie von den Beschr&auml;nkungen des &sect;&nbsp;181 Alt. 2 BGB befreien.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Ms. Dr. Kohlhof is appointed as the Board Member for scientific management (CSO) of the Company for the Term and represents the Company together with a member of the Management Board or an authorized signatory. The Supervisory Board may grant the Board Member sole power of representation as well as exemption from the restrictions of &sect; 181 Alt. 2 of the German Civil Code (BGB).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand f&uuml;hrt die Gesch&auml;fte der Gesellschaft nach Ma&szlig;gabe der Gesetze, der Satzung, der Gesch&auml;ftsordnung f&uuml;r den Vorstand und dieses Dienstvertrages. Der Vorstand hat insbesondere f&uuml;r die laut einer Gesch&auml;ftsordnung des Vorstands unter Zustimmungsvorbehalt stehenden Gesch&auml;fte und Ma&szlig;nahmen die Zustimmung des Aufsichtsrats einzuholen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall conduct the business of the Company in accordance with the law, the Articles of Association, the rules of procedure for the Management Board and this Service Agreement. In particular, the Board Member shall obtain the approval of the Supervisory Board for transactions and measures subject to approval in accordance with the rules of procedure of the Management Board.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dem Vorstand obliegen insbesondere die Aufgaben, die im Sinne des jeweiligen Gesch&auml;ftsverteilungsplans zum Gesch&auml;ftsbereich des Vorstandsmitglieds f&uuml;r die wissenschaftliche Gesch&auml;ftsleitung (CSO) geh&ouml;ren.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In particular, the Board Member is responsible for the tasks that belong to the business area of the Board Member for the scientific management (CSO) within the meaning of the respective schedule of responsibilities.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand &uuml;bernimmt auf Wunsch der Gesellschaft ohne weitere Verg&uuml;tung auch Positionen oder &Auml;mter bei mit der Gesellschaft verbundenen Unternehmen (&sect;&nbsp;15 AktG). Ebenso &uuml;bernimmt der Vorstand Positionen oder &Auml;mter bei Verb&auml;nden, Berufsvereinigungen oder sonstigen Organisationen, in denen die Gesellschaft oder ein verbundenes Unternehmen Mitglied ist. Ihm von dritter Seite diesbez&uuml;glich gew&auml;hrte Verg&uuml;tungen oder Aufwandsentsch&auml;digungen f&uuml;hrt der Vorstand an die Gesellschaft ab. Auf Wunsch der Gesellschaft legt der Vorstand im Interesse der Gesellschaft oder verbundener Unternehmen &uuml;bernommene Positionen oder &Auml;mter nieder und setzt sich nach besten Kr&auml;ften daf&uuml;r ein, dass von der Gesellschaft benannte Nachfolger in die Positionen oder &Auml;mter nachr&uuml;cken</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall, upon the Company's request, without any additional remuneration, also accept positions or offices in companies affiliated with the Company (Section&nbsp;15 Stock Corporation Act - <I>AktG</I>). In the same way, the Board Member shall also accept positions or offices in associations and professional or other organizations of which the Company or an affiliated Company is a member. The Board Member shall transfer to the Company any remuneration or allowances he receives from third parties in this respect. Upon the Company's request, the Board Member shall resign from any position or office accepted in the interests of the Company or an affiliated Company and he shall do his utmost to ensure that the person nominated by the Company shall succeed him in the position or office</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dienstort ist Gr&auml;felfing. Sofern die Pflichten nach diesem Vertrag es zulassen, ist der Vorstand frei in der Wahl des Ortes der Aus&uuml;bung seiner T&auml;tigkeit.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The place of work is Gr&auml;felfing. If the obligations according to this agreement allow it, the Board Member is free in the choice of the place of the exercise of its activity.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 2<BR>
Umfang der Dienste, Nebent&auml;tigkeiten</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 2<BR>
Scope of Service and Side Activity</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand stellt seine ganze Arbeitskraft und all sein Wissen und K&ouml;nnen in den Dienst der Gesellschaft. In der Bestimmung seiner T&auml;tigkeitszeiten ist der Vorstand im Rahmen der betrieblichen Erfordernisse frei.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall devote all his working capacity, knowledge and skills into the services of the Company. He shall be able to schedule his working hours, subject to business requirements.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die &Uuml;bernahme einer entgeltlichen Nebent&auml;tigkeit sowie von Aufsichts-rats-, Beirats- oder &auml;hnlichen Mandanten bedarf der vorherigen Zustimmung durch den Aufsichtsratsvorsitzenden.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The assumption of an ancillary commercial activity as well as mandates in a supervisory board or advisory board or similar mandates require the prior consent of the Chairman of the Supervisory Board.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>F&uuml;r den Vorstand gilt das Wettbewerbsverbot des &sect;&nbsp;88 AktG. W&auml;hrend der Dauer dieses Vertrages wird sich der Vorstand auch nicht an Unternehmen beteiligen, die mit der Gesellschaft in Wettbewerb stehen oder mit denen die Gesellschaft Gesch&auml;ftsverbindungen unterh&auml;lt, es sei denn, der Aufsichtsrat hat vorher seine schriftliche Zustimmung erteilt.</FONT></TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member is subject to the non-competition clause of Section 88 of the German Stock Corporations Act (AktG). During the term of this agreement, the Board Member will also not invest in companies that compete with the Company or with which the Company has business relationships, unless the Supervisory Board has given its prior written consent.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; text-indent: -16.05pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16.05pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Das Wettbewerbsverbot gilt nicht f&uuml;r Beteiligungen an Unternehmen in Gestalt von Wertpapieren, die an B&ouml;rsen gehandelt und zum Zwecke der Kapitalanlage erworben werden. Dar&uuml;ber hinaus sind etwaig bestehende, vorrangige Regelungen aus einem Investment Agreement und/oder Shareholders' Agreement zu Wettbewerbsverboten bzw. erlaubten T&auml;tigkeiten des Vorstands zu beachten.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">The non-competition clause does not apply to interests in companies in the form of bonds traded on the stock exchange and acquired for the purpose of capital investment. In addition, any existing overriding regulation from an Investment Agreement and/or Shareholders' Agreement on restraints of competition or permitted activities of the Board Member must be observed.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 3<BR>
Verg&uuml;tung und Bonus</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 3<BR>
Remuneration and bonus</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand erh&auml;lt f&uuml;r seine T&auml;tigkeit</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member receives for its activities</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.15pt">a)&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">ein festes Jahresgehalt <B>(&bdquo;Grundverg&uuml;tung&quot;) </B>in H&ouml;he von EUR 403,375 brutto, das in 12 gleichen Monatsraten jeweils nachtr&auml;glich am Monatsletzten ausbezahlt wird. Sofern dieser Vertrag nicht w&auml;hrend der Dauer eines gesamten Kalenderjahres besteht, wird das Jahresfestgehalt zeitanteilig gezahlt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp; </FONT>a fixed annual salary <B>(&quot;Basic Remuneration&quot;) </B>in the amount of EUR 403,375 gross, paid in 12 equal monthly instalments at the end of each month. If this agreement does not exist for the duration of an entire calendar year, the fixed annual salary shall be paid pro rata temporis.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.15pt">b)&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">eine j&auml;hrliche variable Verg&uuml;tung, die bei 100-prozentigem Erreichen der festgelegten Jahresziele maximal EUR 161,350 brutto betr&auml;gt, also 40 % der j&auml;hrlichen Grundverg&uuml;tung gem&auml;&szlig; Ziffer a) zuvor. Die Einzelheiten, insbesondere zum Verfahren der Zielfestlegung, zur Feststellung der Zielerreichung und zur F&auml;lligkeit ergeben sich aus dem Rahmenvertrag zur Zielvereinbarung in seiner jeweils geltenden Fassung. Die Art der Ziele, die Voraussetzungen f&uuml;r ihre Erreichung und ihre Gewichtung zueinander werden f&uuml;r das jeweilige Gesch&auml;ftsjahr in einer gesonderten Zielfestlegung niedergelegt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 36.05pt; text-align: justify; text-indent: -20.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp; </FONT>an annual variable remuneration of up to EUR 161,350 gross if the defined annual targets are achieved 100 percent, i.e. 40 % of the annual basic remuneration in accordance with a) above. The details, in particular with regard to the procedure for setting targets, determining the achievement of targets and the due date, are set out in the Framework Agreement regarding the targets (<I>Rahmenvertrag zur Zielvereinbarung</I>) in its current version. The nature of the objectives, the conditions for their achievement and their weighting in relation to each other are laid down for each financial year in a separate target setting.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Grundverg&uuml;tung und die variable Verg&uuml;tung werden j&auml;hrlich durch den Aufsichtsrat &uuml;berpr&uuml;ft. Dabei sind die wirtschaftliche Entwicklung der Gesellschaft sowie die pers&ouml;nliche Leistung des Vorstandes zu ber&uuml;cksichtigen.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Basic Remuneration and the variable remuneration are reviewed annually by the Supervisory Board. The economic development of the Company and the personal performance of the Board Member must be taken into account.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Sagt eine dritte Person (einschlie&szlig;lich solcher Unternehmen, die mit der Gesellschaft verbunden sind) dem Vorstand Anteile an der Gesellschaft oder an mit der Gesellschaft verbundenen Unternehmen oder diesbez&uuml;gliche Optionen oder Anspr&uuml;che auf Optionen oder sogenannte Stock Appreciation Rights oder Phantom Stocks zu, so werden solche Zusagen weder Bestandteil des Dienstverh&auml;ltnisses zwischen den Parteien dieses Vertrages noch begr&uuml;nden sie Verpflichtungen der Gesellschaft.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event that a third party (including companies which are affiliated with the Company) promises the Board Member shares in the Company or in companies affiliated with the Company or options to acquire such shares or rights to such options or so-called stock appreciation rights or phantom Stocks, such promise shall neither become part of the Service Agreement between the parties to this Agreement nor create any obligations of the Company</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im &Uuml;brigen kann der Aufsichtsrat die Bez&uuml;ge des Vorstands insgesamt auf die angemessene H&ouml;he herabsetzen, wenn sich die Lage der Gesellschaft so verschlechtert, dass die Weitergew&auml;hrung der Bez&uuml;ge unbillig f&uuml;r die Gesellschaft w&auml;re; Ruhegehalt, Hinterbliebenenbez&uuml;ge und Leistungen verwandter Art k&ouml;nnen dabei nur in den ersten drei Jahren nach Ausscheiden aus der Gesellschaft herabgesetzt werden (&sect; 87 (2) AktG). Der Vorstand kann in diesem Fall diesen Dienstvertrag au&szlig;erordentlich mit einer Frist von sechs Wochen zum Schluss des n&auml;chsten Kalendervierteljahres nach Erkl&auml;rung der Herabsetzung k&uuml;ndigen (&sect; 87 (2) Satz 3 AktG). Entf&auml;llt eine verschlechterte Lage der Gesellschaft, ist die Herabstufung wieder r&uuml;ckg&auml;ngig zu machen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Otherwise, the Supervisory Board may reduce the total remuneration of the Board Member to the appropriate amount, if the situation of the Company deteriorates to such an extent that the continued granting of the remuneration would be inequitable for the Company; retirement pension, survivors benefits and benefits of a related kind may only be reduced in the first three years after leaving the Company (Section 87 (2) AktG). In this case, the Board Member may terminate this Service Agreement extraordinarily with six weeks' notice to the end of the next calendar quarter after declaration of the reduction (Section 87 (2) sentence 3 AktG). If a deterioration in the situation of society does not apply, the downgrade shall be reversed.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Ein Anspruch auf Verg&uuml;tung von &Uuml;berstunden, Sonntags-, Feiertags- oder sonstiger Mehrarbeit besteht nicht.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>There is no entitlement to remuneration for overtime, work on Sundays, public holidays or other additional work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 4<BR>
Versicherungen und Nebenleistungen</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 4<BR>
Insurance and Fringe Benefits</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Auch soweit keine gesetzliche Versicherungspflicht besteht, zahlt die Gesellschaft an das Vorstandsmitglied monatliche Zusch&uuml;sse zur Kranken-und Pflegeversicherung des Vorstandsmitglieds. Die einzelnen Zusch&uuml;sse entsprechen in ihrer H&ouml;he der H&auml;lfte der vom Vorstandsmitglied gezahlten Beitr&auml;ge, h&ouml;chstens jedoch dem jeweils unter Ber&uuml;cksichtigung der jeweils geltenden Beitragsbemessungsgrenzen gesetzlich geschuldeten H&ouml;chstbetrag des Arbeitgeberanteils der gesetzlichen Kranken- und Pflegeversicherung. Die von der Gesellschaft geschuldeten Zusch&uuml;sse werden dem Vorstandsmitglied jeweils am Kalendermonatsende gezahlt. Die auf diese Zahlungen etwaig anfallende Einkommensteuer tr&auml;gt das Vorstandsmitglied.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Even if there is no statutory insurance obligation, the Company shall pay the Board Member monthly health and long-term care insurance contributions for the Board Member. The individual contributions are in their amount equivalent to the amount of the contributions paid by the Board Member, but limited to the amount of the employer's contribution to the statutory health and long-term care insurance legally owed in each case, taking into account the applicable contribution assessment thresholds. The contributions owed by the Company are paid to the Board Member at the end of each calendar month. Any income tax payable on these payments shall be borne by the Board Member.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand erh&auml;lt in angemessenem Umfang f&uuml;r die im Gesellschaftsinteresse erforderlichen Aufwendungen Ersatz. Erforderliche Reisekosten werden gegen Einzelnachweis erstattet. Die darin enthaltenen Tage- und &Uuml;bernachtungsgelder k&ouml;nnen im Rahmen der steuerlich zul&auml;ssigen Betr&auml;ge auch pauschal abgerechnet werden.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall be reimbursed to an appropriate extent for the expenses required in the interest of the Company. Required travel expenses will be reimbursed against itemization. The daily and overnight allowances contained therein may also be settled as a lump sum within the limits of the amount permissible for tax purposes.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft kann den Vorstand nach ihrem Ermessen f&uuml;r die Dauer dieses Dienstvertrages im Rahmen einer Risiko-Lebensversicherung in H&ouml;he von EUR 500.000,00 f&uuml;r den Todesfall und im Rahmen einer Unfallversicherung in H&ouml;he von EUR&nbsp;700.000,00 f&uuml;r den Invalidit&auml;tsfall versichern bzw. eine bereits bestehende Versicherung fortf&uuml;hren. Der Vorstand hat das Recht, den/die Bezugsberechtigten zu bestimmen.</FONT></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>At its discretion, the Company may insure the Board Member for the duration of this Service Agreement under a risk life insurance policy in the amount of EUR 500,000.00 in the event of death and under an accident insurance policy in the amount of EUR&nbsp;700,000.00 in the event of disability or continue an existing insurance policy. The Board Member is entitled to determine the beneficiary/beneficiaries.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im Falle der &Uuml;bernahme einer bestehenden Direktversicherung kann diese gem&auml;&szlig; &sect;&nbsp;40 b EStG in ihrer geltenden Fassung weiter gef&uuml;hrt werden. Die pauschale Versteuerung &uuml;bernimmt in diesem Fall die Gesellschaft.</FONT></TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event that an existing direct insurance policy is taken over, this insurance policy can be managed in its current version under Section 40 b German Income Tax Act (EStG). In this case, the lump sum taxation is paid by the Company.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="padding-left: 0.05in; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft bietet dem Vorstand die M&ouml;glichkeit zur Teilnahme an einer Pensionskasse, Unterst&uuml;tzungskasse oder einer &auml;hnlichen betrieblichen Altersversorgung (BAV) bzw. zur &Uuml;bernahme einer bereits bestehenden BAV. In diesem Zusammenhang kann der Vorstand einen Teil seiner Gehaltsanspr&uuml;che zugunsten einer betrieblichen Altersversorgungszusage umwandeln. Die dem Vorstand gem&auml;&szlig; &sect;&nbsp;3 (1) lit. a) gew&auml;hrte Grundverg&uuml;tung wird dabei mit Wirkung zum Beginn einer betrieblichen Altersversorgungszusage entsprechend um einen monatlichen Bruttobetrag gek&uuml;rzt, um in eine wertgleiche Zusage auf betriebliche Versorgungsleistung umgewandelt zu werden. In H&ouml;he dieses Betrags verringert sich der Anspruch des Vorstands auf Zahlung der Grundverg&uuml;tung. Sollte der Vorstand die Versorgungszusage im weiteren Verlauf ganz oder teilweise wieder k&uuml;ndigen oder ruhen lassen, so lebt der entsprechende Verg&uuml;tungsanspruch wieder auf.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Company offers the Board Member the opportunity to participate in a pension fund, support fund or similar company pension scheme (<I>betriebliche Altersvorsorge</I>, BAV) or to take over an existing BAV. In this context, the Board Member can convert part of its salary entitlements into a company pension commitment. The Basic Remuneration granted to the Board Member pursuant to &sect; 3 (1) lit. a) shall be reduced by a gross monthly amount with effect from the beginning of a company pension commitment to be converted into an equal-value commitment to company pension benefits. The Board Member's entitlement to payment of the Basic Remuneration is reduced by this amount. If the Board Member rescinds or suspends the pension commitment in whole or in part in the further course of the plan, the corresponding entitlement to compensation shall revive.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft schlie&szlig;t f&uuml;r den Vorstand eine Verm&ouml;gensschaden-Haftpflichtversicherung (D&amp;O) f&uuml;r den Fall ab, dass der Vorstand wegen einer in Aus&uuml;bung seiner T&auml;tigkeit begangenen Pflichtverletzung von einem Dritten oder der Gesellschaft aufgrund gesetzlicher Haftpflichtbestimmungen privatrechtlichen Inhalts f&uuml;r einen Verm&ouml;gensschaden in Anspruch genommen wird. Der Vorstand tr&auml;gt dabei eine Selbstbeteiligung in H&ouml;he des Mindestwerts gem&auml;&szlig; &sect;&nbsp;93 (2) AktG (derzeit je Schadensfall 10% des Schadens, maximal aber das 1<SUP>1</SUP>/<SUB>2</SUB>-fache der Grundverg&uuml;tung pro Jahr (j&auml;hrliche H&ouml;chstgrenze). Kommt es zu mehreren Schadensf&auml;llen in einem Jahr, gilt die j&auml;hrliche H&ouml;chstgrenze f&uuml;r alle Schadensf&auml;lle zusammen. Der Selbstbehalt passt sich bei &Auml;nderung der Grundverg&uuml;tung (bzw. bei &Auml;nderung von &sect;&nbsp;93 (2) AktG) automatisch an; der Vorstand ist verpflichtet, die entsprechenden &Auml;nderungen beim Selbstbehalt des D&amp;O Versicherungsvertrages zu veranlassen, und / oder s&auml;mtliche in diesem Zusammenhang erforderlichen Erkl&auml;rungen abzugeben. Das Bezugsjahr f&uuml;r den anzuwendenden Selbstbehalt ist das Jahr des Pflichtversto&szlig;es.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Company enters into a directors' and officers' liability insurance policy (D&amp;O) for the Board Member for the event that a third party or the Company makes a claim against the Board Member for a loss of assets due to a breach of duty committed in the performance of its duties due to statutory liability provisions under private law. The Board Member bears a deductible in the amount of the minimum value pursuant to Section 93 (2) of the German Stock Corporation Act (AktG) (currently 10% of the damage per claim, but not more than one and a half times the basic annual remuneration (annual maximum limit). In case of several loss events in one year, the annual maximum limit applies to all loss events in combination. The deductible is automatically adjusted in the event of a change in the Basic Remuneration (or in the event of a change in Section 93 (2) AktG); the Board Member is obliged to arrange for the corresponding changes to the deductible in the D&amp;O insurance agreement and / or to provide all declarations required in this regard. The reference year for the deductible to be applied is the year of the violation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 5<BR>
Urlaub</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 5<BR>
Holiday</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand hat Anspruch auf einen Jahresurlaub von 30 Arbeitstagen. Arbeitstage sind alle Kalendertage mit Ausnahme von Samstagen, Sonntagen und gesetzlichen Feiertagen am Sitz der Gesellschaft. Bei unterj&auml;hrigem Besch&auml;ftigungsbeginn oder -ende wird der Jahresurlaub in diesem Kalenderjahr zeitanteilig gew&auml;hrt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member is entitled to an annual vacation of 30 working days. Working days are all calendar days except Saturdays, Sundays and public holidays at the registered office of the Company. If employment begins or ends during the course of the year, annual vacation in this calendar year will be granted pro rata temporis.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Urlaubszeit ist unter Ber&uuml;cksichtigung der Gesch&auml;ftslage mit den anderen Vorstandsmitgliedern abzustimmen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The holiday period shall be coordinated with the other members of the Executive Board, taking into account the business situation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 6<BR>
Bez&uuml;ge bei Krankheit, Arbeitsunf&auml;higkeit oder Tod</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 6<BR>
Beneficiaries in the event of illness, incapacity for work or death</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>lm Fall einer Dienstverhinderung (z.B. infolge Erkrankung) ist das Vorstandsmitglied verpflichtet, den Aufsichtsratsvorsitzenden der Gesellschaft unverz&uuml;glich &uuml;ber Grund und Dauer der Dienstverhinderung zu informieren und auf vordringlich zu erledigende Aufgaben hinzuweisen. Dauert die Dienstverhinderung l&auml;nger als eine Woche, hat das Vorstandsmitglied im Fall einer Erkrankung ein &auml;rztliches Attest oder im Fall einer sonstigen Dienstverhinderung eine schriftliche Erkl&auml;rung vorzulegen, woraus sich der Grund der Arbeitsunf&auml;higkeit sowie deren voraussichtliche Dauer ergeben.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of an unforeseen absence (e.g. due to illness), the Board Member is obliged to inform the Chairman of the Supervisory Board of the Company without undue delay of the reason for and probable duration of the impediment to service and draw the attention on the tasks to be performed urgently. If the absence lasts longer than one week, the Board Member must submit a medical certificate or in the event of any other incapacity or a written declaration in the event of any other disability, stating the reason for the incapacity and its probable duration.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Das Vorstandsmitglied tritt bereits jetzt etwaige (Schadensersatz-)Anspr&uuml;che in H&ouml;he der nach dieser Regelung von der Gesellschaft geleisteten oder zu leistenden Zahlungen an die Gesellschaft ab, die ihm gegen&uuml;ber Dritten wegen der Arbeitsverhinderung zustehen. Das Vorstandsmitglied ist verpflichtet, der Gesellschaft unverz&uuml;glich s&auml;mtliche zur Geltendmachung derartiger (Schadensersatz-)Anspr&uuml;che notwendigen Angaben zu machen sowie hierf&uuml;r notwendige Unterlagen zu &uuml;berlassen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The Board Member hereby assigns to the Company any (compensation) claims in the amount of the payments made or to be made by the Company in accordance with this provision to which he is entitled in respect of third parties due to the impediment to work. The Board Member is obligated to provide the Company with all information necessary for asserting such (compensation) claims and to provide the Company with the necessary documents without undue delay.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Bei einer vor&uuml;bergehenden krankheitsbedingten oder sonstigen unverschuldeten Arbeitsunf&auml;higkeit des Vorstandes wird die Grundverg&uuml;tung gem&auml;&szlig; &sect; 3 (1) lit. a) w&auml;hrend der Zeit der Arbeitsunf&auml;higkeit bis zu einer Dauer von sechs Monaten, l&auml;ngstens jedoch bis zur Beendigung dieses Dienstvertrages weitergezahlt. Dauert die Arbeitsunf&auml;higkeit l&auml;nger als ununterbrochen 3 Monate an, kann der Aufsichtsrat die variable Verg&uuml;tung unter Ber&uuml;cksichtigung der Dauer der Arbeitsunf&auml;higkeit angemessen reduzieren.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of a temporary illness or other non-culpable incapacity to work, the basic remuneration pursuant to &sect; 3 (1) lit. a) shall continue to be paid during the period of the incapacity to work up to a period of six months, at the latest until the termination of this Service Agreement. If the incapacity to work lasts longer than three months without interruption, the Supervisory Board may reduce the variable remuneration by a reasonable amount, taking into account the duration of the incapacity to work.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Bei einer dauernden Arbeitsunf&auml;higkeit des Vorstandes endet der Dienstvertrag mit dem Ende des Quartals, in dem die dauernde Arbeitsunf&auml;higkeit festgestellt worden ist.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of permanent incapacity to work of the Board Member, the employment agreement ends at the end of the quarter in which the permanent incapacity to work was determined.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ist der Vorstand l&auml;nger als sechs Monate au&szlig;erstande, seiner T&auml;tigkeit nachzugehen, kann der Aufsichtsrat verlangen, dass das Vorliegen einer dauernden Arbeitsunf&auml;higkeit durch einen von ihm ausgew&auml;hlten Arzt auf Kosten der Gesellschaft nachgepr&uuml;ft wird. Nimmt der Vorstand den Termin trotz zweimaliger Aufforderung durch den Aufsichtsrat nicht wahr, gilt der Vorstand als dauernd arbeitsunf&auml;hig. Die Aufforderungen haben mit einer Woche zeitlichen Abstands voneinander zu erfolgen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If the Board Member is unable to carry out its duties for more than six months, the Supervisory Board may demand that the existence of a permanent incapacity to work be reviewed by a doctor of its choice at the Company's expense. If the Board Member fails to meet the demand despite two requests by the Supervisory Board, the Board Member shall be deemed permanently incapacitated for work. The requests shall be made at intervals of one week.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Eine Abfindung ist bei einer Beendigung des Dienstvertrags wegen dauernder Arbeitsunf&auml;higkeit nicht zu leisten.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">A severance payment shall not be made in the event of termination of the employment agreement due to permanent incapacity to work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Stirbt der Vorstand w&auml;hrend der Dauer des Dienstvertrages, ist die Grundverg&uuml;tung nach &sect; 3 (1) lit. a) noch f&uuml;r den Sterbemonat und f&uuml;r die zwei darauffolgenden Monate zu zahlen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>If the Board Member dies during the term of this Service Agreement, the Basic Remuneration according to &sect; 3 (1) lit. a) shall still be payable for the month of death and for the following two months.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Die Boni werden entsprechend den vertraglichen Regelungen durch den Aufsichtsrat festgelegt und an den Ehepartner, bei deren Fehlen an die unterhaltsberechtigten Kinder des Vorstands (letztere als Gesamtgl&auml;ubiger) oder seine Erben bezahlt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The bonuses are determined in accordance with the contractual regulations by the Supervisory Board and paid to the spouse, in the event of their absence to the dependent children of the Board Member (the latter as joint creditor) or his heirs.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 7<BR>
Sonderleistungen und Sonderk&uuml;ndigungsrecht bei Kontrollerwerb</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 7<BR>
Special services and special right of termination in the event of acquisition of control</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Kommt es nach der Unterzeichnung dieses Vertrags zu einem Kontrollerwerb im Sinne eines Anteilserwerbs von mehr als 50% durch einen Aktion&auml;r, Dritten oder gemeinsam handelnde Personen oder zu einer wirtschaftlich vergleichbaren Transaktion (z.B. Verkauf des Gesch&auml;ftsbetriebs oder eines wesentlichen Teils davon durch die Gesellschaft, Verkauf von wesentlichen Beteiligungsgesellschaften der Gesellschaft, Verschmelzung auf ein anderes Unternehmen, Verkauf von mehr als 50% der Anteile der Gesellschaft nach einem &bdquo;Delisting&quot; der Gesellschaft, etc.) und will sich die Gesellschaft in diesem Zusammenhang oder in dessen Folge von dem Vorstand durch vorzeitige Vertragsaufl&ouml;sung trennen, ohne hierf&uuml;r einen wichtigen Grund im Sinn des &sect; 626 BGB zu haben, so erh&auml;lt der Vorstand zus&auml;tzlich zu der Verg&uuml;tung und allen Leistungen, die ihm bis zum Trennungszeitpunkt zustehen, eine Abfindung. Die H&ouml;he der Abfindung entspricht der Grundverg&uuml;tung, die der Vorstand bis zum Ablauf der in &sect; 10 (1) definierten Dauer gem&auml;&szlig; diesem Vertrag erhalten hatte, w&auml;re der Vertrag nicht vorzeitig beendet, sondern bis zum Ende der vollen Amtszeit erf&uuml;llt worden, zuz&uuml;glich eines Erh&ouml;hungsbetrages, der 100 % des Anspruchs auf variable Leistungen im Jahr des Austritts entspricht. Betr&auml;gt die ordentliche Laufzeit dieses Vertrages gem&auml;&szlig; &sect;&nbsp;10 (1) zum Zeitpunkt des Wirksamwerdens der Trennung nach diesem Absatz weniger als 12 Monate, berechnet sich die zu zahlende Abfindung auf Basis einer fiktiven Restlaufzeit von 12 Monaten, d.&nbsp;h. die Abfindung wird berechnet auf Basis einer angenommenen Restlaufzeit von mindestens 12 Monaten. </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>If, after the signing of this Agreement, control is acquired in the sense of a share acquisition of more than 50% by a shareholder, third party or persons acting jointly or in the sense of an economically comparable transaction (e.g. sale of the business operations or a substantial part thereof by the Company, sale of substantial associated companies of the Company, merger with another company, sale of more than 50% of the shares of the Company after a delisting of the Company, etc.) and if the Company wishes to terminate the agreement with the Board Member in this context or as a result thereof by early termination of the agreement without having an important reason within the meaning of Section 626 of the German Civil Code (BGB), the Board Member shall receive a severance payment in addition to the remuneration and all benefits to which it is entitled up to the time of termination. The amount of the severance payment corresponds to the basic remuneration that the Board Member would have received until expiry of the term defined in &sect; 10 (1) of this agreement, if the agreement would not have been terminated prematurely, but would have been fulfilled up until the end of the full term of office plus an increase amount corresponding to 100 % of the entitlement to variable benefits in the year of departure. If the ordinary term of this agreement pursuant to &sect; 10 (1) is less than 12 months at the time the separation pursuant to this paragraph takes effect, the severance payment to be made shall be calculated on the basis of a fictitious remaining term of 12 months, i.e. the severance payment shall be calculated on the basis of an assumed remaining term of at least 12 months.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">W&auml;hrend der Vertragslaufzeit stattfindende Anhebungen der Verg&uuml;tung gem&auml;&szlig; &sect; 3 (1) werden bei den beschriebenen Berechnungen ber&uuml;cksichtigt.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any increases in remuneration in accordance with &sect; 3 (1) that take place during the term of the agreement shall be taken into account in the calculations described.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soweit der Vorstand im Rahmen dieser Regelung aus den Diensten der Gesellschaft ausscheidet, wird beim Bonus gem&auml;&szlig; &sect; 3 Ziffer 1 b) f&uuml;r das Jahr des Austritts eine Zielerreichung in H&ouml;he von 100 % unterstellt, soweit die tats&auml;chliche Zielerreichung niedriger liegt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">If the Board Member leaves the services of the Company under this provision, a target achievement of 100% is assumed for the bonus pursuant to Section 3 (1) b) for the year of departure if the actual target achievement is lower</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Abfindung ist in voller H&ouml;he zusammen mit dem Gehalt f&uuml;r den Monat, zu dessen Ende die Trennung nach Absatz (1) wirksam wird, zur Zahlung f&auml;llig.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The severance payment shall be payable in full together with the salary for the month at the end of which the separation referred to in paragraph (1) takes effect.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im Falle dieses Absatzes (1) wird dem Vorstand ein au&szlig;erordentliches Sonderk&uuml;ndigungsrecht zu diesem Dienstvertrag einger&auml;umt. Das Sonderk&uuml;ndigungsrecht kann innerhalb von sechs Wochen ab Kenntnis des Vorstands &uuml;ber den rechtskr&auml;ftigen Vollzug des Kontrollwechsels im Sinne des Absatzes (1) mit einer Frist von drei Monaten zum Monatsende ausge&uuml;bt werden. Dar&uuml;ber hinaus besteht ein Sonderk&uuml;ndigungsrecht des Vorstands auch dann, wenn der Vorstand innerhalb von einem Jahr nach Vollzug des Kontrollwechsels abberufen wird. In diesem Fall betr&auml;gt die Sonderk&uuml;ndigungsfrist zwei Wochen. Die K&uuml;ndigung kann innerhalb von vier Wochen nach Abberufung durch den Vorstand erkl&auml;rt werden.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of this paragraph (1), the Board Member shall be granted an extraordinary right of termination of this Service Agreement. The special right of termination may be exercised within six weeks of the knowledge of the Board Member of the legally binding execution of the change of control within the meaning of paragraph (1) with a notice period of three months to the end of the month. In addition, the Board Member has a special right of termination even if the Board Member is dismissed within one year of the completion of the change of control. In this case, the special notice period is two weeks. The termination may be declared by the Board Member within four weeks after dismissal.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 8<BR>
Diensterfindungen und Schutzrechte</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 8<BR>
Service inventions and industrial property rights</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Erfindungen des Vorstands sowie seine technischen oder organisatorischen Verbesserungsvorschl&auml;ge werden entsprechend den jeweils geltenden Bestimmungen des Gesetzes &uuml;ber Arbeitnehmererfindungen vom 25.7.1957 mit folgender Ma&szlig;gabe behandelt: Der Vorstand wird der Gesellschaft Diensterfindungen, freie Erfindungen und technische wie organisatorische Verbesserungsvorschl&auml;ge unverz&uuml;glich melden und der Gesellschaft zur ausschlie&szlig;lichen, beschr&auml;nkten oder unbeschr&auml;nkten Inanspruchnahme anbieten. Die Erkl&auml;rung der Inanspruchnahme hat seitens der Gesellschaft innerhalb von vier Monaten nach der Meldung zu erfolgen. Die Gesellschaft hat das Recht, jedoch nicht die Verpflichtung, zur Anmeldung von Schutzrechten im In- und Ausland. Im Fall einer Diensterfindung oder eines technischen oder organisatorischen Verbesserungsvorschlags sind sich die Parteien darin einig, dass eine etwaige Verg&uuml;tung f&uuml;r eine von der Gesellschaft in Anspruch genommene Diensterfindung mit der Zahlung der Grundverg&uuml;tung nach &sect; 3 (1) lit. a) dieses Vertrages vollst&auml;ndig abgegolten ist. Im Fall einer freien Erfindung ist dem Vorstandsmitglied eine markt&uuml;bliche Verg&uuml;tung zu zahlen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Inventions by the Board Member and its technical or suggestions for organizational improvements shall be treated in accordance with the applicable provisions of the Act on Employee Inventions of 25 July 1957, subject to the following provisions: The Board Member will immediately notify the Company of job-related inventions, free inventions and technical and organizational suggestions for improvement and offer them to the Company for exclusive, limited or unlimited use. The Company must declare the claim within four months of notification. The Company is entitled, but not obliged, to register intellectual property rights in Germany and abroad. In the case of a job-related invention or a technical or organizational suggestion for improvement, the parties agree that any remuneration for a service invention claimed by the Company shall be paid in full upon payment of the basic remuneration pursuant to &sect; 3 (1) lit. a) of this Agreement. In the case of a free invention, the Board Member shall be paid remuneration in line with market-based conditions.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand &uuml;bertr&auml;gt der Gesellschaft ausschlie&szlig;liche, zeitlich, r&auml;umlich und inhaltlich unbeschr&auml;nkte Nutzungs- und Verwertungsrechte f&uuml;r alle etwaigen nach dem Urhebergesetz schutzf&auml;higen T&auml;tigkeitsergebnisse, die das Vorstandsmitglied w&auml;hrend der Dauer seines Dienstvertrages w&auml;hrend seiner Arbeitszeit oder, sofern sie Bezug zu seinen dienstvertraglichen Aufgaben haben, auch au&szlig;erhalb seiner Arbeitszeit erstellt. Die &Uuml;bertragung der urheberrechtlichen Nutzungs- und Verwertungsrechte umfasst auch etwaige bei Vertragsschluss noch unbekannte Nutzungsarten. Die &Uuml;bertragung der Nutzungs- und Verwertungsrechte umfasst insbesondere auch die Erlaubnis zur Bearbeitung und Lizenzvergabe an Dritte. Das Vorstandsmitglied verzichtet ausdr&uuml;cklich auf sonstige ihm etwa als Urheber zustehende Rechte an den T&auml;tigkeitsergebnissen, insbesondere auf das Recht auf Namensnennung, auf Bearbeitung und auf Zug&auml;nglichmachung des Werkes.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member shall grant the Company exclusive rights of use and exploitation, unlimited in terms of time, space and content, for any works which may be protected under the Copyright Act and which the Board Member produces during the term of this Service Agreement during his working hours or, if they relate to his duties under the Service Agreement, also outside of his working hours. The transfer of the copyrighted rights of use and exploitation also includes any types of use still unknown at the time of conclusion of the agreement. The transfer of the rights of use and exploitation includes in particular the permission for processing and licensing to third parties. The Board Member expressly waives any other rights to the works, which he is entitled as the author, in particular the right to name, edit and make accessible the work.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Soweit T&auml;tigkeitsergebnisse, die der Vorstand w&auml;hrend der Dauer seines Dienstvertrages w&auml;hrend seiner Arbeitszeit oder, sofern sie Bezug zu seinen dienstvertraglichen Aufgaben haben, auch au&szlig;erhalb seiner Arbeitszeit erstellt, nicht bereits nach Absatz (1) und (2) &uuml;bertragen sind, &uuml;bertr&auml;gt der Vorstand der Gesellschaft s&auml;mtliche Rechte an diesen T&auml;tigkeitsergebnissen, insbesondere Marken- und sonstige Kennzeichenrechte sowie eingetragene Designs.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Insofar as works which the Board Member produces during the term of its Service Agreement, during its working hours or, insofar as they relate to its duties under the Service Agreement, also outside its working hours, have not already been transferred in accordance with paragraphs (1) and (2), the Board Member shall transfer to the Company all rights to these works, in particular trademark and other distinctive rights as well as registered designs.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Parteien sind sich einig, dass die Einr&auml;umung dieser Rechte und der Verzicht auf Rechte nach dieser Regelung vollumf&auml;nglich mit der Zahlung der Grundverg&uuml;tung nach &sect;&nbsp;3 (1) lit. a) dieses Vertrages abgegolten sind, soweit dem nicht zwingende gesetzliche Regelungen entgegenstehen. Der Vorstand ist verpflichtet, jedwedes seiner schutzrechtsf&auml;higen T&auml;tigkeitsergebnisse unverz&uuml;glich der Gesellschaft, vertreten durch den Aufsichtsrat, zu meiden und die Gesellschaft im erforderlichen Umfang, auch nach Beendigung dieses Dienstvertrages, bei der Erlangung von Schutzrechten zu unterst&uuml;tzen. Soweit der Vorstand seine Mitwirkungspflichten nach der Beendigung dieses Dienstvertrages erf&uuml;llt, erh&auml;lt der Vorstand hierf&uuml;r einen angemessenen Tagessatz sowie eine Erstattung aller Aufwendungen, die ihm durch seine Mitwirkung entstanden sind.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The parties agree that the granting of these rights and the waiver of rights under this provision are fully covered by the payment of the Basic Remuneration under &sect; 3 (1) lit. a) this agreement, unless otherwise provided for by mandatory legal provisions. The Board Member is obliged to notify any of the works that are capable of being protected by intellectual property rights without delay to the Company, represented by the Supervisory Board, and to support the Company to the necessary extent, even after termination of this Service Agreement, in obtaining intellectual property rights. To the extent that the Board Member fulfils its duties to cooperate after the termination of this Service Agreement, the Board Member shall receive an appropriate daily rate as well as a reimbursement of all expenses incurred by him resulting from his cooperation.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 9<BR>
Geheimhaltung und R&uuml;ckgabe von Unterlagen, Interessenkonflikte</B></FONT></TD>
    <TD STYLE="text-align: center; width: 5%">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 9<BR>
Confidentiality and return of documents, conflicts of interest</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand verpflichtet sich, &uuml;ber alle ihm im Rahmen seiner T&auml;tigkeit oder sonst zur Kenntnis gelangenden gesch&auml;ftlichen und betrieblichen Angelegenheiten der Gesellschaft und aller Verbundenen Unternehmen strengstes Stillschweigen zu bewahren, einschlie&szlig;lich des Inhalts dieses Dienstvertrages sowie den Vertragsverhandlungen, die dem Abschluss dieses Dienstvertrages zugrunde liegen. Der Vorstand verpflichtet sich weiterhin, diese Informationen nicht f&uuml;r den eigenen oder den Nutzen anderer zu verwenden und alle solche gesch&auml;ftlichen und betrieblichen Angelegenheiten betreffenden Gesch&auml;ftsunterlagen der Gesellschaft und der Verbundenen Unternehmen unter Verschluss zu halten. Unter gesch&auml;ftlichen und betrieblichen Angelegenheiten im Sinne dieser Regelung verstehen die Parteien insbesondere Gesch&auml;fts- und Betriebsgeheimnisse sowie alle Informationen und Daten mit Bezug zu vertraulichen Angelegenheiten und gesch&auml;ftsbezogenem Know-how, s&auml;mtliche Informationen &uuml;ber alle mit dem existenten oder k&uuml;nftigen Gesch&auml;ft der Gesellschaft und der Verbundenen Unternehmen in Zusammenhang stehenden Gesch&auml;ftspl&auml;ne und Gesch&auml;ftsstrategien, Verfahren, Preis- oder Marktstrategien und Produkt-, Dienstleistungs- oder Entwicklungsplanungen, geplante Unternehmenserwerbe oder -ver&auml;u&szlig;erungen, s&auml;mtliche Gesch&auml;ftszahlen und Details der organisatorischen Strukturen sowie die wesentlichen Ideen und Prinzipien, welche diesen Strategien und Planungen zugrunde liegen, und alle Informationen, von denen vern&uuml;nftigerweise erwartet werden kann, dass sie zu solchen Strategien oder Planungen f&uuml;hren w&uuml;rden und die von der Gesellschaft, von Verbundenen Unternehmen oder dem Vorstandsmitglied w&auml;hrend der Dauer dieses Dienstvertrages erdacht, erfunden, &uuml;berarbeitet, entdeckt, entwickelt, erworben, beurteilt, getestet oder angewendet worden sind.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member undertakes to maintain the strictest secrecy with regard to all business and operational matters of the Company and old affiliated companies that come to its attention in the course of its activities or otherwise, including the contents of this Service Agreement and the negotiations on which the conclusion of this Service Agreement is based. The Board Member further undertakes not to use this information for its own benefit or for the benefit of others and to keep all business documents of the Company and its affiliates relating to such business and operational matters under lock and key. For the purposes of this provision, business and operational matters shall mean, in particular, business and trade secrets and all information and data relating to confidential matters and business-related know-how, all information, all business plans and strategies, procedures, price or market strategies and product, service or development plans relating to the existing or future business of the Company and its affiliates, planned corporate acquisitions or disposals, all business figures and details of the organizational structures and the principal ideas and principles underlying such strategies and plans, and all information that can reasonably be expected to result in such strategies or plans and that has been invented, redacted, discovered, developed, assessed, tested or applied by the Company, its affiliates or the Board Member during the term of this Service Agreement.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Geheimhaltungsverpflichtung nach vorstehendem Absatz (1) dauert auch nach Beendigung des Dienstverh&auml;ltnisses fort. Im Rahmen einer von dem Vorstand nach Beendigung dieses Dienstvertrages ausge&uuml;bten beruflichen oder unternehmerischen T&auml;tigkeit kann er sein als Vorstandsmitglied erworbenes Wissen einsetzen, sofern dabei die gesetzlichen Beschr&auml;nkungen &ndash; insbesondere nach &sect;&sect; 3, 17 UWG, &sect;&nbsp;823 (1) und (2) BGB i.V.m. UWG, &sect;&nbsp;826 BGB und den datenschutzrechtlichen Regelungen &ndash; sowie die Beschr&auml;nkungen aus dem nachvertraglichen Wettbewerbsverbot nach &sect;&nbsp;16 dieses Vertrages strikt beachtet werden.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The obligation to maintain secrecy pursuant to paragraph (1) above shall continue even after the termination of the employment relationship. The Board Member may use the knowledge acquired as a Board Member within the scope of a professional or entrepreneurial activity carried out by the Board Member after termination of this Service Agreement, provided that he complies with the statutory restrictions - in particular Sections 3, 17 UWG, Section 823 (1) and (2) BGB in conjunction with Sections 3, 17 UWG, Section 823 (1) and (2) BGB associated with UWG, Section 826 BGB and the data protection regulations.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand ist verpflichtet, in Zweifelsf&auml;llen &uuml;ber den Umfang der Geheimhaltungsverpflichtung nach vorstehenden Abs&auml;tzen (1) und (2) mit dem Aufsichtsrat der Gesellschaft eine Kl&auml;rung herbeizuf&uuml;hren.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In cases of doubt, the Board Member is obliged to reach a clarification with the Supervisory Board of the Company regarding the scope of the confidentiality obligation pursuant to paragraphs (1) and (2) above.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand verpflichtet sich, auf Verlangen der Gesellschaft jederzeit und sp&auml;testens bei Ende seiner Bestellung zum Organ auch ohne gesonderte Aufforderung alle in seinem Besitz befindlichen Unterlagen der Gesellschaft oder Verbundener Unternehmen, insbesondere alle Notizen, Memoranden, Aufzeichnungen, Protokolle und Berichte, Akten sowie alle anderen &auml;hnlichen Dokumente (einschlie&szlig;lich Abschriften, Ablichtungen, Kopien oder sonstiger Reproduktionen), die im Zusammenhang mit seiner T&auml;tigkeit stehen, unverz&uuml;glich und vollst&auml;ndig an die Gesellschaft zur&uuml;ckzugeben. Ein Zur&uuml;ckbehaltungsrecht ist ausgeschlossen. Diese Regelung gilt sinngem&auml;&szlig; f&uuml;r elektronisch gespeicherte Daten sowie die jeweiligen Daten- oder Programmtr&auml;ger.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member undertakes, at the request of the Company at any time and at the latest at the end of its appointment to the board and without separate request, to return to the Company all documents of the Company or affiliated companies in its possession, in particular all notes, memoranda, records, minutes and reports, files as well as all other similar documents (including copies, photocopies or other reproductions) in connection with its activities without delay and in full. A right of retention is excluded. This provision applies to electronically stored data as well as to the respective data or program carriers.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Herausgabeverpflichtung bezieht sich auch auf sonstiges, im Besitz des Vorstands befindliches Eigentum der Gesellschaft oder Verbundener Unternehmen bzw. von der Gesellschaft oder von einem Verbundenen Unternehmen geleaste Gegenst&auml;nde. Diese Herausgabeverpflichtung erstreckt sich insbesondere auch auf ein dem Vorstand etwa &uuml;berlassenes Mobiltelefon, Laptop oder sonstige Ger&auml;te der Datenverarbeitung, bei Ende seiner Bestellung zum Organ auch, wenn insoweit eine private Nutzung gestattet war.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The release obligation also applies to other property of the Company or affiliates or items leased by the Company or an affiliate that is in possession of the Board Member. This release obligation also extends in particular to a mobile phone, laptop or other data processing device left in the possession of the Board Member, at the end of its appointment to the Board even if private use was permitted in this respect.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 15.95pt; text-align: justify; text-indent: -15.95pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorstand hat m&ouml;gliche und tats&auml;chliche Interessenkonflikte unverz&uuml;glich dem Aufsichtsrat gegen&uuml;ber offenzulegen und die anderen Vorstandsmitglieder hier&uuml;ber zu informieren.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Board Member must immediately disclose possible and actual conflicts of interest to the Supervisory Board and inform the other members of the Management Board hereof.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 10<BR>
Vertragsdauer, Beendigung, Abfindung</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 10<BR>
Term of the Agreement, Termination, Severance</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Dienstvertrag beginnt mit dem 01.01.2024 (&bdquo;<B>Stichtagsdatum</B>&ldquo;) und endet zum Ablauf des 31.12.2026 (&bdquo;<B>Beendigungsdatum&ldquo;</B>).</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.15pt; text-align: justify; text-indent: -16.15pt">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;
    </FONT>The Service Agreement commences on January 01, 2024 (&ldquo;<B>Effective Date</B>&rdquo;) and ends on December 31, 2026 (&ldquo;<B>Completion
    Date</B>&rdquo;).</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Das Recht zur au&szlig;erordentlichen K&uuml;ndigung bleibt unber&uuml;hrt.</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The right to extraordinary termination remains unaffected.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Im Fall eines Widerrufs der Bestellung, der Amtsniederlegung durch das Vorstandsmitglied oder bei einer sonstigen Beendigung der Organstellung endet dieser Dienstvertrag mit Ablauf von drei Monaten nach dem Ende des Amtes, sp&auml;testens jedoch zum Ende der Laufzeit nach Absatz (1). Eine etwaige fr&uuml;here Beendigung aufgrund Absatz (2) dieses Vertrages bleibt unber&uuml;hrt.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>In the event of revocation of the appointment, demission by the Board Member or other termination of the position, this Service Agreement shall end at the end of three months&nbsp;&nbsp;after the end of the term of office, at the latest, however, at the end of the term pursuant to paragraph (1). A possible termination due to paragraph (2) of this agreement remains unaffected.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Vorsitzende des Aufsichtsrats wird dem Vorstand sp&auml;testens drei Monate vor Ablauf dieses Vertrages, also bis zum 30. September 2026, schriftlich mitteilen, ob und unter welchen Bedingungen der Aufsichtsrat den Vorstand erneut zum Vorstandsmitglied bestellen wird und ob er bereit ist, den Dienstvertrag entsprechend der Dauer der neuen Bestellung zu verl&auml;ngern oder einen neuen Dienstvertrag zu mindestens gleichen Bedingungen mit ihm abzuschlie&szlig;en, Der Vorstand wird innerhalb von zwei Monaten ab Zugang des Angebots des Aufsichtsratsvorsitzenden erkl&auml;ren, ob er die erneute Bestellung annimmt und bereit ist, den f&uuml;r die Fortsetzung oder Erneuerung des Dienstvertrages angebotenen Bedingungen zuzustimmen.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Chairman of the Supervisory Board will inform the Board Member in writing no later than three months before the expiry of this agreement, i.e. by 30 September 2026, whether and under what conditions the Supervisory Board will reappoint the Board Member and whether he is willing to extend the Service Agreement for the duration of the new appointment or to conclude a new Service Agreement on at least the same terms. Within two months of receipt of the Supervisory Board Chairman's offer, the Board Member will declare whether it accepts the reappointment and is prepared to agree to the terms and conditions offered for the continuation or renewal of the Service Agreement.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die Gesellschaft ist berechtigt, den Vorstand nach dem Widerruf seiner Bestellung gem&auml;&szlig; &sect; 84 (3) AktG oder im Zusammenhang mit einer Beendigung des Dienstvertrages, insbesondere nach einer K&uuml;ndigung oder im Anschluss an den Abschluss eines Aufhebungsvertrages, ganz oder teilweise von seiner Pflicht zur Dienstleistung unter Fortzahlung der Grundverg&uuml;tung gem&auml;&szlig; &sect; 3 (1) lit. a) widerruflich oder unwiderruflich freizustellen. Im Fall der unwiderruflichen Freistellung werden offene Urlaubs- und sonstige Freizeitausgleichsanspr&uuml;che angerechnet, die damit erledigt sind. Der Dienstvertrag im &Uuml;brigen wird von der Freistellung nicht ber&uuml;hrt; insoweit bestehen insbesondere die Verschwiegenheitspflicht und das vertragliche Wettbewerbsverbot bis zum Ende des Dienstvertrages fort. Anderweitiger Verdienst w&auml;hrend der Freistellungszeit wird gem&auml;&szlig; &sect; 615 Satz 2 BGB angerechnet. Eine Anrechnung erfolgt nicht, wenn und soweit der anderweitige Verdienst aus einer genehmigten Nebent&auml;tigkeit (&sect; 2 (1) dieses Dienstvertrages) stammt.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Company is entitled, after the revocation of its appointment pursuant to Section 84 (3) AktG or in connection with a termination of the Service Agreement, in particular following a termination or following the conclusion of a termination agreement, to release the Board Member in whole or in part from its obligation to provide services with continued payment of the Basic Remuneration pursuant to &sect; 3 (1) a) revocably or irrevocably. In the event of irrevocable release, receivable holiday and other time off compensation claims shall be credited and settled. The rest of the Service Agreement is not affected by the indemnification; in this respect, the obligation to maintain secrecy and the contractual non-competition clause continue to apply until the end of the Service Agreement. Other earnings during the exemption period shall be credited in accordance with Section 615 sentence 2 BGB. Crediting does not take place if and as far as the other earnings originate from an approved secondary activity (&sect; 2 (1) of this Service Agreement).</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Der Dienstvertrag endet sp&auml;testens am Ende des Kalenderjahres, in dem das Vorstandsmitglied sein 65. Lebensjahr vollendet, sofern dieser Dienstvertrag nicht bereits nach Absatz (1) bis (2) dieses Vertrages vor diesem Zeitpunkt geendet hat.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The Service Agreement shall end at the latest at the end of the calendar year in which the Board Member reaches the age of 65, unless this Service Agreement has not already ended before this date in accordance with paragraphs (1) to (2) of this agreement.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.35pt; text-align: justify; text-indent: -17.35pt">7.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;
    </FONT>Bei vorzeitiger Beendigung der Vorstandst&auml;tigkeit durch die Gesellschaft ohne wichtigen Grund entsprechen die Zahlungen an
    den Vorstand einschlie&szlig;lich Nebenleistungen maximal dem Wert von zwei Jahresverg&uuml;tungen (Abfindungs-Cap) und &uuml;berschreiten
    nicht die Gesamtverg&uuml;tung (Grundverg&uuml;tung, variable Verg&uuml;tung sowie Nebenleistungen) f&uuml;r die Restlaufzeit des Dienstvertrages.
    Bei einem Kontrollerwerb nach &sect; 7 gilt ein Abfindungs-Cap von maximal drei Jahresverg&uuml;tungen.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.35pt; text-align: justify; text-indent: -17.35pt">&nbsp;</P></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="width: 40%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">7.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>In the event of premature termination of the board activity by the Company without good cause, payments to the Board Member including
    fringe benefits shall not exceed the value of two years' remuneration (severance payment cap) and shall not exceed the total remuneration
    (Basic Remuneration, variable remuneration and fringe benefits) for the remaining term of the Service Agreement. In the case of an acquisition
    of control pursuant to &sect; 7, a severance payment cap of a maximum of three years' remuneration applies.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 17.35pt; text-align: justify; text-indent: -17.35pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Sofern der Dienstvertrag nicht &uuml;ber das Beendigungsdatum nach dieser &Auml;nderungsvereinbarung (oder ein sp&auml;ter vereinbartes Beendigungsdatum nach abermaliger Wiederbestellung) hinaus fortgesetzt wird, erh&auml;lt der Vorstand eine Brutto-Abfindung in H&ouml;he von 9 Monatsgrundgeh&auml;ltern. Die Abfindung ist zahlbar zum Beendigungsdatum. Der Abfindungsanspruch entf&auml;llt, wenn der Vorstand ein Angebot auf Wiederbestellung f&uuml;r eine Dauer von mindestens 12 Monaten im unmittelbaren Anschluss an das hiesige Beendigungsdatum zu mindestens gleichwertigen dienstvertraglichen Bedingungen und bei mindestens 12-monatiger Laufzeit in &Uuml;bereinstimmung mit den Fristen gem&auml;&szlig; &sect; 10 Ziffer 4 erh&auml;lt und dieses nicht annimmt. Erh&auml;lt der Vorstand ein solches Angebot im Sinne von &sect; 10 Ziffer 4 versp&auml;tet oder zu nicht gleichwertigen Bedingungen, oder wird ihm mitgeteilt, dass eine Wiederbestellung nicht erfolgen soll, so werden die Zahlungen gem&auml;&szlig; &sect; 3 die dem Zeitraum von der Angebotsunterbreitung bzw. Mitteilung der nicht erfolgenden Wiederstellung bis zum Beendigungsdatum zuzuordnen sind, vom Abfindungsanspruch abgezogen, aber nur den Zeitraum, f&uuml;r den eine Freistellung nach &sect; 10 Ziffer 5 erfolgt ist. </FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 12.9pt; text-align: justify; text-indent: -12.9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">8.<FONT STYLE="font-size: 10pt">&nbsp; </FONT>If the Service Agreement is not continued beyond the Completion Date under this Amendment Agreement (or a later termination date agreed upon after reappointment), the Board Member shall receive gross severance payment equal to 9 months basic remuneration pursuant to &sect; 3. The bonus is taken into account here - irrespective of the actual achievement of targets - on a 100% basis. The severance payment is payable on the Completion Date. The severance payment claim shall lapse if the Board member receives and does not accept an offer of reappointment for a term of at least 12 months immediately following the Completion Date here under at least equivalent terms and conditions of the Service Agreement and for a term of at least 12 months in accordance with the time limits pursuant to &sect; 10 clause 4. If the Board Member receives such an offer within the meaning of &sect; 10 clause 4 belatedly or on non-equivalent terms, or is informed that a reappointment is not to take place, the payments pursuant to &sect; 3, which are attributable to the period from the submission of the offer or notification of the non-occurrence of the reappointment until the Completion Date, shall be deducted from the severance payment claim but only for the period for which a release has occurred pursuant to &sect; 10 clause 5.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 17.35pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Der Abfindungsanspruch entf&auml;llt, sofern die Nichtverl&auml;ngerung des Dienstverh&auml;ltnisses auf einem vom Vorstand zu vertretenen wichtigen Grund beruht.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 12.9pt; text-align: justify; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">The severance payment claim shall lapse if the non-extension of the employment relationship is due to a serious cause for which the Board Member is responsible.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 17.35pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Der Abfindungsanspruch besteht auch dann, wenn das Dienstverh&auml;ltnis mindestens 9 Monate vor dem Beendigungsdatum aufgrund Abberufung / K&uuml;ndigung der Gesellschaft gem&auml;&szlig; &sect; 10 Ziffer 3 endet (vorzeitiges Beendigungsdatum), jedoch nur, soweit das Dienstverh&auml;ltnis nicht aus einem vom Vorstand zu vertretenen wichtigen Grund vorzeitig beendet worden ist. Endet das Dienstverh&auml;ltnisses infolge einer K&uuml;ndigung gem&auml;&szlig; vorstehenden Satz weniger als 9 Monate vor dem Beendigungsdatum, so werden die Zahlungen gem&auml;&szlig; &sect; 3, die dem Zeitraum von dem vorzeitigen Beendigungsdatum bis zum Beendigungsdatum zuzuordnen sind, vom Abfindungsanspruch abgezogen. Die Abfindung ist dann zum vorzeitigen Beendigungsdatum zahlbar.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 12.9pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The severance payment claim also exists if the employment relationship ends at least 9 months before the Completion Date due to removal from office / termination of the Company pursuant to &sect; 10 clause 3 (Early Completion Date), but only to the extent that the employment relationship has not been prematurely terminated for serious cause for which the Board Member is responsible. If the employment relationship ends less than 9 months prior to the Completion Date as a result of a termination pursuant to the preceding sentence, the payments pursuant to &sect; 3 as amended by this Amendment Agreement, which are attributable to the period from the Early Completion Date to the Completion Date, shall be deducted from the severance payment claim. The severance payment shall then be payable on the Early Completion Date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 11<BR>
Ausschlussfristen</B></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 11<BR>
Cut-off Periods</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Anspr&uuml;che der Gesellschaft und des Vorstands aus dem Dienstverh&auml;ltnis oder im Zusammenhang mit diesem Dienstverh&auml;ltnis verfallen, ungeachtet ihres Rechtsgrundes, wenn die bzw. der Anspruchsberechtigte den Anspruch nicht innerhalb einer Frist von sechs Monaten, berechnet ab dem Zeitpunkt der F&auml;lligkeit und der Kenntnis oder grob fahrl&auml;ssigen Unkenntnis des Anspruchsberechtigten von den anspruchsbegr&uuml;ndenden Umstanden, durch Erkl&auml;rung in Textform gegen&uuml;ber der jeweils anderen Vertragspartei geltend macht. F&uuml;r die Beurteilung der Rechtzeitigkeit der Geltendmachung ist der Zugang der Erkl&auml;rung ma&szlig;geblich. Dies gilt nicht f&uuml;r die Geltendmachung von Anspr&uuml;chen wegen Verletzung des Lebens, des K&ouml;rpers oder der Gesundheit sowie bei vors&auml;tzlichen Pflichtverletzungen. Diese Ausschlussfrist gilt auch nicht f&uuml;r Anspr&uuml;che auf den gesetzlichen Mindestlohn sowie f&uuml;r gesetzliche Fristen, die keiner Ausschlussfrist unterliegen d&uuml;rfen. Die Vers&auml;umung der Ausschlussfrist f&uuml;hrt zum Verlust des Anspruchs</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>. Claims of the Company and the Board Member arising from or in connection with the service relationship expire, irrespective of their legal basis, if the claimant does not assert the claim within a period of six months, calculated from the due date and the knowledge or grossly negligent ignorance of the claimant of the circumstances giving rise to the claim, by declaration in text form against the respective other contracting party. For the assessment of the timeliness of the assertion, the receipt of the declaration is decisive. This does not apply to the assertion of claims due to injury to life, bodily injury or health as well as to intentional breaches of duty. The aforementioned preclusive period shall also not apply to claims regarding the statutory minimum wage as well as to statutory time limits that are no subject to limitation periods. Failure to observe the limitation period shall result in the loss of the claim</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Etwaige Anspr&uuml;che der Gesellschaft nach &sect; 93 (2) und (3) AktG gegen das Vorstandsmitglied bleiben gem&auml;&szlig; &sect; 93 (4) Satz 3 AktG von vorstehendem Absatz (1) unber&uuml;hrt.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Any claims of the Company pursuant to Section 93 (2) and (3) AktG against the Board Member shall remain unaffected by the above paragraph (1) pursuant to Section 93 (4) sentence 3 AktG.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 12<BR>
Schlussbestimmungen</B></FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>&sect; 12<BR>
Final Provisions</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center; text-indent: 0in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dieser Vertrag enth&auml;lt die gesamte Vereinbarung zwischen den Parteien. Bereits getroffene Vereinbarungen zwischen den Parteien werden hiermit ausdr&uuml;cklich mit Wirkung ab dem Stichtagsdatum aufgehoben.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">1.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>This agreement contains the entire agreement between the parties. Prior agreements between the parties are hereby expressly cancelled with effect as of the Effective Date.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>&Auml;nderungen oder Erg&auml;nzungen dieses Vertrages einschlie&szlig;lich dieser Schriftformklausel bed&uuml;rfen zu ihrer Wirksamkeit der Schriftform.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">2.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Changes or additions to this agreement, including this written form clause, must be made in writing to be effective.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Dieser Vertrag unterliegt dem Recht der Bundesrepublik Deutschland.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">3.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>This agreement is subject to the law of the Federal Republic of Germany.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Erf&uuml;llungsort ist der Sitz der Gesellschaft, Gerichtsstand f&uuml;r Streitigkeiten aus diesem Vertrag ist der Sitz der Gesellschaft.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">4.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Place of performance is the seat of the Company, place of jurisdiction for disputes from this agreement is the seat of the Company.</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Die deutsche Fassung dieser Vereinbarung ist ma&szlig;geblich.</FONT></TD>
    <TD STYLE="text-align: justify; width: 5%">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt; width: 40%"><FONT STYLE="font-family: Times New Roman, Times, Serif">5.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>The German version of this Amendment Agreement is authoritative.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 16pt; text-align: justify; text-indent: -16pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp; </FONT>Sollte eine Bestimmung dieses Vertrages ganz oder teilweise rechtsunwirksam oder undurchf&uuml;hrbar sein oder werden, so wird die G&uuml;ltigkeit der &uuml;brigen Bestimmungen dieses Vertrages nicht ber&uuml;hrt. Vielmehr ist die ganz oder teilweise rechtsunwirksame oder undurchf&uuml;hrbare Bestimmung durch eine Bestimmung zu ersetzen, die den mit der unwirksamen Bestimmung angestrebten wirtschaftlichen Erfolg soweit wie m&ouml;glich erreicht. Das gleiche gilt im Fall von L&uuml;cken dieses Vertrages.</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 16.15pt; text-align: justify; text-indent: -16.15pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">6.<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp; </FONT>Should any provision of this agreement be or become invalid or unenforceable in whole or in part, the validity of the remaining provisions of this agreement shall not be affected. Rather, the invalid or unenforceable provision, in whole or in part, shall be replaced by a provision that achieves as far as possible the economic purpose intended by the invalid provision. The same shall apply in the event of any gaps in this agreement.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Martinsried, den</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Martinsried, den</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2in">12/19/2023</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 2in">&nbsp;</P></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12/18/2023</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">Immunic AG,<BR>
vertreten durch den Aufsichtsratsvorsitzenden<BR>
/s/ Dr. J&ouml;rg Neermann</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">/s/ <FONT STYLE="font-family: Times New Roman, Times, Serif">Dr. Hella Kohlhof</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Anlagenverzeichnis</B></FONT></TD>
    <TD STYLE="width: 3%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 48%; padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Schedule of Annexes</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Anlage 1:&#9;AR-Beschluss</FONT></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in"><FONT STYLE="font-family: Times New Roman, Times, Serif">Annex 1:&#9;SB resolution</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.1in">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B></P>

<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Anlage 1:</B> AR-Beschluss / <B>Annex 1:</B> SB resolution</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>imux-20231218.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /KM5s7xRiXgOn8uFZXIsSaGD+cP9wZJ1WelBsG11ffl6bykmM+ogoCqpJjrGMZ0O -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:IMUX="http://imux.com/20231218" elementFormDefault="qualified" targetNamespace="http://imux.com/20231218">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://imux.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="imux-20231218_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="imux-20231218_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>imux-20231218_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>imux-20231218_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.20a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://imux.com/role/Cover" xlink:href="imux-20231218.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://imux.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.4</span><table class="report" border="0" cellspacing="2" id="idm139922470915008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Dec. 18, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 18,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">IMMUNIC, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001280776<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2358443<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1200 Avenue of the Americas<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">US<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(332)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">255-9818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">IMUX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>e619130_8k-immunic_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="imux-20231218.xsd" xlink:type="simple"/>
    <context id="AsOf2023-12-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001280776</identifier>
        </entity>
        <period>
            <startDate>2023-12-18</startDate>
            <endDate>2023-12-18</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="AsOf2023-12-18">0001280776</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="AsOf2023-12-18">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="AsOf2023-12-18">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2023-12-18">2023-12-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2023-12-18">IMMUNIC, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2023-12-18">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2023-12-18">001-36201</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2023-12-18">56-2358443</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2023-12-18">1200 Avenue of the Americas</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2023-12-18">Suite 200</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2023-12-18">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2023-12-18">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2023-12-18">10036</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressCountry contextRef="AsOf2023-12-18">US</dei:EntityAddressCountry>
    <dei:CityAreaCode contextRef="AsOf2023-12-18">(332)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2023-12-18">255-9818</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2023-12-18">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2023-12-18">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2023-12-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2023-12-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2023-12-18">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2023-12-18">IMUX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2023-12-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2023-12-18">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( -A#E5<'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #80Y57ZH+R/NX    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M3L,P#(9?!>7>NDDG#E'7"X@32$A, G&+'&^+:-(H,6KW]K1EZX3@ 3C&_O/Y
ML^0&H\8^T7/J(R5VE&]&WX6L,6[%D3EJ@(Q'\B:74R),S7V?O.'IF0X0#7Z8
M X&JJEOPQ,8:-C #B[@21=M8U)C(<)_.>(LK/GZF;H%9!.K(4^ ,LI0@VGEB
M/(U= U? #&-*/G\7R*[$I?HG=NF ."?'[-;4, SE4"^Y:0<);T^/+\NZA0N9
M34":?F6G^11I*RZ37^N[^]V#:%6EZD*J0LF=K'5=Z<WF?7;]X7<5]KUU>_>/
MC2^";0._[J+] E!+ P04    " #80Y57F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M -A#E5>%X^#^;P0  *@1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9AO<^(V$,:_BL;M=.YFDF"+/R$I,$-(<F7NPM% >KUV^D+8 C1G2ZXD0_+M
MNS)@TSNSYDUB&^_#3ZOULVMZ6Z6_F37GEKPFL31];VUM>MMHF'#-$V:N5,HE
M?+)4.F$63O6J85+-690')7&#^GZGD3 AO4$OOS;5@Y[*;"PDGVIBLB1A^NV.
MQVK;]P+O<.%9K-;676@,>BE;\1FW+^E4PUFC4(E$PJ412A+-EWUO&-S>T8X+
MR._X0_"M.3HF;BD+I;ZYDW'4]WQ'Q&,>6B?!X-^&CW@<.R7@^'<OZA7?Z0*/
MCP_JC_GB83$+9OA(Q5]$9-=]K^N1B"]9%MMGM?V-[Q?4=GJABDW^EVQW][9:
M'@DS8U6R#P:"1,C=?_:Z3\110).>"*#[ )IS[[XHI[QGE@UZ6FV)=G>#FCO(
MEYI' YR0;E=F5L.G N+L8*0V7/<:%J3<A4:X#[O;A=$38?<\O")!]X)0GS;_
M']X @@*#%A@TUVMB&.3OX<)8#1OU3Q713J%5K>"J]]:D+.1]#\K3<+WAWN"7
MGX*._RO"URSXFICZX%Z%&=2B)?.WE%?!X>'=RX\(1*N :*$J0R"(<HK'F*VJ
M*/#X)8L-1SC:!4?[O&1,N18J(@\R(E!\E7FI43J445T==0JT#BKX(*VP;^11
MQ)Q,LF117=NXAN\'E\T.]0.$Y[K@N3Z'YYFOA*MLR-F$)96)PG7&3T\OD_'H
M@HPGHRN$JUMP=<_A&L$N:A:3L8SX*_G(WZK(<"4?TD6[_O5U!\&Z*;!NSL&:
MLU<RCH!-+$7(<O<^O9FX8KMS29OM;JN%55?@EV[IGP,XEJ'2J=(YVP696:A^
MHC09J0P2"GE54>4FUZC?/V"01Y8>G ,YC"(P0G-Q.""?X#[R65:3X9(!='DR
MW'"9P3J7Q*XY 3?2L#L&0R[M/T#=&T>>;U4E,BXYRP1L"G!C@*7_![B#?P\X
M<F>PXW.UE95PN-P$QI6O,*Y@;&5;"'!?_YZM*,>I5ALAP^H-QS4G7S&TLE,$
MN,'_D+;= U()A"N]S#"@LC\$9S6( FBJC 4#_$NDIQ]:7#'P_2;F?4'9*P+<
MY/.:&L)L?1H%%WC7;-+W&$K9'@+<U3^I$+(R72N)]=$:$=IN7]YT@RY&5':&
M #?R+UI8RR6D)DDRN6\+II(*%ZJ;@FC9#"ANUS,5BU!8(5?D"9XX+5A<.;?B
M*K4\I>]3W*2GFE^&D!X.C_QN6(5Y$<;JS\ME]?[5Z-62'4WWN!?_0#8V)@.R
M6D!<MA:PM'>*^_%<V#CO; %]MWA/9CS,H-XJ?:I&R=4GS"LSJ\)O%R1EFFQ8
M#%WS9__*C4H8;6GX%#?GN6:1J[K96[)0U36'"XR?7O[$2$I_I[@K'Q)%'E[#
M-9,K?G*^K1&:#&?WP]\QIM+BZ5D6_P#SR<IEZ0,HV+4SCI3)ZBW%!4^66>/H
MO=O]AO'$W#<:$O,E"/E7U[!FO?M98'=B59J_BB^4A1?[_'#-&3P"[@;X?*F4
M/9RXM_OBQYG!?U!+ P04    " #80Y57GZ ;\+$"  #B#   #0   'AL+W-T
M>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%DN7/Z
MZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I#T>N
M6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#;VA2
MK"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? KP(
M&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0&>7=
MJ?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH!:N-
M9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?A+W]
MK;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+"8LU
MF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TUMTQ>
MDO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%.?7A
M'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E=,E[
M7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$#..V
MBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/
M9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>
MF*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%'
M, ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " #80Y57EXJ[',     3
M @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/
MV!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"
MKM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%"
M:4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0
MT^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( -A#E5>J
MQ"(6,P$  "("   /    >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5*A^P%K0A
M#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ&M)>]I3<V;K<7187XM.!Z)1\>1=B
M;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%AL&6L <2[=)IEL]1;#&:Y&+6VG-X"
M$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W!R;Q&-#C%<K<9":)-5U>B/%*0:S;
M%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\@RX/J!5Z
M0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'!=09#K+&)
M)@G60VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV4VPYZ8Y>
M9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " #80Y57)!Z;HJT   #X
M 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4
M-5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K
M!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1U
MW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@
M;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ V$.55V60>9(9
M 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL
M6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4
M'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I
M>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY
M'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?K
MT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;
M@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"
M% ,4    " #80Y57!T%-8H$   "Q    $               @ $     9&]C
M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( -A#E5?J@O(^[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( -A#
ME5>97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ V$.55X7CX/YO!   J!$  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( -A#
ME5>?H!OPL0(  .(,   -              "  ;(,  !X;"]S='EL97,N>&UL
M4$L! A0#%     @ V$.55Y>*NQS     $P(   L              ( !C@\
M %]R96QS+RYR96QS4$L! A0#%     @ V$.55ZK$(A8S 0  (@(   \
M         ( !=Q   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( -A#E5<D
M'INBK0   /@!   :              "  =<1  !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<U!+ 0(4 Q0    ( -A#E5=ED'F2&0$  ,\#   3
M      "  ;P2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(
'  84      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="e619130_8k-immunic.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://imux.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="e619130_8k-immunic.htm">e619130_8k-immunic.htm</File>
    <File>imux-20231218.xsd</File>
    <File>imux-20231218_lab.xml</File>
    <File>imux-20231218_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "e619130_8k-immunic.htm": {
   "nsprefix": "IMUX",
   "nsuri": "http://imux.com/20231218",
   "dts": {
    "inline": {
     "local": [
      "e619130_8k-immunic.htm"
     ]
    },
    "schema": {
     "local": [
      "imux-20231218.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "imux-20231218_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "imux-20231218_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://imux.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2023-12-18",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e619130_8k-immunic.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2023-12-18",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "e619130_8k-immunic.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://imux.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001193805-23-001637-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193805-23-001637-xbrl.zip
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MHO%.-RZ>.DBJ7.T3_4Z #CR *@R<AV/;CCM&'6*Y(V1*1'($\0'M9$Y0U[3
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MWHF['&'Y&?C?1-4ZPD*2(^TUZWR[ONKWK+KVS+IN?APH@B#T@1[;S-7OTFB
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M<$ N0YX03NZWSV["ZZ:G^[;\,@8:S-YU2(9/G-]Y\73 VS-L'AZD1P9(;VY
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M['0,LQ.#X7C83X:[AI/DS)+S 4P&#;W\FV= N386C"^G,XF^R]Q@HG1^ #]
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MV6>*'TYFM#T (N:?\U]AE9F)OLG]&ID#=#^![B+:YWK6"MX^%CP7HX1ON$)
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M/EE9_WLAB6IRQ%'S*#]$ H&\L@-)5</].J<OOAL"4")EHB%#*7$$Q'3TG4E
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M#H I? U!!+Q?H-+UK;4UAT8@]+A+[G2,('QGZWILN?X6?4$W1A\BL/-U'Q<
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ME&T1SEJ$W.86N[.WV)40MN?$OH&5_=.6$K7NWR-_VRF7J95@5[722TD+ \(
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M1\E?*<+-R5?1WM#D35BCLMT5D;*=[)^Q@[2RAX?$M%5U,,4#KT1Q';_OE=6
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MZ07*;G>71JVTN>7J.,+D+D@P6;T(;]9I'_,5;V2R:YFN%]6.E$@ TRT0YY&
MI 4"4*Z8!G:J$T.;G]9SP45T&/@V%H"AK]"F<6W-J#SR[;?%;CJWO0S"M/O0
MCZ1S]H3.,8\KK+X2+T56+%SE&_]X\#L7$1?3]E#V=[<?',#-.,$PF6HC,V>,
M(OU0AM@LW<IV&_#5Y)1#@UIKJCK>QW<HE^[RW)+N4MU.?I3,J8%R[WWR 9I;
M6$1BEPXFR8F5(6&UV&0#BP)9)TCX\M58Y*5I2;;<G.Q=1#J1 Z#X;W0,!E8;
M5JPJ %#]ERXV9IS%1.U5Z7LU!D= D",)+S*!8&)+#%='V%9%+4J)RY)9D]LY
M5VNBJWB>%V(5%9UNN;_3<M+P%3?A:^ (,U0BJUD--'Y@!'M0F O$WD1(CW9!
MPM>>F8-:RM4U:J>'DZ5<NAC:Q:5WLHT<:(&[,^E]F*B'(&2&Y&N_HC)IRM5E
MNS0,49=PT4]HB8^L,OFW,\\Y:#H@WR+C\63[J.<BS?]N2OYAELYHM<?%E/:O
M^[@ 9X7)D$L9U>@!,397_\$><'!^U#UL,%C8I@;VR%)^A/@:C0*YDD<VSF5C
M[TS47^U>I[:A+QI+YC]# H]A5\2=:G\4!G8E7HKT^ +QR[]II62T]*T)DNLJ
M6B1#DJ?D:2G&.!/B\^G]U$,#V#&AH5X4)8MVW":?X$YQ2ER%L75?R1//4X1#
MY-!W3S@]A:NTNO3FN<C5P10KYE8\PR6-]KYZ(.[O)](<5)IUQ>GO+$?CU4ED
M=TFZ3@9E[E!:NJZ?"=<OE!:#&", K@.>0@=4EV+C<0'R=>^D-?;9OK+.-W0!
MW7 M@;M8>^"Q."T.1*%%N%! I1=PQMS>4@,ZJ)]2"/G7KJ3?K7#%?-C)^XR%
MU)6J"0CD_L^6=#" *Z=<;-<L:[;B6A3^Z3%*J%IQ);QFPQ[6WIZFZ\YM72J7
M3O@8:/.&'G1!5A2W@3_'--745X)U1(W)N[0\9*H_<9S$U0PXB&X7Q?A.E<&Y
MNIGX-N;"A4G"9+B2LENGI0V^'=OZ&(%!"9>5* .Z34<>D3G_HVKH5ZQ8 \])
M HOL1=1#(BU^ LLJ(Q--+$S+4@U*NHK/N+S!IP37/=[9A'\VX9_/GOOA*K9)
ME&+EBH3OEW/%WYTJZ6V77V$P UFSM@Z$61<.DD-&,B"H'7@#N5S9HN3\J_*0
MI(KWZ09/WGV"AJM;(C\BXB'E(#$6I24M^C2GOC0T?P/V5+C^V7,E&).1E$4;
M6SK84QM2K%)S]*EU5_3&BW&GO!A7*9+141"]JU]*34E%&BZ8P5&TTJZ:<98>
M)L]M4^.J($OX#FED5R_UT-'(TBIT1PJORK'3D'Y":AN976]D,B?X_ 725_.3
MS8&\4P?R*GSZ^Z5&RX1 LRAK'P4]D++:L7]QA+W#%.N"TO51OH.Z]+%5A(01
M?9=0NCOL9[9[AX[UU0G.7S-U'H@HD.>)(SIAEF^)JYFZXS,<*=<>??IW4Z;5
M-!47WHQYJZI5@P1VC7UU[XLU36YNA#MU(UR5O'HJ\I:$AZDJ#K-[N=WZ;7">
M>WB(NW.,KT=1*Q*64^P]9'M-LC&.9E,OBI(C@QLU^8Z=P:N0*1X4659;I07Q
M(8"^!3U$I\[XK H4Y6P7.VYS1E]Y9 RX/YA04:@<V&4J*2I</0?0)54+0KB4
M8K-*S?EH0Q/]GO79Q;>3/U.;+>VB%$T [N#SNV_7]C^>&<:6=>?KM$GH_%G4
M@'')-+F2<PB)N[PB' LS@E>DRXQK84^O13]1F-,^\R^XS"; G,+Z[O2V$JP9
M-%84V-0Z. *L2I4_'@'37YT_>F#F[M ->G7VR(-%T62@;SX1KNKH#@U]S7!?
MC.VD6,+O<$0#FN*3)K=(<9]83ED8(,8>.3JM= HN+Y]-[LBJ_$NK@;>V1%IC
MZ[FBMY,W!H"=D3)&K^F+;W@TW"V?OD&F+W0[#M^:8!($@C)9I)9Y%SR]<EO<
M#D[Y29$72S+U5DVY0G5ZQMA,0T9KZ9]O5Y- <-X43,,8FK1#D(8%F9M5Y1FP
M;YKQ\M+[^\8?N.&^7_GPO$)4)*_*%-SV4T1_;_):^'A]O5FPP)6[V+]K-O_;
M_]^=QP]WOGOX^-'C)Q\8:+!9R8^PDM_V5O*6',:74+5(/.V^& DPQ"=Z.\);
M9$6LJ^4GCSRL'B;/R^WDWPJ/G]/KV.:Z^$WYT;<N]]GDI :3+ES7PROCP]5K
M8K[]^.EY(>PS'KQ08/OQ)K#]R0+;%U_TSS'<[6*@WUTSXV\WSV@.<WKI*4RN
M/.U!R]:]^LG_#&VTL^\$U^MOZ=G8OGJTO7-=R-P!68S3)F.O[FZ>V_?V!F!R
M-XI\&QSRM33HJT^8+'RR\Z][_^]WSW;?;)$A+\#)&Q4"-[O(O*K:Y8,]0/^+
MK('C?K/&9ZWQ8YZP%[Z>VE Y-<8"!LCV6[\+9%"[KNR1R2<I7:AAV:.B3Q9X
M8;WABI35Z_6)*S=X(3WCR4;/^ 1ZQBW:)'OM?0Z9EX07>O(PX>_E[N2O.Y?G
MC?7CT^S^KS:[?[/[5=+Q]KZ<J O.QY=?: N7EBL?Z@BUMDEHBW1ME7<OG[_]
M^7__ :/D'U?MP3G[Y'QU98#<Y,GV5Q((88';^W[GV[.C) <GRW&1T9PLT^FT
MJ)]%XOM#N62':LT^3 Y0]7/7;0&'W7E()_;++_9*TRP VT'HVJ*@QT7:,%GU
MD"LPE"#+?K@[Y:KNR9XY 1OG+V:5HL#(2S+-*B'I_;%8,J6_37IJS%E(_3/7
M]>(F[,V=VPM?2!_S-0_W?G_^?YSS\//;5[_^\/\#4$L#!!0    ( -A#E5>&
M[4C<F60  !]" @ 2    938Q.3$S,%]E>#$P+3(N:'1M[;UM<]M&L@;Z?:OV
M/^#NK>.5JBC9DN.\K'-2)=FRXTV<^%J.72??0')((@(!+EY$2[_^]M/=,Y@!
M0$FF9%O2\M2>6"2!P;RAIU^>?OK'G]^]_O6GO__MQY^/#I[3OQ'^[\=WK][]
M>O33CP_E7_KUH?[\X^'OS_\O.G[W?[\>_>\_)GE6_2O:>[2HHG?)W)31;V89
MO<WG<3:0+P;1L2F2R3_H1KKUC;UO'A?3)/M71#?^XZ<'V;!<//WQX1NYZ-W!
MX:]'T;.C7W\]?G/P[-5O+__W'X_^P9_?'#Q_;C]K0\MD7,W0@T?_\S0:YL78
M%#NC/$WC16G^%=F_GD;HZ$Z9G!OI[3]XG#^^>VO;.35%E8SB="=.DREUK,H7
M_]"Y^/'=\];3OL'#*O.QLE>/3%:9HAG)N^<K[WVR_JU7>2S]Y^UZ8UO$XW&2
M37=2,Z$E?=3_I!]?_/[;.W_Q=R;Q/$G/_G79\O]X^-/S5T>_';][?_3VW=N#
MES\^/*2^HK6?^L?\J7-TT[T]/GK[_M6SH^C@Y=NCH]='O[UK]WC]F;[1KIXO
MDW(T,]GMG<RAJ98F[. MF3M:YE?S>9TE(UKF0?3C(3J%?A2F,EDTKHO1+!K3
M7^_SHDRJ<Y/APYB:/*@G93*:56415Z:\]9NY.\K"+ I3HNEQ-#R+JIF)GLWB
MI*#[HWS"GX_KA2E.DS(OSJ+#/"[&M_0-H/'M1%D\FDWR=$I+%#T8CO]3YT]?
MTOC2E%Z.>%(]H"^JIQ']'&=9%>W<^A7;B6:F,$E&?3=%5)B)*0I:JBJ/XI)7
M1T;T+)\OXNQ,A]<9UBU9H3H;W][)CL/.W9(IHRWP,RUY%CTO=J.Y&>]&!]FX
M,+3X;_-T$KU^4-?S].DL-06]T;=],U\^AENZ<5>)%IP'%6V<^RI66-Q'K\U\
M:(HO(UL^=1*N<?WMV5MOB@<Q7H&8YCF]\;W34NAW]Y\D69]6K]\E4&[HPAVY
M\KHC,S2HU'R>3?-775;)Y.P:77Q.N]^^Q%%25I&AO^=H/IHG5?0A*4[J;!K%
M0]+VYM'^X]U'CW?W'^U]&YW7\^AU4DW3A%X;:(*V%?J3;,_(5SJBH2DK^E1%
M2QBFV6[T/#%1:JIS>92)#N4"/.JBAJ%W5MRQ@V$:UQ/^_?'>[MX^=8HZQ^V.
M$Y.5%6NO,;4"FX#:/T_,C)JGOZVAP KMF[BH#-T0+4TQ#E3=YWXST6E.H]_?
ME6UV4$]IXB.>AS)?\C/IPI*&_>  ^YBZ6=##RE.6,<.XD"=/Z>/4T#1LJ?@,
MGO$@Y>^V:13M1<&(:3,-#<W51$Z+*11S7_LN:9)'L[0N60NG=<Q,7:V>S4L7
M:8")+&E](GUBP=/RITFHL]0J9N31WB[]CZ;^FVB8E/PPMQK?NE'^2BMU3K=Y
M Z26J0%JIYRBU\GHI!I$;K:P#C2I;FVZR[%%%V*TB7E0GM,.>HIUCN(TO60)
MMH-=C?[V;J0(/:YG9D@/KC%7;E=X9R ^F;K3->H8C2F>5]Z\T6">Q[4I>-+M
M=-#C\;89F%,R)31D7Q#RTB<DF:9%C('A):&5HSE)>6VP2[S1[=Z(T+1_O?&E
MR54\6T\CSY?5=ILX0?6.CE;_4(V6=-[&BT6>L 5&YR\.WY%H\_\L__XWN7B2
M%_S#)*'=&U7TV&B95+/(3"9F1#-=T&9\'6.1]A\/^,7<C?"H-*;+M?DYC1JG
M>TPJ&#]:S3MY BTH_53Q-U!PZ,?G9B07/MX;_/UO(F#0: EK<(1>9K3B([PY
M;-CSO0O:M-C=]#I,\U.\A<ZN[-PWCC%F*TWV![(>+%;PAI[&19+7U"OJ^5AZ
M/RV,P5\T,5NBCQQKH\^T4?EV6WK:F6DZC5;.=73TT8SJBB29WJ?=CJN*-CW=
MT+&#J;DR3^F6/*,)JF8T9EX:NUIT>9*/977^'6=U3#?N87E(7M#3_?F-5&)P
M[]^98N[&\0'KS&TG&;V]V7@0S#-/"8^%;B)]KC+HB8G:\Q)M)=DHK:$(0$[T
M3NIV=U.MV [H+FTTK!(]NC"+-*9GT3N]E-YB#M*4CH9L^O>_9?3"=-:>!I-4
M.-&JI##5F9LS$C4Q)M3N3LP%%I/&OU!= GLKSIQDX*F0RY.R&<TN_,@M7>,A
MNY1_ZCJ@=TC78%^G?ASF597/Z9N.4_KJ-[I;_I^=G>A%8M+QOTBD3\U36IO_
MD-P<P04=[>Q8B?/\U?N^MK]=5)W6^3MU<MOO#FD)3J(]DCVT)Y,Q/;^_J[BU
M3_=K#R!TR/_XD+K7T],AK<G)SM#0\M%P%CR\*_3>[]T%G6EZ_ F]\Z;[(>9;
MIO@Z:WYG Q$MC?[1=;7Y!R4)AJ?1GK@.2?N:QJ0B#'$(T]$#3>'-!)I(!2_O
M)5;,9PN#?-Y!OS7E(L_*9)BDB0A@&O7O0^H BZV."_@FC<R^D7U>>_F2)]Y4
MD(G4E4=/VH))=::V5:K77F--]W:[M_HOH@Q0_AOI6L('QRZX59XK.OF@I_DJ
MKU-TX]2S.P)KXE!?G==FC#F+MI[-$C-Q'W^?3.C0+ ;1L]>_;U]@L>#-8_T[
MJ2I^='#9E,Y#TLKC.2O_]"=9LJX[.5J5[]X4^4E=D-+-^CA][9M7T4F<96P$
MNUN/DNS<I!HF@:U!QT ]S>@0-C!<4AJ?6(>G>::CI1ZIAI^=B$T(PT/>,)GP
MO>_WHH.TVHWVH\.7AS3$20$;Z.K*O5.UK^X2H2VU]PG;;^_+;;]P$UZX_Q+?
MCJ +>G<2;3#L)-6M-&C@="_H6BS/7%"H#*ZK\JFASX5H>6T[XG6<Q5-6O50[
MIE9)38OK:I87-+YQ5-+$QA6ISZ*==_7I>7P6D4J759YAHMH[*36D].9+>9[K
MH.B*--RE@5)+6^^CF2_X2Z>_TI7T9HQ8/.-F*]";G:8C>&DX[/4L.24+\QF]
M&=$6[<'MW9N1YS<@\JXJO+_4.W#GCX+]-8Z"P#NETGQ6.+D[FHF FU2F*['A
M/J$719TVT)[<-=6Y&?"'X[@Z)]DXL+\T#=*;,L[@N G.$-<7]M3 +U*&+AE3
MMEQJLQCV%QQF.=Q$)CRV4GIC^418]73?C5;24Q%!^!,KA.#RM#S-BZ&9Q70L
MT4DR$T=1:U[04S<+63R;J\>K::437"_1I?-Z1F+@/AT&G[(!PVW8\6^4,]CU
M9&"/ZY$(T&%=TC*695O>D^T=CT:TG#$9H8W)GL9+\2T<X+5-#=]W4);Y*&$Q
M*S\6M?ZR*/*1(7.]\7=T3@#V#\ JM]Z( V>=1Z\R\6&,ZC0N!CT"GX>3#ZLX
M$<\2G6Y%?DIGV2I8@O2#CH\R5F&/Y\_IM*1.EE%9#_^"7P,Q+MO4BIGH&>.*
M0VYS-MS;L^'Q6F>#KUJ356B@XP:R%G+.6LX<8XB2>72<9)EAF?>769+JG$S;
M0A..?"C5D+"+E/8X>^_#2ZPACG94\3MU<EHTOZF9/<A9UE\F1MM1PT[0\-;+
MUD]9P' 9+Y--"3S)Z@=(&_E7Q>4)-.88IEF:TRFF/F8GB&/2W9TTOD!!AR12
ML4?R*X/35N_"<TF*P4N-*-Z8))4HQ*%;XF[(I5NSQ^Z\L/KFNHJL:("TN3-2
MP"H$ *,/-6*,724VGY&L(BE509R]-\54[JTX4%[3'6_R,L$!3#*,W0L2D9Q#
M3QR:A+T0G49IBH<UYH-N^@,J9698+=P*G -/HH.3ZN7V;G1$TK/,V[T>^R.Z
MI!?4\:&Z(CC:>V@*4C<E7)I,Q3G!]Y'@ID7#Q]^+*;V+92RM#J ]2(<[+A?K
M5?&&50;#<C'II(0N-)N+DP0.')@ F%S6Y8?F7./='.&=FJ7TF0R.]MS;_M+A
MLH3$A_EN#X>Q'9%OK_B3%?<,(A[NHK&5^R UTU8K=)*]PB!)U/48/]R[9D**
M8$*:E<SG]-E<M'P931S] RL"=A,9&I@;MJW8)99%OQ3.V*"!Q<Z^H26A,S<N
M2_5)=1QJC-\RT6\VS%WP(B<7=R>&5XN?,#JY_\?JIXB:JY@L@ZBFH\LW4/Z)
MX_4_-2WE@$_"G Q2V"T8--: CLO"D)5H"K5+XI1D 2GR9E%%"UVH$OZGG$]5
M#IU*G)<]]O1EFG#LV6G\UC3:.C9L.SAY<USEHQ/ZN5CD&I@\(!MB)_KQU4\0
M13\^?/73-ALS'.&.$9B/SU::,U?I:-Q87&+!D!$RH3=*!HYKV0>7LS ZCYU;
M:SG#6^ /1AUPS7"= =B@ 'H"Y=)5-J0F]%%U&'LO_M^??7X*8KTPH<J(5921
M(?VDM!XX.,8=+" 3@U#5F-WHCPO6?L4DTKVTPZ5U],9.9#./.L40K])X(E*I
MZIC"*Z>(_21&GSC.(W2ZKN9YR08D'3XP"EG5TT@_'1,1R2X.P3=0>FU-FBEK
MZA;].",YJ1WK]GV%YN9"U[<G>+V_"5[?]N#U70E=7UUUOL;!]0<BU8W^0Y9;
M,A2W[3O1%DC+.S&LG/H.SL Y:A-H7F6C7:@[;\5Y"7=I*8JM -.Z<3KUA+X7
MGRP43=7-THITRA+]Q -.&YW.5!Q45%1G7@"<"K\JM*.6V@VD7 97Z0I%[KQV
MBA\I*/[9?-48_<WH+1>N^4H=YAIK_H[/(SVM$!B#Z2R!^P#^I@<,+/EPB?L=
MA!;&5+,JDLHA/$L6BC\:1R31EPZX-0I. >H.7)IU%C/."ND0;_WS5(]/=W;A
M630G#N&TZMG:?)9CP[GCNVB0;GH8?7'7P.WR =P#8__).L8^1X0@1" K7EK[
MR*03&L5N=$PJ9J&6CH7PB$7% FUNY59DX'A,24=E [AL&8 (UHM97$0?XEG*
MHO1WLE4%%']0EVKG06B5$F0*A>]]MYX^9>VZUI/@+*'LY\4)U/C.0KX2J98W
MB"058(EU1_H@2='<HZ1/V4Z@P!OCQ- L3T8N#N(ZP@#1CZ88)25_!JA3A>Q-
M29JO)%(^G^SX8IBU?<&L_3&?Q!Q2+30P; 9T]Y >%;QZ5P#M?1Y$V<V-]'B4
M+W@;VH CA-)Q,C:PVGE/;O!YM_YX6P>?%_BR%17WY%'T/_:0.2B&M,/+DP+Z
M,!R';(_#0_L!RK>DN?PBH;$LXYB=EW;3\12RQV>L.2F*6.@]SLIS?K&Z)V5C
M.XS9(5T5B1EJMM91,6'CB^T"/E-WHZ-2S8@*N+M3ZS=5;V;0M)H1;-^(T;%R
M)G!?H.^>UYQ48Y.L)$M()I3:F<4T\I^3C%$9::).X?<N,BF'O#S &S@G&,%X
MLK[A'M=KK2E906_>6J\J/Q ]D5'?=R5A?8C@"F?>V)SFE9%]0-(1.@ T".@$
MHW@1CT@P#J*3+%^F9CP5J5F>)+0X\)SE?O9.VX-&^\%ZR<CJB!$.I1M<:-)_
MTBRO"QJCA\-P<5&X_))"LE#HW:JBQ%E2SL>V>E@2%X55A<=<-$@\--AA*^8+
M$,L\H]'0'?&)D5F 'E4K-G&E0]&#(@8/8FNP,%,\2F=TG "7.*QMNHO?8>01
M;6*XUX_AWKJ,G\<;I^EM=YK>1[?I+8'.DA+PX \;Z(7ZHT!3ZA02PU7_Z;%-
MO$P"APK= 2QT!Y'[A/_2P*S$QS-MZS6=97$&361HQG$Q827C-"]F- H$Q'W(
MJ<MR#H"GIQ[GT\6*QXJ4IL_H&;UM@%3216N%W].!ALA:-B(U HFO(\3UBU$2
MI\X_X!^6<ZQ3I1%0TA$:;.?0)1.,V]^4"8TI+IJ;58\0%T61T"6C/ ,2H@%=
M7<)M=3<.W5MSOGY.K_$U2#WFX2M,FN0\J>=LC P-,IFJ/L,)B$KP.RSJ[$1L
M(T:HG -4*<AW0=>_M[AZ@6]FX*8XR%*<//M,PD0&#XDS9%)55@15N)"LEUA,
M'3&9V*0!*C2+7N1%Y6(TSISTQ--7 [U?,_K2A6E#MU_&?O@\T,!G>3J6O"/W
M6O-4CMU,9^:CG6BYG[/NZ8T&+L!A)4,_)\TY9Q:5XJ&T '!1Q1.6$U62U>PR
MO641DDTPY*9AVB]Z\V>F>"%)*D0?3%4-S=(40X1I24OL9"E^_ST#$7>C#Q:.
M9]1_H3PG;4'!V:&E\Y@XV!W@DBYPZ^/AAJ92'+C$A7M!DW!?N;YJNHUH07)Y
M+S:Q RL?TFH(.I!S>5Q8>H!@#XDA-)0--(#C983B[15-2H45LCN3B6AQOF*E
MPNZ^>VW6QYMWO!!)D*X"$9?EV0[BR*82O- HC>M27=V,6(MH3X9YC!WH6LG8
MM2V%T#ZO"_8T0'XB\;,C-'MB0LO$@M@09H8?DBEZ/' =RW3IJ.G"ZW+-'>UB
MU6;TWGGN("^D/J!MF>+;_J0?W#A-3HWPB8C2MV0<;6:5O[NAT]V:%^ .*7J]
MPIKEN A5A]TY5'$J<JXE:Q/.M:F0L@@#\P,-<!$O$NAE(GSI^D--FRF9QVP&
M/C9-O&>M<6E&)P)Y_H7NI*9BT0=-L40ZI.57H[<N+AS4.9HE&;W%="Y (ZR6
M<3+UL$(#"%=26:8@B'L+XC3M?%UJPOXK?O]8OW&)=>C20SX"CF>D8T&9,D7Y
M3^\"4CD[<X8#YWRY2]TEL3+$QW>MT& +%$6-#$W,,(&[JIBND*CCG&Z$=",=
M,66'<>/K#22=QL4GN<C.88YYH>-^+/ ?]IFS!#8?Z>#-U*T>C]A";2B]%C7)
M9Y'D(]DZ*E==FJ2%/0\8[6H^DC+,2BXM79%P7+\PTUHDID7%]N^-&'MC]<Y@
M\%%)0T@R<6S[TT/W+4 Q55T!1C6OV="*\B&B!N:Z1O5=)07]3+'NQQ+K;D$
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M0@]+G%UR_B#3GKZ0(^F<-A!B8Q^3.8D=R,D?]@??/7ZDYRYC2?4TK30U^AM
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MI=#D@([*3)V'4J-GVL-42N<L_ VDH!A W J7+4)W?&#B6X^(U9I+?C_K;)C
M8QF2AP7/T/L+V@UOZYF1(., V?45<O<3.#E16\MO=.QL+</4LDL^[0MV69YX
MY 5C-O2RNK T!JAJB^]!S_-O\<LRN<]!74(12,:**^S,!$_=U C-JNH>2LD;
M??]=M+6_;1EY R 'KV:26?*@%YRLC;_;U4+C6A5 4W#556$5L'6*BN@%ZA%Q
MA)F>.2NC#SGK+7 Q'TNU5]X3F4PF7>''=LE2(M4FU1 O#_BH.$EUXNVZ_6QW
M![XXL:H.;\K62%&9(WKL*(BS:F)]TZKDAIMFQ>Y2VB3:#_+DJIZP=2^DMLY>
MGBHY\31A"H8Y:E!^NNWLWO G__.9E:RO($M"B?([M 52;,U@!5(<U84*,ZY'
MDA]8Y56+2+;7UE5_*F<,+8J$=0>.4@^L1[A,JCJXWZI2[&1- +XWC:Z$B/+'
MRBF%EN$MR6JC*4H!V[O7NV5>IV.8W;352"NK8I][7I_YE&ZIE$F!S/BL9-QH
M6=-,((\5#,=FDJAGUWU H%O<G]2'$_B',%=Y!N^"T3ES?'1:@W8&;BBX/J%.
M0@BE)CZU#M\VG6Y+5KQ2%MA1;%<K="_0PUTYTQ4%1#")1<R\5G%!&TL4V3+Y
M2%+*G)3_1%P?-^CR*1Z ,RE IN>B^?^I8?X4.H:Q&:5QN!EX]/Q%>S!(+8#.
MUHB$5YC'9M75I=_9(^#W1<W3$&HL$P$G\Q0@X@9)4!@NKOV94E,WOI5;X%M9
MA]'OB+86NQM8JI "U'(7X]!TR?90&ICF_CC/LBJ>(F_^A<'YB+]#HON"WL-9
M$3.-CR,=8FS5/3+LK\7#5W -XBQG;%"5BD#B0LB>N(9DSGGKS4G(<7R,OCVF
M=8C/@&:J0?>$;-<$7S3$WA[+.6[:8.=O$F+^C</.PP0PA<U[' OI1.K4Z[N+
MHM<AO@)%.7OP<=2_0*X?;"DY\3=@^EM_)*P#IC]@+UV.VBS1"5LD8KJ)I]K?
M]*4Z<!O@J\!KN]S1&:-4G-$]MX5+YD#HNE3?T4Q.'A#6(:;_"VV]$Y/M:$UH
M,F]/O:>'=KQMLA3\C6%D42;<+'Z[P'?"F3B3E#W@; K/RF=;3@TR6WSQ-)_W
M=%W!NUR1-G%@*1+26AM+S$A <\8Y!U?G#C,DU0X/.V%-:TQVL47\B!C%<>&8
MP-23"DLCS+RUP9^C&6GWS!?Q<],+8+EB+8;(YS&P3X6@D,5:]Q8X<[,>]4^[
MS&]OY9.@ ZUY5[/?CZ\T<VD'',^=V<T[H\2?#B;-#U8G#;7X)WTIDE>S'N-L
M J<Q;B&UYH1+P- : +?=@-GZ-^(]TDG6SQ,YXOQG-EB<;D+35-6HM@L_F1X%
MC<=[T%.?8A&?]1AC"K*>F3@%'HEV%DJ;[7#.^ BABJ9YIB971CL'O@F:DZ T
MS5ERFHR!@@IOD>8L9$? X+!U3[&U7"Y\@Q)W7.RN!89=#[OC&$1T190FM&T:
M1O2P(3-?I/F9*?Y9!FW:BYOYO,I4T+O'T?E\*98S8X;4WHU/!''4XA2$%4AG
M$JSZX/D@VRY+T3'AR6*"%)G(<.S\K%;E$?2*YT1'$:QM#UC>&<:*FC_@>J$<
M@:GBC]@BW$%)<"W1]ID [YVY.LP+.GAZEJ!/D_U2495O-U&5353E;D55UH:6
M^>>Z:'5K*G&',4E#10I(O;/BO&*-(B^FMU:-VV@Y=]+Q?STLG3WN%G"EK-1A
MNOK)CZ]^:G9Y[R8'&KDO,'"))C/*"ZG).NXH-'02TUDY^33]Y9Z<]QM_];WP
M5Z]7&WM%IC^@\TW<?AYIN8H@=)[, TE>)J[,J%&R?#6!4?W46#ZSHZ*,J_-=
M1Z@O)]U;DY3F).=0L4K]*=?IEIPFQ(E)VI<<-(^KRJA@IY<DX6Q0K<&51>](
MZ1%;VR.U%51<.36@5PFB\B'EOPA^MO[/:XU)ER6'G0^;#"XC%'&+&(<5J%.'
M4X.S,S,V''^/[-\;)%#S@F?)?%@C?,9PMBP(Y&H@UAJJYB,BI@V-;*=\9(?[
M_JV]L"KB4Y,V+3!16OCX>!HC43DB W2N=3LUJ2=&_)(KQJ.N S!R?D5-R/R8
M4X[8NJ<N(3[*>7U#SL6I@+:+4=(SK>>+J*SG?OUP-GD=ODV/(&;R*;WJY1#U
M0D3TF4J';\3V+1#;:U4);YL4BM3RB#,960,]'MFK(L9#Z1V08@8 (&!5@RJ*
M1?0V*9.3?.=7Q&/*P&O<RSKQY-&CW4>/'@T>/?*>">&<DW4"?5N2,EL/^8-5
M\4M;EZGX;L4C7F6GM&+CQ%*5R^-<HY93#7[X(=[<JO3HW0)W/%["RB_1&,*I
M !2!6? 6R"(D[V4/%1E7P[&, Z%*.$68<VZ8>/-3JZ0\NGN$F^MCA0XJ3BX<
MD]H/O$S;'0H!F]@2OSTE(MLL$2L@*C4G_<8161<G)(<GOG]PD=/1?Q;U\EX\
MX;V&/6=_%Q1Y#O;Z6#V/VCAGC *_5UVM<;>C5SXA*>-ADH*>/7>TR$9@2\H\
MUWY03QD5J$\2&^=SUZ:;RGP*[FB4Q,79P^;OY*X</;?GS;GS!](ZN)=7@B<5
MSU!O-0F_WNYS4L].JD#0RP'&+IH.UX%/\OS-HV@8'1U7+QLW58<R !G$%?_@
MI'?5<'TB6U(U=Y'WK//C-I>?F9&HKGJ@LI^04'-[]N-70./TI-EXDFI,JS_J
MDXREYBY"XQZ(_.Y<-(I!PPT6>M)3QBL2TE4.6V@@[QGE7WXE;I1WI%LS[S*V
M4B_XT:GMI(8K:C!T!%U0N?=+!5"^VP10-@&4NQ5 ^?8FK)UA8E"(/4@NA7A^
M+:8")X$R+PT")N],DLI!%%M#XXU@L,L31'$'DE):5@K31,J!_"((3+FE5<$H
MK UYD*(!+P:S=7CP?ELL#71AQ8'8MCZRB&Z3*I9R[B"3%$8#F(J;9)S&7Y>P
MPPN9I<JB\Y(35LHX3'@E@Z3.V+-FGWQ1Y\MSSE^-ZOF2";7US PF^\(C^G&T
MM;=-JG6U"Z(4+RFGZJ=84'8_9,<@Q^1#4IP(1<^<C"EZTSZMVUXDB_3QN4Y2
M$U.C269*)D7Q3(UFEQ3G9,2A'(T\#OI"I12)FM'+422_$ZP]Z-,M2)&:H!$K
M$SD9?E;M>.4;LFIT'W(7RH@YH[,I/;"I1N% Q&%V%;J@(2R)I'7G$T2,::I!
MNN#U>-^9+++ 15>"YX!YQB?1-,[.9><#T 2GJ[%Y,&$B#E]3U)A26WN\S*/4
M#"6#VU^(-FV&[% ,3UNF!]__:-JGR+[5T;0<Q%\]\31FW5DL\H(F6*MJ"AM1
MLI!"1V3T:O))-*%=@PP4OIP_^96[1C9NIU<C#$=B"T1!P?;75S#G7640DQM$
M+/ARR=!!D4[H<H'V9T6<J%LT!33A/>DFT//H5QQN+LL8TE(9'3V,MY9#C3O=
M1G&S1!G;5U![<&J/Z8_++>JBK&,)#5HN[$"R>>YLR<4AQ3!67BH;W%0SG_-@
M#"T<J9Q,!B\6-X2;)A9=U'VNRFKL=+#6*VYS9MS<.8W3VK0N;S=FLXJZ7H%_
MEFW O$8377RU.VU)Z8]9"#QYH*[4?8L?N1PED%[88W5)?=):4CU#I6VZG.4(
M;A:63\OE.-4%8_%'*%GK%[W/+,64C>YB3EN#8M;\K)3^VWJRI\GI9RKHNO&L
MWP)'QG<WH6L&C"A5Z&L.-#$<<7-50&FGX7:Z9N=G:D1QW8'#8^OY@WB^>/K[
M=M@DNQKB85\EO"7'0T470II17:K#8F6A<X@81'&A ;UQ?4@UK1;N=*E9\EQ+
M\PB?2AN@@\)Y4#-\6',1>>,:NGKKU,:B2$[CBKW?JF^]RE@I;<8I*EGO=$5^
M_A1]SW <Y9<.O.\!-@>J(R_!L4F'#-"V=67"  )TJ=?88&4%]:Z\6(_]X;%+
MCXRVQEQRL(K^,LAQ1E<EL+#WZ'^X6?OEP)& QA!]"!#L_7C\QYN?]GY\B'\>
MTH?#G_;QX? GVL@C15?U*<8@*D9B>+35XB_UP.B"6]_>C7[)X;,2AJ^Y@6.,
M)LYUU>9$RPS+JJ/I@1982SH<J9UG-.O'CKYNT]&YFBNR5'8MF*=[0;M9M5LL
MEF!ZX*2Y0)&-MMB ZE[/273]"[5-NY5,?!+S):?U/@U?(<Y;=T0YIA(FHT!3
MS<*'L:U':G(P&N;QD=<W3.!H FBT"J=("K":,=Z?AYK2)S,V5XQ?TF_NM2 4
M88X\F &&9-8A' <*N5+#3LQ/&L@34N;K)8\+GX)1<,:[DJKSD!H145:YI0 H
M[Q&6X5,.A-4*.#N9G-8IWLP<17L8+3"9)",NX9,F-F33<6)ZLK\'CM] 'U;1
M%(7IY21Q3L ?A&))M%,MI*&WV3A*H9Y"X01U;LDDHCP.N.+ &C2AKZHS5<FJ
M!F[1HI_C2%W-E#[:1 /%;T:.@IX)NUK4)2NG [@[EST!JJ%DKM-FY/1N "$Z
MX3)\ D?JG&QUT7Q]1=VZ?%4D7%)[SRN]%VVI#YF4=LATO7,<SV$G+Z!V8G8E
M8P'IX?-<BJ72J9EI%2E!$%:\!UG!9\U9F66#--0M_9+/"AH(XT'$#0T/-.>C
M ^Y(E_!Z\4Y@!BD\K"&[[VM&4A:$W  G5*L!6M@A<O@;I(LWV:43GR-.E(C'
M>!>;3> "DK39I'R6_M!C)&R)!K_RMM92\2H\[>Y:ZA,GR"A6B(NO-0P+H<XO
MC9?6G.MN(RNTFS<RK$;[4$U7WK=CP_/GT0^T04AL!TT=K6-A)CAU1[)"35"Z
MZ888<K) 7',7O_/%NM].DSQ=6>[V2X45OM^$%39AA4_/-&Z[Y=A9]HE&[95]
M>I_RX#N0 O]$\L/_X%*/=S?-78?QL_ G;!+:;[V+Y-K5X:"<!H0G8MQ+58R:
MMS/;:X\?:;(TW0:^:?^3L%^S56D3>?AK*#,'=2E!,S1R',_E=D>9HCP10<*U
MI5"!]4.&6U*==\E0D9TD>>/.[.5"'X=^N0?V()3BIA73;8=C&1*PHH_!*!L[
MSB]CU:Y0U03#[I%==8.U]%H8-;\RQ,A!^V@S@86%P23Q6;D;?? ^"5,K*6XN
MBX:_-1]'AM208U0I$+(797UAQ:]-_*)).:3=D95LH/")8=<!F[^::(JR,I[2
M7F$_-_NXQTTU[]!I+1I\>V2) Z%X5:T<:MW&*JY:OFKCP;[[XGG==%/1(TKV
M6,+-<QE#1ECE)K7"5QQ(8PD/M[,?@:6&$^I*P.8[)<ZNE_6H,@0^@R0?-U'"
M42[$> '!L[!+S5GVN7R0HX]F5*-VBHC&U>0$P[I$ <6R8;+;R()[*PO63>]3
M6> A+NBT#5 R<)JP@UZ)> .7>8$B]V&4A+.F<2GSTL6I"^UD$TZ_$Y99^HF)
M82,AK4/&WI&KZ8FTOE.OGH -=OGI>([UONQAR[=U EXA[D0G]ZMLM-O"&LG
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MQ9Z6SSD)@G_L-29F>6IT .B%D&TS'520OJY9UY8P2).M;7;Z^ J$\RN+/)/
ME>D'@0YZ4KB/KLRS<T0V/SH4ZD!YR/F[&50]S2E0IZ,4C9MP9@6].W%3QMHK
MSCXJ4"G-" R';%]L$,F<+[Q\DEX:+BZOHYX\Z__$.S#/7,+ETS9$4ZR#2Q@"
M;!HX9KE04%&69SL\D"JQXP >U-$$5 +"/<.9F*1MQV97UX]^YTDR<0'N^:"R
MD?EHY@M9.GH#\W'/9/44#[+O!X0IL^OC%Q:HN]$SOH\1L[DE)4-9ND6*$HO)
M1-!3).9=321=0]>]G$ZNA!U<O$\M\?RIP:+!!D((S?$.A )T):? )HA]O_RO
MZ^(YVYY%!+W:/M;8TTY^B5-<5/P%-E.I:@55O3_RQ@0VWS[9C7[%25_B'DYD
MY,<T/#5],;:+:]-!:>J-;IWFRHI):C_=N:BS$V!)95RS^#X%NJZ'\;Q"T*DW
M4Y!E,^\!DE=G)*/D0.TM'<=Y^$:+=TXYA_[;)ZZTRHK8%RCA_.)M6+IQX]Q#
M+5>(PLM+N-&IT!N+^JJNGA\VKIZ-J^>NN'J^6^-,.30)A/"YM51;& MW1K3,
M/L5OM/U$S$JP3-A-!/+M0H"6+OS%=VB5.>:*;P7?^O+ZV>JT;A0$L^*/R3Q.
MQ>,$ CD7I/HWGW&A-P5D+PX)7>X\BQ>"_G2Y!@@C"OFY'&$ZIGA>M=PR6SV^
MFD%T&A<)*_7OPZLE@[[5]^TPA/66Q'5J(20]KH3=Z%!1,//H%^C7.(J9(=RG
M1(N^DXQ_G-WA2'EFW'05*V?H_MOEG_)F7 PR60 9P;2R/8:SYM];U;Z5(F@3
MRJ<YV2DCF$0#:Y*683:=,WUM9OL$!H^C.;8F(8Y=\W%DC)A@IW%:"_'-,N>C
MOOPG<!R-=;M56HR\,X5'>!_8G.QKL<JK.&VUT;6:O9<@N!3-MCJ^[0(^ C!A
M,\X#]_?8?KH HUAXKF%--8R\6F@=;T:?[?[=((JCWD&+.X+?C7K>0'7Z9DWS
M13?VU[VRO[Y?J^ZXV#\KC!^/J8QTXG;.0%"-]<&!YJX7&E\@X3V,&;NP9>$>
MGEE71.X2I"+W-QW3D^>8,[K\ V,MAR[^LAW-2%35XIP6=E'Q,U]0H)-3S0^+
MFA2Z'7>N0(__6;((9Q+Y^$&P(24C&:?&-8:96AG)X)3]R&L5U7U(+: !LG.]
M/4*)%#2G&P<;D+I/>\&1Q5D7=WL4%J;">?[MF8F"&J2*S.%SL\'4[.T[_$LR
M)^V!T4;H*U=0\<-(M.ZS!,6>37>1^G Z2[PA4]-?,-Y'J0@<)@E[M3-'KWC!
M'1*5AJOQ$]XQC&RI-8XVYD@/UV%9N31[CZ(_$P3GHV^"K:$YG+#>9;<K4&<W
M.KI@ VE=#H<4:FKB8(I['HG2.&[;*S4$39P\LC5GWOP,Y$I!+\WF&"UJ8' Q
M#"X3PHO;67MI5L(DS'J4IO!RV A8J*RN#LO9JDSP8!1TB8M767P4Q_Z&A; _
M"!/&:T&L63T[[ D>+IUU7;5AIYYM=5Z3:9,96V/Y-)_WO2FHQ<RE? 8L*:*L
M%D9%V^E!N[Q39EKQ-D_E;);LB8LRT97WR%OS*>=#2V.\Q W?Q".&YBQ7]WDK
M>\FOI'M -X^Y@::I+=!-6&25C^[EB@6X;!S5B]R2\0: G>U+2Z5.BQR5=3IZ
MD_D/O/ND7OT@H"/4$F!ML+@LAB)1BFZ+P W%9U([-^N;B%4W<FA$N\U6/#SS
MS;#FUJ'% ]*B#-:=+U"F*)80M]0O#A!-$YY=JY<Z#!8= XJU\M.KPX!7>QT9
M\B^+Z=JA:4Q.X9*K5F&C5FP@5J@O[5O7T<:J/"),:3)GMJ[N"M$+K5&:;TCE
M[I*!-%/)12+<W'FDRZA-HM6BNXW27N?R(1(]H]E!C*@]$0..K-G"+Y8].6ZM
M3N(JQ31Q&=G2SICJVX(#]7H"UQ9759$,ZXHWGEI>&C_BD VC[>JAS1>P93QD
MMQ12#SH)4PTPGGS$U8$Q[_IMV/,FW-7:)H,F;#4VX"@S?D=6;'[J/TTD[\ B
M&$%>V*&ZJ"J<M-J[\<7+_V1CYUS%SOE2#NC]1QL'],8!O=8K]]WNX]4;_4:\
M:E>SR9JH8?0;M-PPO>'28A]*SF;FK-@ZX\*6LC2"Z&_[G%'$8W:)/KJ6#W._
M\WK<[)Q^HKK#QR@PZ?Y!M:+( DY.3?^"5XP.B[H4/Z1W9O11=0,/0DT@EVPW
M^BS'PP5[]=JYO"M7[//XK[[;7776W?R;)BA'+:$SYJ*8X@&)5[Q0OO_@!S\-
M:VQZ3$LO/Y6+XN!=?=C&TW;H'*_D6>#X_E83>.HZM<A,T91;LE0'#K.X<F3J
ME5#@XJ=)"]</+F[F%<J$3<M8B@N>7!K16,EP[T<<=R8D*$S 8$Y:-7;CH'C0
MI>NRAHMBL,I',?>"?UEW!]R<UZ'/XX<=R\U?V ?U"UZ;=V'_T>ZCU4+FLPAL
M97"DL9968*^2S<QQXLRY'WJ2I-JFI8IRLKUS,J+$7I T8GI)>X)3-@QUH?K_
M.-HZB@LR*EI/VQXT]H:KM%BQY3:S@),5([, $:X;Z,)G:<,BH6E :Y](KZXP
MLXI@B;-F:A?TN,(GP?8GE\L+:67$#G+5GT$VO& <<YS.@@FO8(_R(^:*ECE;
MZ>KY5+.U=_56C'(=LW.50T9:JF9<0*WMU.GMU.<@A+OTR[M [;8GI&<'=:FA
MA8GX[%?RN-T2LC;M][.ZV@&4^0WOS/(VT+%M.-<^-=1Y$&;S=)0\*0?H<X3;
M@G[]VMG*W"X%?_;?19\G* G"53:FMK)? @R+L#E)U!%C%;V75 R.KDCP1720
MLDE<,Y+H994341F;;'?1WCA"IDE==+<-_0TT 2ZC'L1#ITL)8I43>:S-JQ"I
M6A-\?J&>-7,P+?)A-(EGU@8N2]9Z_LA.[&626-_M>Z8J&X 5[M=I875-T2;_
MF/-RH+L"T3IJ<N\U?/N.]A;G;;<H6]$[J?91-DRM2B^)K N3@(*=TY_G6(E=
M&K$'9CK4\O/6)N#U$:WNQ&8;O93[<;O3 >EKQRA0M+L[CU63G1HNZ")4[X)W
MDM4+ %6M]C%?X48FU9\9:5&@1[D#,-T"=QX(8%JBV\6"*4W'.C&T^6D]9USW
MA9%=0\'-N:)B&K/5!,!3UWY3GZ4ESV40<;,/W4A:[YY0$V9A4=#78L>E^<P6
M:W&W>]?9:*^H_R>RO]O]X.!DROEPT5@;F5B%'=ER,L1Z;E>VW8 K@*:T&=1:
M75;A/KX_@<'U21)WHV>2T--3A[S+0D!3*\@OJ/6]N5NBI4F0*-1X0:= VAWR
MD%S]$'EH4I J/"5S 8$[I ,H0AP=@X+:!,G(KBVJYD<;Z8FMQDGME<E'5:8'
MP)@C-RQ0(6&A2$121]C4\<P+B3*26IB9*=<7(DD\S7+1*O-6M^SGI!C5+.%&
M+ 5.,4,%<G!5P>4;!M"GA<) ]'4$J&@71"SUXBF(C6PEGF9Z.(?'9C&A7<B\
MLUUD[ H@GKGR_?PQA-32H+*\3)HR19DV'T/0)<CY$2WQJ=$" ,W,<VJ4#LBU
MR$@WV3YJ^"797W7!%Z;)A%9[F(]I_]JO<Y!7Q"E2_(*J,N!XSK00_= "_E&I
MK\9@H=O'L#CG<A&B130*I/"=FC#%BFW;H+_:O58U/E?FE,PG!MLMX7$/.]5<
MY(<I)?J'9.X<T;B_:*5DM/1K[.5\E;1(,1T\!4]+/L0[(29SYU(7Z+8E[_FJ
MO%E!'L-73#C8W]O$>S;QGKN2<+ .$^N1DB)>9F'X<*,?'G-J$%=LM?G,4U%8
M>O/8F#/Q G\HVOMF6UROCZ4YZ(JK"M5?DWOQSJ'EU^>,/2!U9M2KY/2EI^NR
MQOZR^L=S+T0)L'&/EM""[*4>>5BC?-4S:>E=UJ\L_PV!'FZX#L%]K%NP+TZB
M8S$@$, 2@.H%[JV;FZW//*@7";2J-[;JWZUP?7W>R?LO\XH]%_3^^X;7T8,^
M)UR/-YY7;#4W@/[S):JL&G'=O&%'"JSK0TV5GIJJ4*H=_S8P$_;=: -_J)<#
M_UE<EV-7+-9R848?DN*$V13%41560N"XKIGEPWO%>'B=X@4!]2UL0.:^E2SJ
M*BF,]^O05$L$LB2^4Z!2Z"Z]\@@EN8O*OJO8D@$<E XL,M!18HG,IA%,V91L
M8C'I#9]JL(KT^ PK(VRP>?<J!VD=]3G('+(UK8^*J2*JSI7CMLVST)M9J\E(
MQT*D"^_("4>!$1'T/(%<C6M6<%I1<4(2SOESO3OOD2197_U]AK"&U(I$_Y6%
M-.^RFKK$3OX%9*GP[[-_2@+Q ZGC-31DYXZ-SZA*S=&WQLJ%C4BX5R)AG4(,
M+:W$^?.E-I)4/>&B#!PJ*\RB'J;)2?3<U!5D IE?]^CE7;^<0$L-2$K?Z2C\
M*DM[++] ;A;I^F]E,D?X_B72+[.SKTE7LK^_\1YNO(=WQ7NX3@F"HT*CC<*7
MF1>5BR(?2]WRT(TXP&O)K/0"!'51TN.J<+%IA-2!7A H@I6C%[9[_YV ZS/(
MOV&F/'!E(#440G'$-.H2KXRKEFMPH-1Z].U?=9&4XT0\=1.F!BL7-5+>-:;8
MEM KFMPH1?=**5J7PGHL&@X=UW%9,GK!:4J->P:O>0=F<G_TH>LQTHI.PUGY
M#DF\(B49KV9=S?*"(ZX;P^2>O8/K\%4>D\I2&242<9[^KG.BCU2=86\EB,K9
MY6 9SAG4Y@!'H MASDIA?V#/J&1'<!TB(,)46_!1: IY*S3=H(E ='O6Y1C?
MC=Z3+C@WLT(4!'A]+^^^6=G_<&88LM>>K_,ZHO?/H)J.S>/(E,]#J-SE$?Y8
MF!>\)!5G6 F'>B5JBZ+'CIBRP>;4 #WF5X:GIQ4@VJ"QHFRF5A02O%JB+/((
ME_YJW<X],W>/).CZO)W'L[Q.P=9\)M34@0SU7<IP& W-*)_#TW-* QKCFSHS
M2(0?&8;2]_!@#RSM5S(&W9C+.;?,6NZA9<]3&\*OH7'4T+O1VQA J($21*_H
MBVMXT-\MEU90&-;M.$H;>Y,@T)[1+#',SN#8E)N2=?"]C_(LGY-QO:B+!0K8
M,W9I[!-82_]<NYJ<@/=-04J,34I:'&Y8D"G94H[P^D*NT6N&ZZZTOV_\AAON
M^]HOSVL$/[*R2$!E/T:0]R;%PI?KZQKY*?K7&[\K(C,N[HAU3K!7(GK4[UT)
MA-P^0K%[^P_W?GBX_VC_L7@?ONC#?=?)YP(ZK+VN70&]^6_WO]@_W^O^^5Q8
MF+67\!6T&CH)#EX.!&KALGDM$RWR.E85()1;'I8/H^?%;O1O!?A/Z7%LWEQ=
M**V[=?'H]7._"ZXF4Q@Z'U^KYIB:HG^5G*-YA;>VZ_F\S/E\P8U7<DD_WKBD
MOYI+^NJ+?HL=U=:;^<-UO)D_'OYTD*4T51D]]!P&399T\%FK'OWX?_KVT\5B
MP/;Z>[HWM%X>[>Y=%W=V3/;8N$[99WJ09>:CN0&LV8W"QWJ'?"W]=/T)DX6/
M]O[UX/_]X>G!VQTRDP5]>*-R_V87F5=5NWQ\B(2%/*WA%M^L\45KO,\3]M+5
M+.LK6<: .@\U?NMW@0SJP-80BK-10A+6KR&4=PG[KJP>K&D9K%8;UF[P2NK$
M-QMUXBNH$[=HDQPV\AQG7N0+](C4[$,G._GGEO"\L7Y\G=W_9+/[-[M?3SK>
MWI]VU'GOQ]__IBU\\KGRN5ZAQ@3Q38ZV2?+AU?-W/__O/V![_&/='ERR3RY7
M5[IZ_O[>[F.^E\_;SL][WUP:A3@^FP_SE&9EGHS'>?4T., _E\OS77QBQG'T
MLLCKQ6 %2-@4;.GM(%SV][^]RT'"44S]5#UMY<TL+N;QR-0\967T"N^F4";%
M*1C"4)Z@C%XG8/3(DGK>N6.+G3DEC+-*8E5@&Y@L8V9T1*4>A3F?5'__&W@1
M;'&;[Z/CJF8"#-K,T0?JH]G&9F\K01<!\2[<%6+,7F63;?;UK=O7#=P:"3<(
M5X&&>HGL]K(>ELDX(:E'6_M*VYBIJ4%G==$^CD&/-668-B!JG(<./NL\+#KS
M?33+ZZ($4"I:&G.R?2LV[-J2_<KG[U=YC'?ZK'?1P\/?G_\?HWE_?O?ZUY_^
M?U!+ P04    " #80Y57D#.81SUA   )< ( $@   &4V,3DQ,S!?97@Q,"TS
M+FAT;>U]>U,;2;;G_XK0=ZCU[DQ A(S!KVZW/8X5(-NZ%X,#</MV3$QLE$HI
M5.U2E:8>8.;3[WGEJU02LAML9&GBWC:(4F96YLGS/K_SZMWY^Z/7[=:K=[WN
M(?P;X/]>G??/CWJO7SWB?^&OC^3/K_9/#O\(SL[_..K]X\$H2\O?@KW=:1F<
MQQ-5!,?J*CC-)F':X0\ZP9G*X]$#^")\]8/^WB3,+^+TMV#WP>N_IX-B^O+5
MHP^U1Y8=^F5@!H-'=U\&I?I2/@R3^ (^BE1:JOS!ZU?[KWOO/QR=_/&^=WP>
M=-^>]GKXTZM'^Z_O>.9;?KV=O3BEGY[M[#Z;EOZ<?U9%&8^NY<,X'2J<XPD\
M]^#U^3@N@MYDFF37$_BXW>I>Y$KAC\%6.5;!WY/AOZOL)6S4J_YK\[=7C_JO
M<9/^GM-?MP,8A%Y,#8,X+;,@2X-#%:G)0.7!WJ^=X/'NXR=!F X#-1JIJ(PO
M51 6038*_BM,JS"_#O;HF:<-D_;T-]JMP[!4]:D[P>":1AZH\DJI-(!O]=^_
M_WC</^@$_>.#'7RX$X2PGB2\"G,51%D^S?*PC&&1L],=9)-IF%[/3H-SP"/=
MX\/37O>LW3H].7H3O/_8>W?4.\4GFY;^1445+GUVM*NX' >Y*F(\C#A,@G X
MA%]I3UZ].0%J= CBX2B<Q,GU;S==IG^^>H1??3U_@$]Q>C&$_R\>O$YN?/B&
MV?XE ^S\>"J^W=OT?.?9,US.-RSDT[L>4D<G %IHMX26@B&<,QPN?!B6^)?
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M/.2)9](,.0V+<R@PA4OW'16>Q/'1L*0*.,K$P39H"3N4".Z!JW0TX(.E>WP
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M'\"*V(:R$[C9O5J[B$>(OD7XLAW*#-99C#>.;S*3FV8 >P.,.7%@UN$+3=K
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M".9.:)\L;!JY\QC!=(?LN;55CX6U%@N_@YA#MW.&&V#1)F?0<#8W"DF$AK7
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M&VET3]63V$:AI-!9[#C*+HJU ]'H)H6ULRB+D\TKKW2*/'V4 (\UF^C1!%E
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M+=,ERJ1CFVH63.]/,!Y1;',@@0+TM.W:X;(3O$'O2I4C+&ECHQC;_*6^2@T
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M@3_93G"ND00[?'TDZNR7'>F(LX1[^,M#QV(D\IC77CDN\/XD?*0IGZCUG'%
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MO\3+M__5_NC1XST]S1G)HF=TK3D-7^XE_^3VXM[ER8#P '6,7*4Y^LF?Z0P
M?O,@N6A.BU)83(4(9L$>BE&<Y0JW# UWAN[*,/ZD/F,H-! >_$53)L]@P#M2
M57>1E=$[\XFO4P4TTX Z=9:9+SFN!(\,^&D$R.-(+G$;6@O9-7$<*3[(B3-$
M[H6BX!DBP,!N8F0'FM/$_9&%^IW)0)$C%&4_D<)'0W1+YCK-WSVW9Q!QPN,)
M'F=,C2-Q;9-Q39#TVXE10=RAT]+GN<XN]D$\FYK%)+OD#DFY\4VE7.[.>_\.
MQODFLZ19P9L4OD(LOY)4/"A3.TOS5FS4AB:YYH1<4O(7J3VEW^CUA1=FPI&C
M=-?NRKNF/AB]<\P"-7KZ /D O5]F7)Q:2:69VMK0)N7DP#:Q6*XL[1P6B ;)
M8BX&VJ3LC-+>(H(I!),N[*5=7SIX@1L5TS5 I%HF_!SQ.*FU!&E3*O2?E69I
M&?C<^JBD,SZHILW=_^[%]U>_E)SVY.@D)PV]1SEG<"))2::!=,N @:'@Z"#,
MK9%2@N9337Y2E2 MHP'JJ%*\>NE\P3.3YC[4QCDX4#PD%PHCSJ ,3(NSG%OD
M'V=X?1D" H5"H1Z6%H4Y.WG ;MJ'E(8/%4?Z<AM'VL:1;C>.].[.AEL*!VP*
MTAO29Y0::9TJYH1RI!JMP=2UV<4KC24!B/S40)'C4)*P:Y1UR*UQE->D"YQX
M/2?"I3B"=LG]4_2SW/>S)5.GR[ED-0#D\X2Y;T#,?!K!H/>9N'-#OJ2>5>ME
MWK"" &E0VM.4]#.G Y %JQF9?00>BRM+$JE8TG.F)(&R8N6E;)3Y.@V2/<&!
M;($V7[(F<%GPIC8G'#*M.?<7YO?[P7C<EHOQEM3.3\7]^&%=]YL@_([-7-C;
ME  B>27YQ,/U"$BT3Q8Q>\(EJ#O/M\ 'W8.8%?2 G6T<K1]F:S#YN[%U\$U]
MW@J;_+H*R1,.\LH=Q/@19"/Q!54Q=U0, @P[6*U*JVGQR6NHA)5<^6IAZ,5:
MRF4X9$=TLY,-,E5 ]YDY(PI<XHDO>!#R[OF0"6>/5&L*>O30DGG!O!-S'9#.
M-8NKE>2).O;43B;,W6'$NQ']$CL33RT3B)*H-@%EP'G(HM\"!@20Q_;<>BZ'
M!S"PEFEE![A6*\3M/? @P/M=FR@"^?HKL6#X6!<@> 6$K#9.5Y2R3Y'H@A_<
M#;#VBIT)ZHI,%=E@PNVMMP$G$&WND32CPU(_:&Y3MH'&),*6-N#E;TL2M#;?
M4"4)E]G:7I4#R$XZ/;* ,-0@(386B5LI=E>EV"9T4B^6+M=&,EV4A+J#PX:@
M.O3"P79 4FV9&RZ?PT R$*,AT= & 3':\68L16Y&=*SGZE843N_Y /<0R03X
M)TB86D"PREII@'#''TQE%5 K.8T_[&>3CU/X,F-&ON@9>G])YN_K9F$EJ#5*
M?F38$W@%QY"7XZC1J3<7+)-%G;%D*MF9>1(D54[95LF;TJ57HIX6O@>;P'_$
M8\M<! =-!:&53A7WUIL)GKJY%>(DE9-*LI5\\W5R_^$#Q[$5(0IX-=/<<1T\
MXU1!_-VM5&0:559LR16?V)KR;.9E\@RLY1S1I&<NJN2/@F4LG,_'4FF*]T0N
MDTE7A+%$TNI)#&<:4N0!'Y4GF4Z\6[<?W>[ %R=.+/.F[(P4O+W)(T\JEM<S
MY[56A2S>-&MVE[(\T'Z0)]?-C U4H:GR)M]<Z<;F*;QJR1(5;^X2+^[FS%"_
M0H21MF5':W#S(!DO[;292+)57=0=$JA! TP=K<P<NRI3%F@<_APY5W&5UDUT
MOY/O['U-"RXP[ 4X0I5O:Z^IJ">S3O.&!#ESH$=$C4'OSHHFF\(6I#U%JD)M
M0BY)?>83NJ76[%:R+?.*D8I50S.!E$"0D]E9JBY?_P$15/&+4A].X,O 7!4Y
M3%ZK<^9YD+3(U0+D%/")0L?!:9-9<^H\P5TJK,ZA\$(9G";&K59L\]+#P\)(
M0SS"F,32,+$&&?#44=:NJO0M'4?VI/H7 L:X09=/ \V<5T)WMF'B_S;0R4L=
MP]1.,A-O!AX]?]$=#-=>AMWNW_T7F,=VU=77W]LCX.9"Z:08W"H3 >_S'+#5
M-D1=6J[@-XC;_%#^Y<=;__+6OWQ'_,N;T#H=T7O,#@<^PDFM[/B1H8KX)'&H
M8DP'>ESD>6WFR/=^9J%UX.^8$+2D0V]1&N;'</ F04C=?9_NC<B82BXGEQ<,
M_*DS$0I<URX0F9".!>_.)0D:#E[2M\>T/.8<4*4&G!_) N<0?=$2(P8LD;AI
MBYB_36#YEQXQ#WO+EBX3=RH<"IFW93Y?[+P.\04H'MFU#W7K&;)/8;B*UK6%
MT'_R'HQ-(/0'[+XK0&V=G @%$MO)XL(.-WVEGMT6U2K8V3Z'<LY@H7YML27@
MMS[Y?+(0@036(@ N?J*M=V+S':W/9^>L1[JGKRD6(# HRP"O7*A&PG8!WH27
M<2'Y>X [E8%+A0UGM7Y='1Q48^YW79&Y7"0L]9@U.J2UWH#8[$!(30L.QBX]
M=$L*SQSVPJ#.<N]#O/@1!O7*X 7"U),902/,@[5)N-PS65@6G?JQ[04@=4;K
MTK"8!@2M%(BQN$:"!<[]K"?#TR[S.T@<'76@,^^N K@=FDLW8+/T/@[>&17^
M]!AH?K!ZQ*C%/^E+.7DU!=+D,WB3<0MI.R?,H$UK %!VBRD<WHAWR/^P>7;(
M$6?DL]'H=1.:IKI!X3,X)544M*[PT0"_[\J<#QC$BJ!>6),!+$8["^4B=IC%
M8((81ML\%^I-QTV$C(J:DV@US5EZFDX!48MOD>8<GDJ0WO WG&)K>7:&%@+N
M/!AM"XRI'O?',4KHBB1+:=NTE9WCANQRE17GMOQ7%;7I+F[G\SI30>\>A^V+
M,_%>,*!+?0[F1.!@;3S=N7GH/6;/2O1\$+%6E>B8<!LB7[.2B8S'SL_J,#>C
M5SPG.HIH;0>0\-XYH9#X R[=Q*&9VKS%%N$.2EIKA;;/!57O709DNI'@&5B"
M+6C@SH9;;ES2+LSW \ZQ#9HL$^4PC>(6Z3*27U7JJS9895!4D8AB$M8Q[AR5
ME:DO=CW+HJ@OKTGIMR<%^^E5ULVYA)) S>&D)QE7<<3"U+55<48O2<JI'XB2
M,)#@C9E;D;T!9YN$SRM2""!TPY!(S ,IXHZU@8M& P)5Q3[_PQ98;X7$:&4@
MHL$--B8SGE2BW+I8R!V2A[=>IXX=FNERW,"ER7'O/'*NJW/<"2[[%E[LEB>M
M1\??XXA\[2XDM>W49FT+3.43/][,#;*2$A)(2ZV#H AL Y\R%_,Z!1/H?%&'
M%0IPYAO&A[.TIR[!9\WI%F,&3M>95&@U2=8L5TG5+,-R3"P"?2!<)2#G\U=!
MA2@<]4)'\)YX*K?']B=P;&]4;:YK(6J8/*!VX[ FS#-D%<DQ'I_>$6U;IVQH
M<"Q*O/5U6J4GQ<[/\,]4D14YF&+Z>&]O=V]O;[2W%U<L?5.0%04K0W)E.@_Y
MC0V0*UN7J?AZS2->Y*2GIM/4,7'*XWRCCG %=CE7S:NK@/LE,L_Q$M:^U)$K
MD1W54H4Q]!IA761:Y%\H+*&9<T$^MDEKCDKS(U(85._&"+?W=Z*$.Z@Y$V2:
M5A/$,+OF$0[8U)5,65,-+TP)71,V;#@7RR1E6IW0.3P+[8550:+_/!E,<GW,
M>PU[SOTN<+,"Y*Q&+1%MG--[ )ZHK]>XW]%KGY!6AHOR,6;,A8LEE*S\,]T'
M#=3D@?HDOG*6NRXW2.938L&3U)3G7[1_O[<B@+<M>CZ=-^?C<<E]M8W1;F.T
M=R1&NR%V$(@R\3H/,G:WDAZ L]*>U)&V(5H4>T=[>= A%^Z7>\DX.3JNG[<N
M\%XZL=:VI!^":HF>C0XI/VH^BM+!AB=NZQ2C[(/EW@'^?>U#\;.+'&^.$AO
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M],N22VUUK,<>>G;RWR:M4F=93F3:MLDFG[QIN$FRB6=#$]RJ+04Z>0'VZ#P
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MF+.4;VM+@ZP#PP!'9DCHTLV<QN=DJW4"<-VP@84K@6N1@?>Y>C +\)_'16?
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MU+D&)5NA'U,HR:$^WL!)[#DS_@JU0^/KC1P82WN&4%2  R2GB6CF6 -+H<I
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M\>DEF+\ QX8]H@O*P;>U0!NF:GKY&U!+ P04    " #80Y57R=1UI_T*  "
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M'&PN7]3J7"Z3!C:VIO<)3\MV%S^5.%B$3(<#*<K#D(KS1%+M-D0/0RVE:WH
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M !(              ( !WA0  &4V,3DQ,S!?97@Q,"TQ+FAT;5!+ 0(4 Q0
M   ( -A#E5>&[4C<F60  !]" @ 2              "  3YV  !E-C$Y,3,P
M7V5X,3 M,BYH=&U02P$"% ,4    " #80Y57D#.81SUA   )< ( $@
M        @ $'VP  938Q.3$S,%]E>#$P+3,N:'1M4$L! A0#%     @ V$.5
M5S\PBPXQ8   !"$" !(              ( !=#P! &4V,3DQ,S!?97@Q,"TT
M+FAT;5!+ 0(4 Q0    ( -A#E5<?W*_4)0,  -<+   1              "
M =6< 0!I;75X+3(P,C,Q,C$X+GAS9%!+ 0(4 Q0    ( -A#E5?)U'6G_0H
M ("&   5              "  2F@ 0!I;75X+3(P,C,Q,C$X7VQA8BYX;6Q0
M2P$"% ,4    " #80Y57VZX"!U$'  #-5P  %0              @ %9JP$
K:6UU>"TR,#(S,3(Q.%]P<F4N>&UL4$L%!@     (  @ "0(  -VR 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
